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Order Chiroptera is oft incriminated for their capacity to serve as reservoirs for many high profile 
human pathogens, including Ebola virus, Marburg virus, severe acute respiratory syndrome coronavirus, 
Nipah virus and Hendra virus.  Additionally, bats are postulated to be the original hosts for such virus 
families and subfamilies as Paramyxoviridae and Coronavirinae.  Given the perceived risk bats may 
impart upon public health, numerous explorations have been done to delineate if in fact bats do host more 
viruses than other animal species, such as rodents, and to ascertain what is unique about bats to allow 
them to maintain commensal relationships with zoonotic pathogens and allow for spillover.  Of particular 
interest is data that demonstrate type I interferons (IFN), a first line defense to invading viruses, may be 
constitutively expressed in bats.  The constant expression of type I IFNs would hamper viral infection as 
soon as viral invasion occurred, thereby limiting viral spread and disease.  Another immunophysiological 
trait that may facilitate the ability to harbor viruses is a lack of somatic hypermutation and affinity 
maturation, which would decrease antibody affinity and neutralizing antibody titers, possibly facilitating 
viral persistence.  
 
In 2009 and 2010 two novel influenza A viruses (IAV) were discovered via qRT-PCR using pan-
influenza primers in New World bat species.  Given the unique hemagglutinin (HA) and neuraminidase 
(NA) glycoproteins compared to those already recognized, the two viruses were classified as H17N10 and 
H18N11.  H17N10 IAV genome was discovered in rectal swabs collected from little yellow-shouldered 
bats in Guatemala, and H18N11 IAV genome was discovered in a rectal swab and gastrointestinal tract of 
a flat-faced fruit bat from Peru.  The entire sequences for both viruses were identified using next 
generation and Sanger sequencing, but the virus was never isolated from wild bat populations.  Both 




function of NA remains undetermined.  Given the divergence from other IAVs, the attention bats receive 
as reservoir hosts, and the lack of isolation of wild virus, H17N10 and H18N11 remain shrouded in 
mystery.  Reverse genetics was used to rescue both viruses and we performed experimental infections in 
Jamaican fruit bats (Artibeus jamaicensis), drawing upon the colony housed at Colorado State University.  
Evidence for H17N10 infection could not be elicited after inoculation, and thus it was concluded that 
Jamaican fruit bats may not be susceptible.  Bats inoculated with H18N11 seroconverted (determined by 
ELISA), had viral RNA detected in rectal but not oral swabs by qRT-PCR, and had viral RNA present in 
the length of the gastrointestinal tract detected by qRT-PCR.  Hematoxylin and eosin stain used to 
characterize histopathology revealed minimal pathology that was predominately localized to the 
gastrointestinal tract in the form of neutrophilic, plasmacytic and lymphocytic cellular infiltration.  
Furthermore, two naïve transmission bats were exposed to inoculated bats and demonstrated 
seroconversion and viral RNA detected in rectal swabs by qRT-PCR.  Results demonstrate that Jamaican 
fruit bats are susceptible to H18N11 and indicate transmission occurs fecal-orally.  Tissue tropism is for 
the gastrointestinal tract.  These data recapitulate transmission and tissue tropism as seen in the reservoir 
of IAV, water fowl, and low-pathogenic avian influence viruses in gallinaceous birds.  However, this does 
not indicate that bats may be a reservoir for influenza viruses as H18N11 is not known to cause disease in 
humans and is highly divergent from other IAVs.  More likely, this demonstrates an early divergence of 
H18N11 from other IAVs and a long-lived co-evolution between the host and the virus.  Further 
investigation of H18N11 may provide information on relationships between bats and their viromes, which 
is of great importance given so many bat species harbor highly pathogenic zoonotic viruses.   
     
The impact of Zika virus (ZIKV) on the New World has been great—infecting more than 200,000 
people and manifesting in some patients as severe neurological complications including microcephaly in 
infected fetuses and Guillain-Barré syndrome.   An enzootic cycle is implicated as an important part of 
viral ecology, yet little is known about this cycle.  Historically, different bat species demonstrated 




positive tissues.  Jamaican fruit bats are endemic to a region that temporally overlaps with the distribution 
of ZIKV in the Americas and Caribbean.  We sought to identify if these bats were susceptible to ZIKV 
and conducted a time course study to delineate progression of viral infection and pathophysiology. 
ELISAs were used to identify seroconversion.  Quantitative RT-PCR and immunohistochemistry were 
used to determine tissue tropism, and hematoxylin and eosin stain was used to characterize 
histopathology.  Jamaican fruit bats seroconverted post-inoculation with ZIKV.  Evidence for virus was 
found by qRT-PCR in the brain and urine for ZIKV infection in some bats.  IHC revealed positive testes, 
brain, lung, and salivary gland and a trend toward mononuclear cells, macrophage and fibroblast viral 
tropism.  Histopathology was seen in the brain, testes and salivary gland.  Based on these data it was 
concluded that Jamaican fruit bats could become infected with ZIKV.  These bats may have a role in viral 
ecology.   
 
 Tacaribe virus (TCRV) was isolated in the 1950s from wild artibeus bats captured in Trinidad, 
West Indies. The initial characterization of TCRV suggested that artibeus bats were natural reservoir 
hosts. However, nearly 60 years later experimental infections of Jamaican fruit bats resulted in fatal 
disease or clearance, suggesting this species is not a reservoir host. To further evaluate the TCRV 
reservoir host status of artibeus bats, we captured bats of six species in Trinidad for evidence of infection. 
Bats of all four frugivorous species had antibodies to TCRV nucleocapsid, whereas none of the 
insectivore or nectarivore species did. Many flat-faced fruit bats (A. planirostris) and great fruit bats (A. 
literatus) were seropositive by ELISA and western blot to TCRV nucleocapsid antigen, as were two of 
four Seba’s fruit bats (Carollia perspicillata) and two of three yellow-shouldered fruit bats (Sturnira 
lilium). Serum neutralization tests failed to detect neutralizing antibodies to TCRV from these bats. 
TCRV RNA was not detected in lung tissues or lung homogenates inoculated onto Vero cells. These data 
suggest that TCRV or a similar arenavirus continues to circulate among fruit bats of Trinidad but there is 





 In order to make species specific reagents and expand laboratory research on Jamaican fruit bats, 
de novo assembly of the Jamaican fruit bat genome was performed with Soapdenovo2.  The final genome 
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1.1: Introduction to Bats and Family Phyllostoma 
1.1.1: Bat Evolution 
Approximately 65.5 million years ago (Ma) there was an abrupt decline in species diversity that 
marked the Cretaceous-Paleogene (K-Pg) boundary.  It is generally accepted that the mass die-off was 
from the direct impact and subsequent environmental changes of an asteroid, ~10 km in diameter, that 
collided with Earth in what is now the Gulf of Mexico (1).  Mammals as a class existed prior to this 
juncture, alongside dinosaurs.  Molecular clocks estimate that placental mammals split from the basal 
group of eutherians 80 to 100 Ma during the mid to late Cretaceous period, prior to the K-Pg boundary 
(2).  Based on combined phenomic and molecular parsimony, it is hypothesized that a single placentalial 
lineage survived the K-Pg event and this lineage radiated into the 18 extant eutherian orders during the 
early Paleocene, 66 to 56 Ma, including order Chiroptera (3).   
 
Geographical ancestral reconstructions suggest that bats originated in Laurasia, possibly North 
America (4).  Phylogenetic analysis of cytochrome c of 648 bat species places the origin of the order at 
58.9 Ma, during the Cenozoic Era (5).  Another study estimates a common ancestor of 64 Ma (4).  Yet 
another study used molecular analysis to support the hypothesis that bats evolved from a horse lineage 
approximately 88 Ma (6).  The oldest, most complete, full flight bat fossils date back 52.5 Ma (7), found 
in what is now Wyoming.  However, it is generally accepted that the fossil record is askew from the 
actual age of species due to a limited number of fossils found.  The bat fossil record is sparse with an 
estimated 61% to 88% of the fossil record unaccounted for (4, 8).  Regardless of any incongruence in 
dating the age of bats, the scientific consensus is that they are an ancient order of mammals.   
 
There are currently more than 1,100 bat species on every continent except Antarctica.  Bat 





Yinpterochiroptera and Yangochiroptera (10).  Yinpterochiroptera are then divided into six families 
comprised of Old World bats (4, 11).  Yangochiroptera are divided into 12 families consisting of both 
New World and Old World bat species (4, 11). By the end of the Eocene (33.9 Ma), all 18 extant bat 
families had been established, highlighting the age of the order and suggesting that each bat family is 
distinct from one another as separated by time (4).  Family Phyllostoma is comprised of New World leaf-
nosed bats and is placed within Yinpterochiroptera.  It is estimated to have split from its sister lineage 
28.5 Ma, with the oldest fossil dated back to 16 Ma (5).    
 
1.1.2: Family Phyllostoma 
Within the family of Phyllostoma is the genus Artibeus.  There are 13 species of Artibeus bats 
with molecular clock analysis dating the crown ancestor at ~5.1 Ma.  The Jamaican fruit bat (Artibeus 
jamaicensis), which is the focus of much of this work, is estimated to have split from a common ancestor 
2.5 Ma (12).  At Loltun Cave in the Yucatan Peninsula, 1,522 subfossil bones were found in late 
Pleistocene and Holocene sediment, placing the oldest fossils at 2.5 Ma to 11.5 thousand years ago, 
corroborating molecular dating (13).   
 
Morphological phylogeny places the distribution of Jamaican fruit bats from Mexico south to 
Ecuador, following the boundary of the Andes Mountains.  On the east side of the Andes Mountains they 
populate Bolivia, Paraguay and Brazil north into the Caribbean Islands and the Florida Keys.  Many 
species of the Artibeus genus look similar, and the species inclusion parameters allows for broad 
morphology (13).  When phylogenetics are combined with morphology, there is evidence that the Andes 
Mountains serve as a natural barrier for Jamaican fruit bats, limiting the South American distribution to 
the west side of the mountains.  On the east side of the Andes Mountains a morphologically similar 






The flat-faced fruit-eating bat also inhabits the southern Caribbean Islands of Trinidad/Tobago, 
Grenada, and the Grenadines.  Where the Caribbean Islands are concerned phylogenetic criterion identify 
Jamaican fruit bats on the northern islands as far south as the Grenadines and Grenada.  However, the 
Jamaican fruit bats are not as abundant as flat-faced fruit-eating bats on the islands they co-habitat 
(Grenadines and Grenada).  Additionally, there is a third species present on these two islands, and islands 
immediately north.  This third species, A. schwartzi, may be a hybrid between the Jamaican fruit bat and 
the flat-faced fruit-eating bat based on mitochondrial DNA sequences.  If A. schwartzi is a hybrid then 
this is one of the few documented cases of mammalian natural hybridization (12).  This information 
emphasizes how little is known about bat phylogeny and biodiversity, particularly as it pertains to 
Artibeus bats.   
 
Jamaican fruit bats occupy a variety of habitats including humid tropical forests, drier tropical 
forests, and areas populated and modified by humans—emphasizing the species adaptability.  They roost 
in dense foliage, hollow trees, caves, buildings, and will make temporary leaf tents.  They are generalist 
frugivorous but prefer figs, and will selectively eat leaves high in protein.  The juice of the fig serves as a 
staple in their diet with much of the fruit fiber ignored.  It is published that this form of eating satisfies 
their water intake so they do not have to drink water (13); however, this author has observed bats of the 
Artibeus genera consuming water in the wild (unpublished data). 
 
In the wild the lifespan of Jamaican fruit bats is estimated to be nine years.  Females are sexually 
matured at 8 months and males at 12 months.  Females are reported to have a bimodal polyestrous 
breeding cycle with peak breeding season occurring at the end of the wet season and parturition occurring 
in the dry season; although different populations breed year-round with lactating or pregnant females 
being trapped throughout the year.  Indeed, the captive colony at Colorado State University seems to 





have complete dentition at 40 days and fledging begins at 50 days.  By 80 days pups are at their adult 
weight. 
 
Jamaican fruit bats roost in harems that contain approximately 14 females and two harem males.  
Harem females stake out the optimal territory for mating while males dominate and defend resources.  
Female sub adults leave the harem together to roost with a different harem.  Males tend to stay with their 
natal harems.  Sexually mature satellite males are pushed to the edges of the roosting space and may 
group with other satellite males and non-reproductive females (13).  
 
1.2: Bats as Reservoirs and Original Hosts for Viruses 
Bats are notorious for being reservoirs of zoonotic infectious disease, particularly high-profile 
viruses such as lyssa-, filo-, henipa-, and coronaviruses.  Additionally, bats may be the original hosts for 
virus genera Lyssavirus, Hepacivirus, and Pegivirus, and virus family Paramyxoviridae (14-25).   
 
1.2.1: Lyssavirus 
Lyssa is the Greek goddess of rage and furry.  The genus Lyssavirus includes 14 species that may 
cause rabies-like disease characterized by encephalomyelitis, including rabies virus (RABV) (26).  
Lyssaviruses are rod shaped and enveloped, with a single-stranded, non-segmented, negative sense RNA 
genome (27). RABV is the best-characterized lyssavirus and while difficult to ascertain the global human 
mortality incidence, it causes tens of thousands of deaths annually.  RABV infection is near always fatal 
(28).  The virus can infect all mammal species, but is predominately carried and transmitted by dogs in 
the Eastern Hemisphere, and bats, dogs, fox, raccoons, skunks, and other wild mesocarnivores in the 
Western Hemisphere (26).  The origin of the strains circulating in wild mesocarnivores (with the 
exception of skunks) is a dog-derived variant; however, there are more than 30 RABV variants associated 





RABV is most often due to bats, and the incidence of human cases of bat associated RABV in North 
America is 2.2-6.7 cases per billion people per year (15, 27).         
 
 Sequence data of modern RABV indicate the age of the virus to be 1000 to 1500 years old (15, 
27), but there are historical documents that imply the disease was recognized in ancient Mesopotamia in 
1800 BC (15, 29).  Old World bat species are most likely the origin for lyssaviruses, and responsible for 
global dispersion as they are the principle hosts of the 14 extant virus species world-wide (14, 15).  
However, presently, only New World bats harbor RABV, and serve as the dominant mammalian host in 
the Western Hemisphere.  Non-RABV lyssaviruses exist in bats in the Eastern Hemisphere (27, 30).  
Historically, RABV switched hosts a minimum of twice, once from Old World bats into New World bats, 
and once from Old World bats into dogs in Europe or Asia.  Phylogenetics dates the introduction of 
RABV lineages in the Western hemisphere to 1400 years ago, before the European exploration of the 
Americas.  Historical records support phylogenetic dating, connecting human cases of disease in the 
Americas to bats but not to dogs.  The dog variant, which is currently the most prevalent strain in the Old 
World, was most likely introduced to the New World in the 17th century when advances in technology 
shortened the time it took to travel to the Americas from months to weeks.  RABV incubation period is 
three to eight weeks, and so travel that consists of months could serve as an inadvertent quarantine period 
and may have limited the spread of Old World canine variants to the New World.  The first recorded dog 
epizootic occurred in 1709 in Mexico City, and the first recorded human epizootic from a dog variant in 
the New World occurred in 1776 in the Greater Antilles.  After that the frequency of epizootics increased 
and spillover into American mesocarnivores occurred (15).   
 
The prevalence of RABV in bat species is variable.  In big brown bats (Eptesicus fuscus), the 
most frequently submitted animal for RABV diagnostics in the United States, seroprevalence ranges from 
3% to 35% in parts of the USA and Canada, while the actual virus is detected in 1% to 6% of big brown 





which seroconverted.  This experiment recorded an overall 35% seroconversion rate of 43 inoculated bats.  
Humoral immunity did not persist and only three bats were seropositive 175 days post inoculation (DPI).  
Bats were then inoculated a second time and again had a 40% mortality rate and 60% seroconverted.  
Thirty-three percent of bats that died due to RABV infection seroconverted.  When surviving bats were 
inoculated a third time mortality dropped to 6%, and 27% of the bats seroconverted (30).  These data 
demonstrate that RABV does not have as high a mortality in bats compared to other mammals, and that 
seroconversion may not be protective.  It also indicates the bat innate immune response may provide 
substantial protection to disease and mortality caused by RABV, as surviving bats did not always 
seroconvert.   
 
A bat-associated RABV inoculated into grey-headed flying foxes (Pteropus poliocephalus) had 
similar results.  This experimental design was unique in that grey-headed flying foxes live in Australia 
where lyssaviruses have been identified, but RABV is not present.  Two out of four inoculated bats 
succumbed to disease and were euthanized.  Additionally, ten bats were inoculated with ABL, a 
lyssavirus isolated from a grey-headed flying fox, and three fell ill and were euthanized.  Clinical disease 
and subsequent histopathology consistent with meningoencephalitis and nonsuppurative ganglioneuritis 
was present for both lyssaviruses.  Of the bats euthanized none seroconverted.  Five of the seven bats that 
did not demonstrate disease in response to ABL infection seroconverted.  One of two RABVs inoculated 
bats seroconverted 70 DPI (31).  These data further support the innate immune system as a robust means 
of defense against RABV in some cases.  The similar disease pathology and results in both 
Yinpterochiroptera and Yangochiroptera may highlight the conservation of viral kinetics across lyssavirus 
species and conservation of viral-host ecology.      
 
Lyssaviruses challenge the way in which the term “reservoir host” is interpreted.  “Reservoir 
host” is generally defined as a host that maintains a virus in nature with minimal pathology and disease 





disease (15, 30, 31).  Disease and pathology is variable in bats dependent on the pathogenicity of the 
strain.  While bats may be susceptible to rabies disease they are definitely unique in that in other species 
RABV are considered to have a morality rate of close to 100% (27, 30).      
 
1.2.2: Filoviridae  
Family Filoviridae is comprised of three genera, Ebolavirus, Marburgvirus, and Cuevavirus (26).  
The viruses are enveloped and filamentous in shape, with a single-stranded, negative sense RNA genome 
(33).  Cuevavirus consists of a single species, δloviu virus that was discovered in Spain in Schreiber’s 
long-fingered fruit bats (Miniopterus schreibersii) in 2002.  Its genome shares a 73.7% nucleotide 
homology to Zaire ebolavirus, suggesting a distant relation to the other filoviruses and has not been 
known to cause human disease (34).  Ebolavirus and Marburgvirus cause a hemorrhagic fever in humans 
and non-human primates with a potential for mortality upwards of 90% dependent on strain (16, 35).  
Marburg virus (MARV) was first discovered in 1967 when two outbreaks in humans occurred 
simultaneously in Yugoslavia and Germany.  It was determined that the virus spilled over from African 
green monkeys (Chlorocebus tantalus) imported from Uganda for research.  Subsequent outbreaks in 
Africa were sporadic with many linked to caves and/or bats.  In the mining village of Durba in 
northeastern Democratic Republic of the Congo (DRC) outbreaks of hemorrhagic fever disease have been 
associated with the Goroumbwa Mine since 1987 (16).  
 
After a MARV outbreak persisted from 1998 through 2000 and infected 154 people with an 83% 
fatality rate, vertebrate and arthropod specimens were collected from Goroumbwa Mine to hone in on a 
wildlife reservoir.  Although not published until 2007, specimens were collected in 1999 and represented 
eight species of bats, seven species of rodents, and a handful of shrews, crabs, a frog and more than 2,000 
insects including crickets, spiders, wasps, moths, flies, streblids, nycteribiids, and mites.  A MARV 
ELISA uncovered one species of insectivorous bat with antibodies to MARV; the eloquent horseshoe bat 





ELISA results was supported by viral nucleic acid detected by PCR from both species of bats, as well as a 
second insectivorous species; the greater long-fingered bat (17).  In 2005, PCR and antibody evidence 
was published that inferred bats as a natural reservoir for Ebola virus (36).  Given the association of 
MARV with caves, and its close relation to Ebola virus, bats became the focal point of investigation as a 
potential wildlife reservoir for MARV (16).  
 
To date, the largest MARV outbreak occurred in Angola in 2005 infecting 374 people with an 
88% fatality rate.  The viral source was never identified, but an investigation of bats in nearby Gabon and 
the DRC found both antibody and nucleic acid evidence for MARV infection only in Egyptian fruit bats 
out of ten different species tested (19).  It is noteworthy that neither Miniopterus nor Rhinolophus species 
were assayed in this investigation.  In 2007 in Uganda, four people succumbed to hemorrhagic disease 
caused by MARV.  Exposure was linked to the Kitaka Mine, which is the home to an estimated 100,000 
Egyptian fruit bats.  Egyptian fruit bats and bats from the Hipposideros genus were tested for MARV.  
Samples were collected both in late summer in 2007, and spring in 2008.  Of the 611 Egyptian fruit bats 
tested in 2007, viral RNA was detected in 33 by PCR, and five strains of infectious MARV were isolated.  
These were the first infectious isolates obtained from a suspected reservoir species.  All Hipposideros 
species had negative assay results (18).   
 
Further support of bats as the reservoir for MARV, and elucidation of viral ecology was found in 
Python Cave in Queen Elizabeth National Park.  Python Cave is home to more than 40,000 Egyptian fruit 
bats, and it seems no other bat species reside there.  Two independent cases of Marburg hemorrhagic 
fever in tourists were connected to this cave in 2007 and 2008.  Bat samples were collected in 2008 and 
2009, during breeding and birthing seasons.  Of the 1622 bats tested, viral RNA was detected in 40 by 
PCR, seven new isolates were obtained, and 250 bats were seropositive.  There was no evidence of 
vertical transmission.  Samples collected during a period when juvenile bats were aged at six months, and 





versus 4.2%, respectively.  During a different period, when juveniles were aged at three months, and 
recently weaned but still had maternal antibodies, the prevalence of viral RNA detected in tissues by PCR 
was 1.7% in young juveniles compared to 5.7% in adults.  Based on these data it was concluded that 
Marburg virus is maintained by older juvenile bats that are independent of their mothers and no longer 
have maternal antibodies to confer protection (16).   
 
While epidemiological data and laboratory data identify Egyptian fruit bats as a reservoir for 
MARV, experimental infections assist to ascertain mode of transmission and provide controlled data to 
further support Egyptian fruit bats as a reservoir.  An experimental infection of five-month old Egyptian 
fruit bats used a second passage strain of Marburg virus isolated from a naturally infected Egyptian fruit 
bat.  All animals in this experiment did not show overt signs of disease, and maintained a healthy body 
weight and body temperature.  Viremia was detected from day one to day ten post inoculation, and 
seroconversion occurred after day ten.  In addition to viremia, the virus was found to have tropism for 
predominately spleen, liver and skin from the inoculation site through day ten.  However, multiple tissue 
types, including but not limited to, heart, kidney, adrenal gland, lung, intestine, testes, salivary gland, 
brain, and bladder had viral RNA present by qRT-PCR in at least one animal, suggesting, in some cases, a 
broad tissue predilection is possible.  Through the progression of the study, viral RNA presence in tissues 
waned, but the spleen remained positive, albeit weak, through day 28 post inoculation.  Of particular 
interest were those organs that might facilitate viral shedding: large intestine, bladder, kidney and salivary 
gland.  Of the oral swabs collected, viral RNA was detected on days four thru 14, offering one possible 
route of transmission, and viral RNA was identified in rectal swabs collected on days four thru 11 
offering a second route of transmission (37).  Experimental transmission of infected bats to naïve bats has 
yet to be demonstrated.   
 
The epidemiology, serology, genomic material found in numerous tissues, isolation of the virus in 





provide strong evidence that bats, specifically Egyptian fruit bats, are a reservoir for MARV (16-19).  
Given that some of the first evidence to support bats as a reservoir of MARV was found in a wild-caught 
eloquent horseshoe bat and a greater long-fingered bat in addition to Egyptian fruit bats (16), but has not 
been further explored, and in combination with studies that indicate sympatry—the inter-mingling of 
species—is a major trait associated with viral richness in bats (38, 39), field investigations in additional 
bat species may be warranted. 
 
Ebola virus was first documented in 1976 when two near over-lapping out breaks occurred in the 
DRC and Sudan that, respectively, had 318 and 284 cases both with 79% mortality.  The two outbreaks 
were caused by two different strains of virus, and given the ~2000 km that separate the countries, it was 
concluded that the sources for each outbreak were local and independent of each other (40).  In the 
aftermath of the DRC outbreak, more than 800 bedbugs and 147 mammals, comprised predominately of 
rodents, were collected in attempt to find the viral source with no success (41).  The Sudan outbreak was 
suspected to be caused by exposure to a mammal in a cotton factory but none of the 501 shrews, bats, 
rodents, a single toad, and lizards collected from this site had evidence for Ebola virus infection (42).  
Another investigation in the DRC and Cameroon collected samples in 1979 and 1980 from 117 species 
consisting of predominately rodents and bats, and yielded a single positive serum sample from a flying 
squirrel (Anomalurus derbianus) by indirect fluorescent antibody assay, but not by a confirmatory 
radioimmunoassay.  All tissues were negative (40).     
 
The sporadic nature of Ebola virus outbreaks, coupled with temporal distance between outbreaks 
hampers field investigations to determine the reservoir (43).  While bats have been incriminated as a 
reservoir for Ebola virus since the initial documented outbreaks, it was not until 2005 that bats became the 
sole suspect.  Between 2001 and 2005 outbreaks of Ebola virus in humans were linked to outbreaks in 
gorillas and chimpanzees.  In 2003 investigations of the viral source for the great ape epidemics occurred, 





were captured including bats, birds and small terrestrial vertebrates.  The bats were the only animals with 
evidence for Ebola virus infection, and this was the first study with positive diagnostics for Ebola virus in 
bats.  Four out of 17 hammer-headed bats (Hypsignathus monstrosus), eight out of 117 Franquet’s 
epauletted fruit bat (Epomops franqueti), and four out of 58 little collared fruit bats (Myonycteris 
torquata) were IgG seropositive for Ebola virus.  Additionally, four out of 21, five out of 117, and four 
out of 141 of the same bat species, respectively, had viral RNA detected by PCR in spleens and liver; 
tissues with which Ebola virus has tropism.  Bats that had viral RNA in tissues were seronegative (36).  
Five months later repeat diagnostics from one of the collection locations demonstrated a drop in the 
detection of viral RNA by PCR from 22.6% to 2.2% and an increase in animals that seroconverted from 
0% to 7.5% (36, 44).  This demonstrated that animals cleared virus, and an adaptive immune response 
may be protective, highlighting the elusiveness of the viral ecology.   
 
Multiple serosurveys were conducted in bats to provide evidence of the susceptibility of bats to 
Ebola virus.  In the Republic of the Congo (RC), Gabon, and Senegal, 2070 bat samples were collected 
between 2003 and 2006.  No bat samples collected from Senegal were seropositive.  In RC and Gabon, 
across Ebola virus epidemic and non-epidemic areas, there was a 5% seroprevalence in Franquet’s 
epauletted fruit bat, hammer-headed bats, and little collared fruit bats (45).  Between December 2006 and 
December 2013, 748 serum samples from straw-colored fruit bats (Eidolon helvum) in Zambia, a country 
surrounded by those that had epidemics of Ebola virus but thus far, itself, has not had the misfortune, 
were assayed by ELISA with 8.6% prevalence.  RT-PCR was performed on tissue samples and no viral 
RNA was detected (46).  Straw colored fruit bats have been documented to be both non-migratory and 
migratory and travel up to ~2000 km (47).  This may explain how seropositive bats were identified in a 
country that had no documented Ebola virus cases.  Between May and June 2007 in Ghana, a study 
focused on non-migratory species of bats.  Out of 88 serum samples, 32 were positive for IgG by ELISA 
including Franquet’s epauletted fruit bat, Gambian epauletted fruit bat (Epomops gambianus), hammer-





(Epomops buettikoferi) was tested and was negative.  Seven ELISA positive sera were also positive by 
western blot (48).  Again, in Ghana between 2008 and 2009, 262 samples from straw-colored fruit bats 
and hammer headed bats were collected.  One straw-colored fruit bat had an IgG antibody titer of 80 to 
Ebola virus via indirect fluorescent antibody assay. Results were confirmed with western blot.  Three 
hammer-headed bats were assayed and negative (49). 
 
The first experimental inoculation of bats with Ebola virus occurred in 1996 in which wild-caught 
Angolan free-tailed bats (Tadarida condylurus), little free-tailed bats (Tadarida pumilus) and Wahlberg’s 
epauletted fruit bats (Epomorphorus wahlbergi) were inoculated subcutaneously.  In addition to these 
three bat species, pigeons, numerous amphibian species, a variety of insect species, and 28 different plant 
species were infected with Zaire ebolavirus (EBOV).  While a brown house snake (Lamprophis 
fuliginosus), a mouse (Mus musculus), and a social spider (Stegodyphus dumicola) had positive tissue 
samples post inoculation with low titers (FFU/ml), it was the three bat species that had virus detected 
most consistently with titers of 102 to 107 FFU/ml.  All other specimens were negative (43).  
 
A second inoculation experiment inoculated Egyptian fruit bats with EBOV, Sudan (SUDV), 
Bundibugyo (BDBV), Tai Forest (TAFV), and Reston (RESTV) Ebolavirus species.  No bats showed any 
signs of disease.  SUDV RNA was detected in skin from the inoculation site, liver, spleen, axillary lymph 
node, and urinary bladder at 5 and 10 DPI.  EBOV, BDBV, and RESTV RNA was detected in skin from 
the inoculation site at 5 and 10 DPI, and axillary lymph nodes at 10 DPI.  TAFV was detected only in 
skin of the inoculation site at 5 and 10 DPI.  No virus was detected in oral and rectal swabs and no 
remarkable histopathological lesions was observed.  This same investigation executed inoculations side-
by-side with MARV.  Comparatively, MARV had a much broader tissue tropism, bats were viremic, had 
foci of cellular infiltrates in the liver as determined by histology, as well as antigen staining in these foci 
(50).  Results for Ebola virus were recapitulated in another study where EBOV was inoculated into 





The naïve bats did not seroconvert, had no evidence of infection, and were subsequently inoculated 
directly.  Bats seroconverted with titers greatest at 28 DPI but beginning to wane by 37 DPI.  Ebola virus 
RNA was detected in various tissues at different time points, including stomach of intraperitoneal 
inoculated bats, skin, liver, lung, and spleen.  Virus was not isolated from any tissue.  All oral, nasal, 
vaginal, penile and rectal swabs were negative (51). 
  
The straw colored fruit bat, Gambian epauletted fruit bat, Egyptian fruit bat, Franquet’s 
epauletted fruit bat and hammer-headed bats have all been found to be seropositive albeit a low 
prevalence (45, 46, 48, 49).  Wild-caught hammer-headed bats, Franquet’s epauletted fruit bats, and little 
collared fruit bats have all had viral RNA detected in tissues (36).  Given that no other wild-caught animal 
species have demonstrated robust evidence of Ebola virus infection, and that ample evidence exists to 
support bats as the reservoir for the related MARV, bats are the dominant reservoir suspects.  However, 
viral RNA has not been detected in bats since the initial investigation and Ebola virus has never been 
isolated from a bat (44).  Furthermore, inoculation experiments demonstrate a different pathophysiology 
and infection time course which serves as a reminder that Ebola viruses and MARV are not synonymous 
(51).  Ebola virus data may suggest that the route of infection in bats is different from MARV, or the viral 
ecology is unique, or it might suggest that bats are susceptible to Ebola virus but serve as an incidental 
host and not the reservoir.     
 
1.2.3: Henipavirus 
The genera Henipavirus has five species, two of which have significant public health 
implications, Hendra virus and Nipah virus (26).  Henipaviruses are pleomorphic, enveloped viruses with 
a non-segmented, negative sense, single stranded RNA genome (27, 52). 
 
Hendra virus (HeV) was first recognized in 1994 when two outbreaks occurred in two different 





disease and/or encephalitis (53, 54).  It was hypothesized the reservoir host for the virus was a bat based 
on a paper published in 1974 suggesting bats were associated with multiple viruses and may be ample 
reservoir hosts (55), and two publications that isolated a paramyxovirus from bats—one in India (56) and 
one in Brazil (57).  This hypothesis was supported with serological data from more than 5000 samples 
taken from 46 different animal species.  The only animals that were seropositive were pteropid bats with a 
4% prevalence in four different species; the grey-headed flying fox (Pteropus poliocephalus), the black 
flying fox (Pteropus alecto), the little red flying fox (Pteropus scapulatus), and the spectacled flying-fox 
(Pteropus conspicillatus) (58).  Serosurveys conducted in humans yielded no seroconversion despite 
some of the participants having been exposed to bats (59, 60).  This suggested that transmission was by a 
novel route, and given that the HeV outbreaks in horses occurred during the breeding season of three out 
of the four bat species that were seropositive, birthing fluids and fetuses became the focus for finding the 
virus (60).  In 1996, HeV was isolated from the uterine fluid of one bat and fetuses of two bats out of 465 
pteropid samples assayed via a RK13 cell culture system.  Cell culture results were confirmed with qRT-
PCR, sequencing, indirect fluorescent antibody assay, and electron microscopy (60).   
 
Experimental inoculation studies of HeV in grey-headed fruit bats (Pteropus poliocephalus) 
resulted in seroconversion at three weeks post inoculation.  There were no signs of clinical disease and no 
pathology on necropsy.  Two bats with the highest antibody titers showed vasculitis on histology, 
predominately in mesenteric and gastrointestinal arteries with HeV antigen present in these lesions on 
immunohistochemistry (IHC).  Virus was not isolated from any tissue of any bat, and urine and feces 
were negative.  In the same study, naïve bats and horses were exposed to inoculated bats and neither 
experimental group seroconverted.  Horses were then inoculated with HeV, and with the exception of one 
horse that had no apparent clinical disease; inoculated horses developed varying degrees of pyrexia, 
respiratory disease, and lethargy.  Virus was not isolated from the horse that was asymptomatic.  
Symptomatic horses had vasculitis and interstitial pneumonia, and one had lymphocytic meningitis.  





extracted from the bladder.  Given that field isolation of HeV occurred in pregnant bats, it is not 
surprising that natural transmission from non-pregnant bats to horses was not achieved (61).  Another 
experimental inoculation study conducted on pregnant grey-headed fruit bats yielded no signs of clinical 
disease and no teratogenic effect in the fetuses.  Inoculated bats seroconverted as determined by ELISA 
and serum neutralization assay.  None of the fetuses seroconverted.  HeV was isolated from the heart and 
buffy coat of one bat, and spleen and kidney of its fetus.  The virus was also isolated from the kidney, 
heat, and spleen from a second bat but not from that bat’s fetus.  An additional two bats had no virus 
isolated from any tissue.  No gross pathology was seen, and histopathology observed in vasculature was 
described as fibrinoid degeneration, perivascular cuffing by mononuclear cells, and pyknotic endothelium 
with antigen present as determined by IHC.  In a single bat, there was immunostaining of the placental 
veins but all fetuses were negative for viral antigen by IHC.  This corroborates field studies and gives 
evidence to vertical inter-species transmission.  It does not provide evidence as to how spillover to other 
species may occur, but urogenital swabs were not taken nor did pregnancies go to term to assess viral load 
in birthing fluids (62).  
 
While mode of spillover of HeV has not been fully elucidated, it seems to be associated with 
parturition.  Epidemiology, seropositive wild bats, isolation of the virus from pteropid species, lack of 
evidence of virus in other animal species aside from humans and horses, and experimental inoculations 
that demonstrate no clinical disease in bats all support pteropid bat species as a reservoir for HeV. 
            
Nipah virus (NiV) was first detected in Singapore and Malaysia in 1999 after an outbreak that 
began in 1998 resulted in 105 human deaths due to encephalitis.  A concurrent respiratory disease 
outbreak in pigs resulted in more than one million animals culled.  Initially the etiological agent for the 
outbreak was thought to be Japanese encephalitis virus, but when pigs were shipped from one part of 
Malaysia to another and outbreaks followed in pig abattoir workers, it was identified that transmission 





antigenic and molecular commonalities with HeV, bats were the primary reservoir suspects.  Sera from 
multiple genera of bats, as well as wild boar, domestic dogs and peridomestic animals were tested for 
antibodies to NiV.  All non-bat species tested negative by indirect ELISA.  Five species of bats were 
antibody positive; 31% of island flying foxes (Pteropus hypomelanus), 17% of Malayan flying foxes 
(Pteropus vampyrus), 5% of cave bats (Eonycteris spelaea), 4% of lesser dog-faced fruit bats (Cynopterus 
brachyotis), and 3% of house bats (Scotophilus kuhli).  The virus was isolated from the urine of island  
flying foxes by lying tarps under roosts to collect pooled urine.  From three field excursions made to 
collect urine, the final one resulted in the isolation of NiV on Vero cells detected by novel CPE, indirect 
fluorescent antibody assay, and confirmed with sequencing (64).   
 
In the original NiV outbreaks, pigs served as an amplifying host; however, in the years to follow 
more outbreaks occurred in people sans pigs.  In Bangladesh between 2001 and 2007, there were a total of 
122 human NiV cases with a 71% fatality.  Based on heterogeneity of NiV strains it was purported that 23 
different introductions of the virus were made from Indian flying foxes (Pteropus giganteus)—the only 
fruit bat species to inhabit Bangladesh.  Once introduced into human populations, human-to-human 
transmission was possible, different from the Malaysian outbreaks in which human-to-human 
transmission could not be confirmed (65).  In a 2005 outbreak, it was discovered that there was a 
connection between human infection and fresh date palm sap.  Date palm sap is collected by strapping 
clay pots to trees (Phoenix sylvestris), stripping the bark near the top of the pot, leaving the pot overnight, 
and allowing sap to seep into the pot for collection the following morning.  Bats were frequently heard in 
the trees at night, feces were commonly seen on the clay pots after collection, and occasionally a dead bat 
was seen in the pots.  It was determined that the sap was contaminated with virus and many infections 
were food-borne (66).  
 
When captive-bred, grey-headed fruit bats are experimentally inoculated with NiV, animals 





and monitored for a total of 22 days.  They were afebrile and had no weight loss.  Virus was isolated from 
urine from a single male bat at 12, 16 and 18 DPI, and from kidney of a different male bat and uterus of a 
female bat at 7 DPI.  On necropsy, organs appeared within normal limits and there were varying degrees 
of nephritis and hepatitis in multiple but not all bats (67).   
 
The epidemiology, seroprevalence, isolation of virus, evidence to demonstrate route of 
transmission, and lack of NiV found in other animal species unquestionably support the hypothesis that 
bats are the reservoir for NiV.  Experimental inoculation data of NiV in bats corroborates this hypothesis 
as NiV causes no apparent disease and has minimal pathology, in line with what is expected from a 
reservoir host.  
 
1.2.4: Coronavirinae 
Subfamily Coronavirinae consists of four genera:  Alphacoronavirus, Betacoronavirus, 
Gammacoronavirus, and Deltacoronavirus (26).  Mammals are generally infected with alpha and beta 
viruses and birds with gamma and delta.  There are six coronaviruses that are associated with human 
disease.  Four of these are etiological agents for the common cold; alphacoronavirus HCoV-229E and 
HCoV-NL63, and betacoronaviruses HCoV-OC43 and HCoV-HKU1.  Severe acute respiratory syndrome 
coronavirus and Middle East respiratory syndrome coronavirus make up the rest of the human 
coronaviruses and are novel in the severity of disease they incite.  Coronaviruses are spherical, enveloped 
viruses with a positive-sense, single-stranded RNA genome (68).   
 
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in Guangdong Province, 
China in late 2002.  Thereafter, reports of a severe febrile respiratory disease in humans quickly emerged 
from Vietnam, Canada, Hong Kong, and more than 20 different countries infecting more than 8000 
people with more than 900 deaths (69).  In 2003, the etiological agent for the disease was identified as a 





coronaviruses were thought to predominately cause mild respiratory disease in humans (70, 71).  Due to a 
high seropositivity in food handlers and people that worked in live-animal markets it was suspected that 
the original source of the virus was an animal (72).  Investigations commenced that placed masked palm 
civets (Pauma larvata) at the forefront of possible reservoir species suspects (73).  As studies progressed 
it was found that there was a seroprevalence disparity between civets on farms and civets in markets.  
Civets in the market had a 78% seroprevalence while those on farms had a prevalence of 40%.  It was 
concluded that a percentage of civets were exposed to SARS-CoV at the market place, and therefore may 
not be the reservoir (74).  When civets were experimentally infected with SARS-CoV they demonstrated 
clinical signs of disease including pyrexia and lethargy, lending evidence to the hypothesis that civets 
were not the reservoir but rather an amplifying host (75).  With the attention bats were getting as reservoir 
species for other pathogens, and the increase in bats being sold in markets for food and traditional 
Chinese medicine, bats became the new suspect in the search for the reservoir for SARS-CoV.  Four 
hundred and eight bats from nine different species were sampled in China.  Three species from the genera 
Rhinolophus were seropositive to SARS-CoV with a prevalence of 28% to 71%, dependent on species.  
Fecal samples tested positive by qRT-PCR and a whole genome from feces was sequenced with 92% 
homogeneity to a human strain (76). 
 
Middle East respiratory syndrome coronavirus (MERS-CoV) was first diagnosed in a Saudi man 
in 2012 that died of progressive respiratory and renal failure eleven days after admittance to the hospital 
(77).  Currently, the World Health Organizations reports 2103 laboratory confirmed cases with more than 
700 virus related deaths in 27 countries.  Unlike SARS-CoV, where cases of viral infection subsided after 
the epidemic was brought under control, MERS-CoV lingers with sporadic cases, predominately in the 
Middle East.  The most recent case occurred in November of 2017 (78).  After the isolation of MERS-
CoV from a human, investigation to identify the reservoir host quickly began.  An array of farm animals 
were screened for antibodies to MERS-CoV, including, goats, sheep, cows, alpacas, Bactrian camels and 





seropositive, and none of the other species demonstrated seroconversion (79).  With seroprevalence in 
dromedary camels upwards of 90% in certain regions of the Middle East, the isolation MERS-CoV from 
dromedary camels, susceptibility and minimal disease on experimental inoculations, and evidence for 
direct transmission from camels to humans; dromedary camels are considered a host for MERS-CoV (79-
83).  However, coronaviruses with high nucleotide identity to MERS-CoV were found in bats.     
 
Lung and alimentary tissues from 5,481 bats from 21 different species were assayed via RT-PCR 
for coronavirus RNA in Japan.  There was a 29% prevalence of Ty-BatCoVHKU4 virus in the 
gastrointestinal tract from the lesser bamboo bat (Tylonycteris pachypus), and 25% prevalence of Pi-
BatCoVHKU5 in the gastrointestinal tract of Japanese pipistrelle (Pipistrellus abramus) with no signs of 
disease.  Pi-BatCoVHKU5 shares 92.1% to 92.3% amino acid identity to MERS-CoV while Ty-
BatCoVHKU4 shares 89.6% to 90% of the RNA dependent RNA polymerase gene (84).  RNA dependent 
RNA polymerase (RdRp) genes are highly conserved (68).  The more mutable S gene of Pi-
BatCoVHKU5 had a 66.8% to 76.4% amino acid identity and Ty-BatCoVHKU4 had a 63.4% to 64.5% 
amino acid identity to MERS-CoV.  Molecular clock analysis estimates the time of divergence between 
the three viruses to be hundreds of years ago (84). 
 
Shortly after the discovery of Ty-BatCoVHKU4 and Pi-BatCoVHKU5 CoV, coronavirus RNA 
was discovered by PCR in 220 out of 732 fecal samples collected off tarps, and 7 out of 91 rectal swabs 
from seven different species of bats in Saudi Arabia at locations where people contracted MERS-CoV.  
Amongst these viral RNA positive samples was an amplified 190-nucleotide product for RdRp gene that 
had 100% nucleotide identity to the index case for MERS-CoV (85).  These findings laid the groundwork 







Across multiple locations in Ghana, West Africa, as well as Germany, the Netherlands, Romania, 
and Ukraine, 5030 fecal samples were collected from different bat species and screened for coronaviruses.  
Positive samples, by RT-PCR, came from 46 out of 185 specimens from Gambian slit-faced bats from 
Ghana (Nycteris gambiensis).  The amplified fragment that included the RdRp gene from this novel 
betacoronavirus had a 90.4% to 91.2% amino acid similarity to Ty-BatCoVHKU4 and Pi-BatCoVHKU5 
and a 92.5% amino acid similarity to MERS-CoV.  Furthermore, positive samples were found in 
pipistrellis bats (Pipistrellus pipistrellus, P. nathusii, and P. pygmaeus) in the Netherlands, Romania, and 
Ukraine.  Forty of 272 had coronavirus RNA detected by PCR in fecal samples with a 98.2% amino acid 
homology to MERS-CoV and 94.1% to 94.5% amino acid identity to Ty-BatCoVHKU4 and Pi-
BatCoVHKU5.  Again, the gene amplified was the highly conserved RdRp gene (86).  Another study 
found RNA from a novel coronavirus with high similarity to MERS-CoV in five out of 62 fecal samples 
from Zulu pipistrelle bats (Neoromicia zuluensis) in South Africa.  Four of the five positive samples were 
alphacoronaviruses and one was a betacoronavirus and was dubbed PML/2011.  RT-PCR amplification of 
the RdRp gene for PML/2011 yielded an 816-nucleotide fragment that had a single amino acid difference 
from MERS-CoV.  The virus differed from Ty-BatCoVHKU4 and Pi-BatCoVHKU5 by 1.8% at the 
amino acid level (87).  In addition to these studies, betacoronaviruses have also been detected in a Savi’s 
pipistrelle bat (Hypsugo savii) in Spain, bat guano in Thailand, and a Nyxtinomops bat species in Mexico 
(88-90).  Given these data it appears as if betacoronaviruses have a diffuse geographical distribution.   
 
The broad distribution of MERS-CoV-like viruses in bats is highly suggestive MERS-CoV 
originated in bats; however, it is not definitive.  There is no clear epidemiology to suggest MERS-CoV 
originated in bats nor has the virus been isolated from bats.  There has been one experimental inoculation 
of bats with MERS-CoV.  Ten Jamaican fruit bats were inoculated intranasally and intraperitoneally with 
105 TCID50 MERS-CoV strain EMC/2012.  All bats appeared clinically normal throughout the duration of 
the study.  Viral RNA was detected in oral swabs and rectal swabs by RT-PCR for up to 9 DPI and 





blood, predominately at time points prior to 14 DPI.  Infectious virus was isolated from lungs, bladder 
and nasal turbinates at 2, 7 and 14 DPI.   Histopathology was minimal and included multifocal interstitial 
pneumonia and mild rhinitis in two bats.  A single bat seroconverted at 14 DPI.  These data were 
consistent with what is expected from reservoir hosts—infection with minimal to no pathology; however, 
Jamaican fruit bats are a New World bat and so unlikely to be an original host (91).  Furthermore, bat 
speciation occurred millions of years ago (4) and bat physiology is not well enough delineated to know if 
what happens in one species recapitulates what might happen in another.   
 
The emergence of SARS-CoV and MERS-CoV spurred a frenzy of identifying bat coronaviruses, 
and postulations that bats are the original host of coronaviruses.  Literature suggests that bats harbor more 
coronaviruses than any other animal species (21).  In addition to the identification of SARS-CoV in bats 
and close relatives to MERS-CoV in bats, other coronaviruses that group closely with less pathogenic 
human coronaviruses have also been detected.  HCoV-229E is an alphacoronavirus that causes mild 
respiratory disease in humans worldwide.  A search for coronaviruses in straw-colored fruit bats, 
belonging to the Hipposideridae family, in Ghana was conducted by passively collecting fecal samples 
from a colony of 300,000 bats.  Seven specimens had RNA for a novel coronavirus RdRp gene by RT-
PCR.  Amongst these novel coronavirus RdRp sequences, was an alphavirus with a 92% nucleotide 
identity of the RdRp gene with HCoV-229E and labeled bat 229E-related CoV lineage 1.  The bat virus 
and the human virus were predicted to share a common ancestor 208 to 322 years ago (92).  Another 
investigation of 2087 bats comprising 11 species in Ghana found 229E-related CoV RNA by RT-PCR in 
81 fecal samples collected from Hipposideridae bats.  The full-length virus was sequenced and compared 
to multiple strains of human coronavirus HCoV-229E, SARS-CoV and related viruses, and animal 
coronaviruses via Bayesian phylogenetic analysis.  Bat 229E-related CoV lineage 1 and an alpaca 
coronavirus formed one species in the analysis.  The alpaca virus took an intermediate position between 





virus that spilled into alpacas and then into humans—further implying that bats may be a reservoir for 
coronaviruses (93). 
 
1.2.5: Hepacivirus and Pegivirus 
Not only do bats harbor multiple viruses with significant public health consequences, they also 
may be the original hosts for family Paramyxoviridae, subfamily Coronavirinae and genera Lyssavirus 
(as discussed) (20), Hepacivirus, and Pegivirus (23).  Hepacivirus and Pegivirus belong to family 
Flaviviridae, a group of enveloped, spherical or icosahedral viruses with non-segmented, single-stranded, 
positive-sense RNA genomes.  Hepacivirus species include hepatitis C virus (HCV), GB virus B (GBV-
B), and non-human primate hepaciviruses (NPHV).  HCV infects approximately ~3% of the human 
population causing hepatic fibrosis and cirrhosis, and inducing liver neoplasia.  Pegiviruses include GBV-
A, GBV-C and GBV-D.  GBV-A and GBV-C have tropism for the liver in humans and NHP.  GBV-A 
was discovered in humans but it was most likely incidental, and rather NHPs are the native host.  GBV-C 
has been found in up to 15% of human populations as well as chimpanzees, but does not appear to cause 
disease.  GBV-D was identified in a fruit bat in Bangladesh (94).  A survey sampled 40 different bats 
species for a total of 1581 bat sera and 83 tissue samples from eight different countries and revealed a 
broad geographical and phylogenetic flavivirus distribution.   Seventy-eight sera samples, one lung, and 
one rectal swab had flavivirus RNA detected by deep sequencing and qRT-PCR, with a 24% to 100% 
amino acid homology to Hepacivirus or Pegivirus.  Phylogenetic analysis that included previously 
described non-bat viruses (HCV, NPHV, GBV-B, GBV-A, GBV-C, GBV-D) showed that all the 
previously described non-bat viruses clustered within the bat viruses.  Given the global distribution and 
range of bat species that were positive, in combination with phylogeny of all known Hepaciviruses and 









Paramyxoviridae contains numerous genera of viruses that infect humans and animals including 
measles, distemper, mumps, parainfluenza, Newcastle disease, and henipaviruses.  An extensive Bayesian 
analysis of 51 species of paramyxoviruses from six genera demonstrated that a salmon paramyxovirus 
clustered with a rodentian-morbilli-henipavirus and human respirovirus clade, generating the conclusion 
that morbilliviruses may have originated in rodents.  Yet, the study did not exclude bats as an origin 
species based on a lack of paramyxovirus data in bats at the time (22). A survey for paramyxoviruses was 
conducted in 86 bat species constituting 4,954 individuals and 33 rodent species with 4,324 individuals in 
15 different countries.  RT-PCR and deep sequencing yielded a 3.3% and 3.1% prevalence in bats and 
rodent, respectively.  A total of 66 novel paramyxoviruses were discovered.  Of particular interest was the 
discovery of a bat Rubulavirus with 89.5% to 90% amino acid identity to mumps virus, a highly 
contagious human-to-human spread pathogen with significant public health consequences.  Additionally, 
viral fragments and one full genome sequence were found in a straw-colored fruit bat in Ghana, Africa 
with high homology to the henipaviruses, suggesting that the ancestral virus to Hendra and Nipah virus 
came from Africa.  While virus prevalence was similar between the two animal orders, rodent viruses had 
low divergence and clustered tightly within three clades while bat viruses had a broad distribution across 
the phylogenetic tree and high divergence, this may indicate that bats are a major source for 
paramyxoviruses.  In order to determine which mammalian host order had the most robust spillover 
events, host-traits were analyzed in concordance with a viral phylogenetic tree.  This analysis revealed 
that host switches from bats into mice, carnivores, primates, and cetartiodactyls occurred with greater 
frequency than spillover from mice, carnivores, primates, and cetartiodactyls into bats, mice, carnivores, 
primates, and cetartiodactyls.  These data indicate that bats are a major reservoir for paramyxoviruses 









Hepadnaviridae is a family of double-stranded DNA viruses comprised of two genera:  those that 
infect mammals, Orthohepadnavirus, and those that infect birds, Avihepadnavirus.  The most well 
characterized hepadnavirus is hepatitis B virus (HBV), which is estimated to infect more than 325 million 
people globally (95).  Phylogenetic studies date the human-HBV relationship back at least 15,000 years; 
however, Avihepadnaviruses date back 19 Ma, suggesting that HBV may have much older origins that 
have not been uncovered (24).  
 
Serum and liver from 3080 bats, representing 54 different species, from Panama, Brazil, Gabon, 
Ghana, Germany, Papua New Guinea and Australia were assayed via PCR for hepadnaviruses.  Ten 
samples from three different bat species of both New World and Old World distribution had RNA 
present, comprising three novel strains.  On histology, minimal cellular infiltrates in the liver were 
described.  The bat hepadnaviruses form two monophyletic clades, clustering according to geographic 
distribution within New World human genotypes, New World non-human primate and New World rodent 
hepadnaviruses according to Bayesian phylogenetic analysis.  Furthermore one of the three strains of bat 
hepadnavirus was able to infect and replicate in human hepatoma HepG2 cells, possibly hinting at 
zoonotic potential (24).  Because of these data it is suggested that bats may be an origin for HBV and 
other mammalian hepadnaviruses (24, 25).  There are multiple other hypothesis for the origins of HBV 
including parallel evolution between humans and non-human primates, a common viral ancestor infected 
anatomically modern humans and human migration out of Africa disseminated the virus globally, and 
cross-species transmission between human HBV and non-human primate HBV occurred (25).  More 
research needs to be conducted in order to support or reject any of the hypothesis, including the bat 








1.3: Traits that Make Bats Unusual 
As described, bats maintain many high-profile viruses that cause substantial disease and mortality 
in humans.  This drives bat research in an attempt to understand the mechanism by which bats can host 
such a great variety viruses (96).  It is true rodents are also considered significant reservoirs for zoonotic 
viruses, yet bats harbor significantly more zoonotic viruses than rodents (38).  Numerous hypothesis have 
been proposed to explain the mechanism, including the age of order Chiroptera and potential for co-
evolution with numerous viruses, their immunophysiology facilitating infection and spread with minimal 
disease, they are the only mammal capable of sustained flight and this feature may result in distinct 
molecular physiology, their life span is longer than what would be expected given their metabolic rate to 
body weight ratio, they are gregarious and may roost in great numbers often with multiple species (97-
99).  
 
1.3.1: The Ancient Age of Bats and Viral Co-Evolution  
Does the ancient age of bats facilitate the success of bats as a reservoir for viruses?  Molecular 
dating sets the age of Chiroptera between 58.9 and 88 Ma and deduces that all 18 extant families existed 
33.9 Ma (4-6).  Order Rodentia is another major reservoir for human pathogens and is estimated to have 
diversified 64 to 88 Ma (100, 101).  This order contains more species than any other, with more than 
2,000 documented—twice as many as bats.  Like bats, rodents inhabit every continent except Antarctica.  
Molecular dating suggests the 34 extant families of rodents were established 22 Ma, during the Neogene 
(101).  Modern birds are estimated to have split into modern orders 70 to 120 Ma based on molecular 
dating, suggesting the modern orders pre-date and survived the K-Pg boundary event (2, 102).  Within the 
avian class there are 23 orders.  Amongst these orders are the Anseriformes, waterfowl, which are the 
reservoir for avian influenza viruses (103).  Waterfowl branched from the crown-group approximately 80 
Ma (102).  The order of rodents, bats, and waterfowl are all quite old and so millions of years of co-






Order Carnivora arguably contains some of the most charismatic mammalian animals within its 
more than 280 recognized species comprised of 11 families.  Molecular clock analysis date Carnivora to 
55 Ma.  Families diverged from crown-groups over a great expanse of time, for example 7.2 Ma for 
Hyaenidae (hyenas) and 28.6 Ma for Viverridae (civets) (104).  Order Primates, which includes Homo 
sapiens, contains some discrepancy in the dates it emerged with molecular clock analysis targeting the 
origins between 55 and 95 Ma, and the oldest fossil dated 54 million years old (105, 106). Furthermore 
molecular clock analysis further dates superorder Xenarthra (sloths, armadillos, and anteaters), order 
Pholidota (pangolins), and order Proboscidea (elephants) at ~60 Ma (107).  None of these orders are 
incriminated as reservoir hosts, yet are similarly aged to Chiroptera.  Order Eulipotyphla contains moles, 
shrews, hedgehogs, amongst others, and is older than both Rodentia and Chiroptera at 71 to 86 Ma (100), 
and are not documented to harbor any zoonotic viruses.   
 
Age of an order may facilitate the amount of time an animal has to co-evolve with its virome but 
does not indicate an inherent risk for spillover events.  More aptly it suggests that cross-species 
transmission had the potential to occur for millions of years and may have (108).  It does not explain why 
viral spillover from bats is currently observed with greater frequency than ever before.  If age of an order 
were an indicator of how many viruses that order could maintain, then it might be expected to see a more 
homogenous viral spread across orders of similar or older age.       
 
1.3.2: Bat Immunology 
Given that bats host numerous viruses, yet seem to have minimal pathology, it has been suggested 
that bats have evolved immune mechanisms to facilitate a commensal relationship.  As technology 
advances and more tools become available, molecular investigation becomes more accessible (96).   
 
RNA isolated from the thymus of a juvenile male flying fox, and RNA isolated from a pool of 





stimulated with LPS and Ionomycin, sequenced, and transcriptomes acquired.  Seventy genes were found 
to be involved in toll-like receptor cascades, 50 in B-cell activation, 79 in T-cell activation, 72 in natural 
killer (NK) cell cytotoxicity, and 41 in antigen presentation, comprising 3.5% of the total bat transcribed 
genes.  Ultimately, the transcriptome analysis demonstrated that the overt flying fox immune system has 
the same parts-list as other mammals (109), although does not necessarily elicit functional differences.  
On a transcriptome level, any differences that exist between bat immune systems and other mammals to 
facilitate co-existence with zoonotic viruses is in the details.  
 
1.3.2.1: Innate Immunity 
 The interferon family of genes, having evolved 250 Ma, is present even in the earliest jawed 
vertebrates—Gnathostomes; as well as cartilaginous and bony fish, amphibians, reptiles, birds and 
mammals (110, 111).  There are three types of interferon (IFN) in mammals labeled types I, II and III.  
Type I and III IFN are the predominate responders to viral infection.  IFN-α, - , -ω, - , -ζ, - , τ, and  
constitute the type I IFNs with IFN-α and IFN-  the bulk of the interferon response (112).  The black 
flying fox has ten IFN genes:  three IFN-α, one IFN-β, one IFN-ε, and five IFN-ω that span a total of 250 
kilobases (kb), a remarkably small size compared to other species.  The type I IFN locus has a tendency to 
increase in association with evolutionary complexity, for example fish loci span a distance of ~25 kb, 350 
kb in mice and 1,000 kb in pigs.  The bat genome is contracted at 2.0 gigabases (Gb) and so a smaller 
locus may be expected, which is in line with birds and consistent with evidence that flying animals have 
smaller genomes (113, 114).   
 
Interferon is generally unmeasurable in a healthy, uninfected system and increases within hours in 
response to infection.  Black flying fox IFN-α is uniquely, constitutively expressed in twelve tissue-types 
assayed from three wild-caught, apparently healthy animals.  IFN-  seems to only be constitutively 
expressed in the testes.  Similar results were seen in lesser short-nosed fruit bats (Cynopterus brachyotis) 





cell lines made from black flying fox tissues constitutively express IFN-α.  Levels remain similar even 
after stimulation with polyI:C.  In contrast, IFN-  production increases after cell stimulation with 
poly(I:C).  The implications for having interferon that is always expressed are substantial and may be a 
means to immediately control viral replication upon infection, minimizing replication (115). 
 
After the production of type I IFNs, IFN-α and IFN-  induce the Janus kinase/signal transducer 
(Jak/STAT) signaling cascade.  STAT1 and STAT2 are components of this cascade and are present at 
basal levels in the cytoplasm in an unphosphorylated form, prior to stimulation.  Upon stimulation, 
STAT1 and STAT2 are phosphorylated and form heterodimers with IFN regulatory factor-9 (IRF-9) that 
then translocate to the nucleus, resulting in transcription of interferon stimulated genes (ISG).  This 
cascade of events further induces the body to take an anti-viral posture against invaders.  In order to 
elucidate the conservation of this system compared to other mammals, STAT1 from primary kidney cells 
generated from a mature female Egyptian fruit bat was cloned and sequenced.  The amino acid similarity 
between Egyptian fruit bat STAT1 and STAT1 from other mammals was high, 97% with horses, 96% 
with cows and 93% with humans, mice and domestic dogs, highlighting the evolutionary conservation of 
the protein and suggesting that function is the same.  Indeed, functional exploration revealed that STAT1 
is phosphorylated and translocates to the nucleus after stimulation with Rabies virus or IFN-α.  
Furthermore basal levels of STAT1 are present in all tissues assayed, including brain, muscle, heart, lung, 
liver, kidney and spleen, but expression is variable depending on tissue type with the liver having the 
highest mRNA expression (117).  These data demonstrate that STAT1 function is the same in bats as it is 
other animals and infers that the Jak/STAT pathway is also conserved.  The yet unanswered follow-up 
question generated from these data is if type I IFNS are constitutively expressed, then what prevents ISGs 
from constant stimulation.     
 
 Unlike type I IFN, type III IFN expression in bats is similar to that of other mammals and is not 





vertebrate classes have varying numbers of functional genes, for example:  four in humans, two in mice, 
and one in zebrafish and chickens (120).  As the proposed evolutionary original interferon and generally 
highly conserved across species, bat type III interferon follows expected patterns.  The Malayan flying 
fox has three loci (IFN- 1, IFN- β, IFN- γ) with IFN- β possibly being a pseudogene, and two have been 
found in the black flying fox (IFN- 1 and IFN- β).  Aside from a 4 kb intron in black flying foxes, 
compared to ~1.1 kb intron in other mammalian species, gene structure appears to be conserved.  Given 
the small size of the bat genome, having such a large intron seems peculiar and the intron may have an 
undiscovered function.  Because up-regulation of IFN- 2 in bat cell lines occurs only after transfection of 
polyI:C, and not simply treatment with polyI:C, there is some question as to what pattern recognition 
receptors set the cascade of events into motion for type III interferon production, possible only cytosolic.  
Mice use both cytosolic and endosomal pattern recognition receptors.  Additionally, IFN- 1 concentration 
is 100 times greater than IFN- β in polyI:C transfected PaLuT02 cells (immortalized black flying fox 
lung cells) and primary cell culture from multiple bat tissue types including lung, liver, heart, kidney, 
small intestine, brain, and salivary gland.  This is different from mice that produce IFN- 1 and IFN- β in 
near equal amounts in response to a stimulant. Furthermore, IFN- 1 expression is restricted to lung, liver, 
and heart primary cells compared to IFN- β.  The type III IFNs were also produced later after cell 
treatment compared to type I IFNs, 0.5 hours compared to 1.5 hours.  Type III IFNs are considered the 
evolutionary origin of the interferon family but through time type I IFNs may have taken center stage as 
the primary responder to viral infection, particularly in bat species that express type I IFN constitutively.  
Given the differences between type I and III IFN expression in bats, the two systems may work in tandem 
with one another.  It is also postulated that because so many viruses have accessory proteins that dampen 
the type I IFN response, the type III IFN may serve as a backup when the type I IFN response is mitigated 
(119).   
 
After the production of IFN- , IFN-  interacts cellular receptors:  IFN- R1 and Iδ10Rβ.  Binding 





defense against viruses.  IFN- R1 has high ligand specificity for type III IFNs, and is expressed only on 
epithelial cells in humans and mice, with variable expression between organs of each species.  IL10R2 is 
part of a receptor complex for multiple cytokines and, given this, has a more ubiquitous distribution.  The 
black flying fox IFN- R1 has a 66 to 7λ% nucleotide homology to other mammalian IFN- R1 and a 50 to 
65% amino acid identity.  The shared identity of black flying fox IL10R2 to other mammals is 75 to 85% 
at the nucleotide level and 63 to 78% at the amino acid level.  Both are expressed on multiple tissue types, 
and IFN- R1 is present on epithelial cells, as well as a mixed population of immune cells, and stimulation 
with IFN-  results in ISG induction.  Bat IFN- R1 and Iδ10Rβ distribution and functionality are 
consistent with what is seen in both mice and humans, and given the nucleotide homology, this system 
seems to be conserved in the animal species assayed.  The presence of IFN- R1 on epithelial cells from a 
variety of tissues types and hematopoietic cells indicates bats are well poised to take on an antiviral state 
should infection arise (118).  
 
1.3.2.2: Cell-Mediated Immunity   
Major histocompatibility complex class I (MHC-I) is present on all nucleated cells and platelets 
and is a major defender against intracellular pathogens, such as viruses.  The complex contains a peptide 
binding grove (PBG) that, canonically has a rigid α-helix and proline on either side that limits the size of 
the antigen it can fit to 8-11 amino acids.  When MHC-I bands a peptide, it presents the peptide to 
cytotoxic t cells.  If the t cell antigen receptor is a match, it will bind to the antigen-MHC-I complex with 
co-stimulation of CD8 and induce apoptosis.  Characterization of the MHC-1 molecule in black flying 
foxes demonstrates that all of the ancestral conserved genes are present.  The MHC-1 region in big brown 
bats is ~1.2 megabases (Mb), compared to humans where the region is ~1.7 Mb.  Again, this is consistent 
with the comparatively small size of the bat genome compared to the average mammalian genome of ~3.5 
Gb.  3D protein modeling conducted to elicit the conformation of the PBG.  Bat PBG has proline on 





contained coils and turns that might allow for the accommodation of larger peptides, possibly making 
endogenous antigen presentation more efficient (121). 
 
1.3.2.3: Antibody-Mediated Immunity 
Antibodies function to dispel of pathogens by binding to them and neutralizing them, 
agglutinating or precipitating antigen to make ease of phagocytosis, or to activate complement pathways.  
Placental mammals have five classes of antibodies:  IgA, IgD, IgE, IgG and IgM.  When an animal 
encounters a microbe, IgM is the first to be produced.  Daughter B cells then undergo class switching to 
produce a different antibody class dependent upon the demands of the body.  Each class of antibody has a 
distinct function.  IgG is the dominant isotype in sera.  IgA is the dominate isotype in mucosal surfaces.  
IgE is specialized to respond to allergens.  IgD is mainly an antigen receptor on naïve B-cells (122).  
 
In the quest to understand the adaptive immune system of bats, transcriptome investigations to 
characterize the antibody repertoire were implemented.  Three bat species belonging to suborder 
Yangochiroptera were used: little brown bats, big brown bats, and Seba’s short-nosed fruit bat, and a 
member from family Pteropodidae as a representative of the Yinpteropodidae superorder—the short-
nosed fruit bat (Cynopterus sphinx).  Results demonstrated that bats have all five canonical 
immunoglobulins.  IgM and IgA appeared to be the most conserved in comparison to other eutherian 
mammals.  IgD was present in the little and big brown bats but absent in Seba’s short-nosed fruit bat and 
the short-nosed fruit bat.  The IgD transcriptome in the brown bats demonstrated the least homology 
amongst mammals, and so it may have been missed in the other bat species.  Although rabbits do not 
produce IgD, and so if it is not present in some bat families, it would not be completely novel.  IgE lacked 
the N-glycosylation site of CH1 similar to opossum and platypus, but different from humans, mouse, 
cattle and pigs.  Furthermore, the N-glycosylation motif was missing in CH2 in the four bat IgEs, 
compared to other mammals, and bats had one N-glycosylation site in the CH3 domain, compared to three 





Carnivora.  IgE shared homology with order Carnivora but also horses, humans and pigs.  Variation was 
observed amongst IgG from the four bat species, and phylogenetics demonstrated that IgG developed 
after the speciation of bats ~58.9 to 64 Ma.  The greatest variation of bat IgG subclasses were seen in the 
hinge region—which is generally the site of greatest diversity in other species (123).  These results 
demonstrated that bats have an immunoglobulin repertoire consistent with other mammals, despite some 
differences.   
 
To assess the antibody repertoire on a protein level an investigation used Protein G and Protein A 
affinity columns to isolate IgG from black flying fox serum and plasma.  The IgG depleted serum and 
plasma was processed with immobilized anti-Fab-specific antibody to capture IgM and IgA.  The results 
demonstrated bands for heavy and light chain IgM but not for IgA.  IgA constitutes 15-50% of the 
immunoglobulins found in human serum, but may be trace in the serum of black flying foxes as LC-
MS/MS can detect a small fraction.  LC-MS/MS can detect IgA in lavages from bat small and large 
intestine, milk and tears, as expected with IgA being the predominate immunoglobulin of mucosal 
surfaces.  IgG was also abundant on mucosal surfaces.  IgM was visualized in two bands suggesting that 
there may be subclasses in black flying foxes.  As the first antibody to appear during an infection, it was 
hypothesize that more than one subclass may allow black flying foxes to mount a more robust first 
adaptive immune response to pathogens (124).     
 
The basic structure of immunoglobulins is a pair of heavy chains and a pair of light chains 
comprised of a conserved constant region on the C-terminus and a variable region on the N-terminus.  
The variable region has a unique amino acid sequence that facilitates binding to a unique antigen that is 
generated through site-specific recombination of germline gene segments—V, D, and J in the heavy chain 
(H) and V and J in the light chain (L).  Germline diversity occurs in naïve B-cells, prior to antigen 
stimulation.  The varying numbers of germline gene segments (V, D and J) are rearranged to produce 





24 DH segments, and 6 JH segments that can be arranged to produce 5,760 different H chains.  Somatic 
hypermutation (SHM) occurs after exposure to antigens.  It is the product of single base pair mutations 
that occur in gene segments increase avidity and affinity of immunoglobulins to antigens (125-127).  
 
The VH segments are spread amongst three clans, identified as I, II or III.  Most mammals only 
have VH segments representative of one clan, i.e. pigs having VHIII genes only and sheep have VHII 
representatives.  Rodents and primates are the exception with segments from all three clans.  A 
transcriptomic investigation of the black flying foxes found 23 unique VH sequences spread amongst the 
three clans.  The Malayan flying fox also has VH sequences belonging to all three clans (125).  Little 
brown bats have more 236 different VH3 family gene sequences, a minimum of 24 DH segments, and 13 
JH segments, yielding more than 70,000 VDJ transcript possibilities (123, 128).  A large number of 
expressed VH repertoires may allow the bat to immunologically defend itself from a greater number of 
antigens compared to those animals with fewer, and may possibly be the product of co-evolution of bats 
with numerous viruses (116, 123, 125, 128).  
 
While there is evidence for robust germline diversity amongst different bat species, SHM seems 
to have less significance in the bat’s defense against pathogens.  εutation frequency for the FRγ and 
CDR2 region of the VH3 genes from adult little brown bats was determined and compared to germfree 
fetal pigs.  They both had similar, low rates of mutation frequency.  This is to be expected in a germfree 
fetal pig that has not been exposed to pathogens and has not yet undergone SHM.  For an adult bat, this is 
unique and may suggest that bats have limited SHM and therefore reduced affinity maturation (128).  The 
inconsistent neutralizing antibody titers elicited by bats in infection studies corroborates these data (30, 
49, 50, 129).  It’s possible that the great germline diversity in bats negates the necessity of SHM but may 
also impact viral-host ecology, decreasing avidity of antigen specific antibodies, and altering 






1.3.2.4: Relationship Between Flight and Immunity 
It has been proposed that there may be a relationship between the capacity of bat to maintain 
viruses with minimal disease and flight, being that bats are the only mammals capable of sustained flight.  
The two dominate hypothesis are (1) flight produces high amounts of reactive oxidative species (ROS) 
that may damage DNA so it was necessary to have a physiological system in place that mitigated or 
repaired damage created by ROS and (2) that flight emulates fever, and this fever is a means by which to 
control viral infection.   
 
To test whether bats had exceptional means to mitigate the effects or ROS or repair DNA 
damaged by ROS, high-throughput sequencing was done on samples from a representative of the 
suborder Yinpterochiroptera, the black flying fox (Pteropus alecto) and a representative of the suborder 
Yangochiroptera, David’s εyotis (Myotis davidii).  Flight has a high metabolic expense, which may 
result in the accumulation of ROS.  It was found that ATM and c-REL in both species, TP53 and BRCA2 
in David’s εyotis, and LIG4 in the black flying fox were positively selected for.  The proteins of these 
genes are proponents of DNA repair or apoptosis.  C-REL belongs to the nuclear factor B family, an 
important transcription factor in innate immunity.  In both bats, the gene locus with the PYHIN gene 
family is absent.  PYHIN is associated with cell cycle regulation and at least one gene is present in all 
other explored groups of eutherian mammals.  Given that genes important for DNA repair and 
maintenance of physiological homeostasis were positively selected for, it may be that the evolution of 
flight facilitated viral maintenance (6). 
 
Due to the seeming absence of the PHYIN gene in black flying foxes, additional searches were 
conducted in other species of bats.  Whole genome sequences of ten different bat species were done:  the 
Malayan flying fox, the black flying fox, the straw-colored fruit bat, greater horseshoe bat (Rhinolopus 
ferrumequinum), greater false vampire bat (Megaderma lyra), the little brown bat, David’s Myotis, 





The PYHIN (PYRIN and HIN domains) gene family has immune sensors for intracellular DNA that can 
subsequently activate inflammasomes or interferon pathways.  It is the only DNA sensor that triggers 
inflammasomes.  All bats lacked the PHYIN gene family with the exception of Parnell’s mustached bat, 
which had a partial sequence.  Within this sequence there was a frame shift mutation with multiple 
premature stop codons to indicate that the gene was no longer functional.  Evidence for an ancestral 
PHYIN gene family in one bat may suggest that bat families independently lost the gene.  It is 
hypothesized that the loss of the gene family may have been the byproduct of flight as a means to 
decrease inflammation and mitigate interferon response to native DNA that had been damaged due to the 
ROS formed during sustained flight (130).  Whether or not this hypothesis holds, the lack of the PHYIN 
gene family does have interesting implications for the host relationship with DNA viruses.  However, all 
the high profile human pathogens that bats harbor are RNA viruses so it does not explain how bats are 
able to maintain the viruses of human interest.  
  
The second hypothesis surrounding flight and immune function was that flight increases 
metabolic rate and body temperatures.  These increases might mimic fever and cause natural, regular 
fluctuations in bat physiology, thereby controlling viral infection and explaining why bats maintain a vast 
number of viruses without apparent disease (131).  Bat body temperatures may fluctuate in response to 
flight (131), but bats are heterotherms—regardless of whether they are temperate, sub-tropical, or tropical 
species (132).  Body temperature in bats fluctuates due to ambient temperatures, seasonality, and the 
weather (132).  Non-hibernating pteropid bat temperatures may range from 33°C to 37°C throughout the 
day.  Hibernating bat species’ body temperature may drop to 5°C during hibernation (133).  These 
numbers, however, are just examples.  Temperatures are so variable across studies that it is difficult to 
identify normal bat temperature (132, 134, 135).  Furthermore, studies determined that ambient 
temperature may be the ultimate determinant in body temperature during flight, rather than the metabolic 
expense of flying itself (134, 135).  Additionally, the dominant mechanism for bats to disperse of heat is 





flight, and the wing membrane is tight, they have maximum skin exposure to optimize heat dispersal 
(135).  The act of flight is the major means by which bats cool down.  Thus, to have flight mimic fever is 
contradictory to bat physiology.  
 
 Fever, in response to infection, is triggered by interleukin (IL)-1, IL-6, and tumour necrosis factor 
(TNF) that act on the hypothalamus to induce the production of cyclooxygenase-2 (COX-2).  
Prostaglandin is in turn produced which increases the body’s temperature (127).  Given that fever in 
response to infection is a complicated immunopathway, the idea that flight simulates fever has received 
some criticism (116).  As heterotherms, fluctuations in body temperature are normal (132), and this is not 
synonymous with fever.  
 
 Fluctuations in body temperature have been demonstrated to effect viral-host ecology in bats, but 
not in a response to elevated temperature, but rather decreased body temperature.  A coronavirus was 
isolated from North American big brown bats and little brown bats, and infection was persistent for four 
months while the bats were in hibernation (136).  A different study explored this same coronaviruses in a 
similar population of non-hibernating bats and failed to find viral persistence suggesting viral 
maintenance varies between seasons (137).  Silver-haired bats (Lasionycteris noctivagans) experimentally 
inoculated with different RABV strains showed prolonged viral incubation periods and viral latency 
during hibernation compared to non-hibernating bats (138).  Hibernation is the result of a decrease in 
metabolic function, not merely body temperature and so without further exploration it cannot be 
concluded that the drop in body temperature alone facilitates microbe persistence (139).   
 
1.3.2.5: Viral Mechanisms to Dampen the Immune Response 
The evolution of virus-host relationships demands adaptation and the out-maneuvering of the 





times, and being so both the immune system of the bat and the viral adaptions to the host must be highly 
adept at compensating for the other’s evolutionary defenses (96).   
 
Numerous zoonotic viruses of bats have accessory proteins that antagonize innate immunity in 
humans.  ORF 3b, ORF 6 and N protein of SARS-CoV; the V, W and C proteins of Nipah virus; VP35 
and VP24 of Ebola virus; and VP40 of Marburg virus interfere with IFN production.  Furthermore, 
downstream effectors if IFN are inhibited.  ORF 6 of SARS-CoV; V protein of Nipah; VP24 of Ebola and 
VP40 of Marburg viruses antagonize STAT1 in the Jak/STAT pathway (140-142).   
 
An investigation of cell response to henipaviruses using primary P. alecto foetus cells (PaFe), 
primary P. alecto kidney cells (PaKi), immortalized P. alecto lung cells (PaLuT02), and immortalized P. 
alecto fetus cells (PaFeT) was conducted.  Transfection with polyI:C was used as a positive control.  
Results demonstrated that cells inoculated with virus had a decreased expression of type I and type III 
IFNS that were comparable to mock infected cells, as determined by PCR to measure mRNA, and ISG 
production was also suppressed, specifically ISG54 and ISG56.  In vitro research in human cell lines also 
demonstrated IFN antagonism in response to virus; however, the viral protein that antagonizes the 
response between bats and humans seems to be different for Hendra virus.  In human cell lines it is the 
protein products from the viral P-gene, but not so in bat cell lines, but the mechanism in bat cells has yet 
to be elucidated (143).  
 
Myxovirus resistance (Mx) genes are ISGs that respond to viral infection by disrupting viral 
structures.  Mx1 genes were cloned from six different immortalized bat cell lines belonging to Seba’s 
short-tailed bat, Daubenton’s bat (Myotis daubentonii), common pipistrelle bat (Pipistrellus pipistrellus), 
straw colored fruit bat, hammer-headed bat, and Egyptian fruit bat.  Mx1 expression had a suppressive 





reservoir for Ebola virus.  In addition to Ebola virus, bat Mx1 antagonized viral polymerase activity for 
Rhabdoviridae and Bunyaviridae (144).  
 
In R06Ej cells (immortalized fetal Egyptian fruit bat cells) and RoNi/7 cells (immortalized kidney 
Egyptian fruit bat cells) infected with EBOV and MARV, generates a more robust innate immune 
response for MARV infected cells than EBOV infected cells.  At 24-hours post infection with EBOV, 
IFN and ISG expression was relatively unchanged in R066EJ cells and antagonized in RoNi/7 cells.  
MARV infection in these same cell lines resulted in an increase expression if IFN-  and IFN-  as well as 
ISG54 and ISG56, but did demonstrate a suppression of type I IFNs.  Viral accessory proteins VP35 and 
VP24 are critical for suppressing the innate immune response (145).     
 
This highlights that relationships between viruses and different hosts varies on a molecular level, 
which would be expected for a reservoir host that does not have disease in response to infection and may 
have co-evolved with the viruses for great lengths of time, compared to an incidental host that hat severe 
disease.   
 
1.3.3: Susceptibility to Disease 
While there is a massive amount of data to support that bats are capable of maintaining numerous 
viruses without apparent disease, it is important to state that bats are not immune to disease from 
infectious agents.  They are a mammalian species with the same over-arching mechanisms of immunity.   
 
Since 2006 white-nose syndrome has claimed an unprecedented number of bats in North 
America, upwards of millions, resulting in the fastest decline of an animal species in history.  It is a 
disease caused by Pseudogymnoascus destructans, a psychrophilic fungus that infects hibernating bats.  
The fungus affects the skin of the nose and ears, and wing and tail membranes, which results in water and 





(146).  The immune function is down regulated in a normal, healthy, hibernating bat and while wing 
lesions have few infiltrations of immune cells, infected bats demonstrate leukocytosis on complete blood 
counts.  The fungus most likely came to North America via human travel from Europe (147, 148).   
 
Due to the rapid decomposition of carcasses, it can be difficult to determine the cause for 
mortality events amongst bat species, and many infectious disease instigated die-offs may go undiagnosed 
(147, 149, 150).  Outside of white-nose syndrome, a recent review recorded 25 multiple mortality events, 
worldwide, in bats caused by infectious diseases (147).  Salmonella Enteritidis and Salmonella 
Typhimurium have been isolated from Vespertilioinidae bats.  Histopathology revealed the bats had 
interstitial pneumonia and purulent meningitis, amongst other inflammatory lesions (149).  Additionally 
in Vespertilioinidae bats, Clostridium perfringens and C. sordellii have been documented to cause 
hemorrhagic diarrhea in Europe, and Escherichia coli can cause urinary tract infections (149).  Borellia 
can cause disease and pathology (151).  A pipistrellus bat was found moribund in England and died a few 
days later from hepatitis and septicemia caused by a novel species of Borellia (152)  Pasteurella 
multocida serotype 1 is the top differential for a mortality event that occurred in big brown bats in 
Wisconsin in 2008.  Five carcasses were used as a representative population with multifocal pneumonia 
and diffuse serosal congestion or hemorrhage of the intestines appreciated on gross necropsy and 
coccobacilli visualized in vascular lumens of the lungs, liver and spleen.  Cause of death was described as 
septicemia that produced an interstitial pneumonia with P. multocida isolated from lung, liver, spleen, 
heart and mammary gland tissues (153).     
 
Viruses too, can cause pathology and disease in bats (151).  A novel adenovirus, bat adenovirus 2 
strain P. pipistrellus virus 1 (AdV-2), was identified by virus isolation on Vero E6 cells and electron 
microscopy in intestine, liver, kidney, and lung of Pipistrellus pipistrellus bats that were found moribund 
and later died.  Tissues decomposed too rapidly to accurately assess histopathology but given that no 





bat’s moribund state and death (150).  Tacaribe virus (TCRV) is an arenavirus first isolated from Artibeus 
bats in the 1950s.  During a rabies virus investigation, TCRV was isolated from bats with neurological 
disease when no rabies virus was found (154).  Nearly fifty years later, an experimental inoculation of 
Jamaican fruit bats with TCRV resulted in neurological and respiratory disease with wide tissue 
dissemination of the virus, and lesions characterized as mild to moderate neutrophilic interstitial 
pneumonia, lymphocytic leptominingitis, gliosis, and neutrophilic encephalitis (129).  Not to mention the 
well-established lyssavirus pathology with which mortality ranges from 6% to 40% in experimentally 
inoculated bats (30).  Infected bats have clinical disease and on histopathology meningoenchalomyelitis 
and nonsuppurative ganglioneuritis are seen (31).   
 
1.3.4: Ecological Perspectives on Bats as Reservoir Hosts 
A trait-based analysis that used generalized least squares demonstrated that sympatry in bats is a 
trait strongly associate with zoonotic infection (38, 39).  Sympatry in rodents is also a significant 
correlative trait to the number of zoonotic viruses; however rodent sympatry does not occur to the same 
degree as bat sympatry.  Species mingling in rodents occurs when territories overlap.  Mixed species in 
bats occurs because it is a behavioral norm for the gregarious order to roost in high densities with 
numerous species.  In fact the effect of sympatry as it correlates to disease emergence is nearly four times 
greater in bats compared to rodents (38).  Given that there has been a natural case of species hybridization 
in bats (12), and limited molecular phylogeny conducted on bats to concrete taxonomic relationships, it 
may be that bats of different species interbreed on a regular basis and this produces a greater rate of bat 
genomic variation.  This could be a factor in co-evolution between the hosts and the viruses.   
 
Numerous bat species, of both temperate and tropical varieties, migrate (155, 156).  North 
American species of bats will migrate south for the winter or migrate dependent on seasonal food 
availability.  Tropical bat species have been documented to migrate to breeding grounds (155).  African 





months, and up to 500 km within a few days’ time.  Migration is motivated by spatial and temporal 
availability of fruit, traveling to those areas where fruit is most abundant (156).  The fact that bats are 
capable of flight, allowing for them to cover large distances, may facilitate viral spread to both naïve bat 
populations and/or to areas where human-bat interactions are heightened (97, 98, 156).    
 
1.4: Anthropogenic Change Facilitates Viral Emergence 
There is an unprecedented amount of research directed towards bats as “special” and the 
mechanism by which they are exceptional reservoir hosts.  The difficulty in the word “special” is that it 
infers a human-centric perspective on disease emergence.  It asks what is different about bats that allow 
them to have such a substantial impact on human health, but does not consider the reverse.  What is 
“special” about humans that facilitates disease emergence from bats?  When the focus shifts from bats as 
“special” to humans as “special” it becomes easy to ascertain alterations in human activity that have 
occurred since the documented emergence of Marburg virus in 1967, and subsequent emergence of the 
numerous bat-associated human pathogens since.  
 
With more than seven billion people on Earth and the exponential growth in human population, 
the line that separates human territory from natural habitats becomes ever-increasingly blurred and 
interactions between humans and wildlife surge.  Resource consumption intensifies in order to provide for 
the number of people on Earth.  Tropical deforestation occurs at a global rate of 2-3% with land use 
driven by agriculture, lumber harvesting, road construction, urban expansion, mining and more (157).  
Between 1990 and 2015, 129 million hectares of forest have been lost.  This is an area the size of South 
Africa (158).  Loss of habitat is predominantly due to deforestation and may make previously secluded 
bat populations more accessible for hunters.  Logging and slash and burn techniques directly decrease bat 
habitats but also, combine with human landscape alteration, alters environmental landmarks, such as 






Alterations of the natural landscape for human use will bring humans markedly close to wildlife 
species and with 75% of human emerging infectious diseases tied to wildlife (160), this may make people 
vulnerable to an even greater number of EIDs (161).  Expansion in urbanization and increased contact 
between bats and humans is identified as a major risk for viral spillover (39, 162).  The emergence of 
Hendra virus into human populations is linked to anthropogenic change.  Bats took advantage of human 
food sources, including fruit trees planted in horse paddocks.  Consequently bats migrated less and local 
populations increased four-fold between 1999 and 2014, increasing interactions between bats, horses, and 
humans that created an opportunity for Hendra virus emergence (162).  Interesting that it is the lack of 
migration that resulted in disease emergence when it is the migratory capacity of bats that is implicated in 
disease spread.  It may be that a deviation from normal behavior due to human interaction is the greater 
risk for viral exposure and spillover.    
 
Carbon emissions have increased 90% since 1970.  Seventy-eight percent of this is due to fossil 
fuel combustion from human use (163).  Between 1940 and 2006, the global mean surface temperature 
increased 0.55C (164, 165).  2016 was the third year in a row to set a new record for global average 
surface temperature, driven by a rise in carbon emissions (166).  Rising temperatures result in rising sea 
levels, distorted seasonality, and altered landscapes (164, 165).   
 
The combination of climate change and deforestation were driving factors in the emergence of 
Nipah virus.  Epidemiological studies traced the emergence of Nipah virus to anthropogenic forest burn 
exacerbated by El Nino event in 1997—1998.  Anthropogenic burning is one of the greatest threats to 
rainforest destruction.  The intention is to clear areas of land for industrial crops or burn agricultural 
waste.  In 1997 rainforest in Kalimantan and Sumatra were burned (167).  At this same time was a record 
holding El Nino Southern Oscillation event.  Every few years, over the tropical eastern Pacific Ocean, 
there are fluctuations between warming and cooling phases in combination with high and low air surface 





variable from drought to flooding in the tropics and subtropics (168).  The 1997—1998 El Nino event 
resulted in drought in Southeast Asia.  The anthropogenic fires were exacerbated by the drought, resulted 
in five million hectares of land burned, and a dense haze that was most severe in south Malaysia in the 
region of the first Nipah virus outbreak.  While it is unclear the full extent that such air pollution has on 
the environment, oral local histories declare that there was severe crop failure due to the haze and so it is 
possible to assume that rainforest flowering and fruiting was decreased as well.  Loss of habitat, and 
decreased flowering and fruiting altered natural fruit bat ecology, and may have forced bats to migrate to 
cultivated orchards.  Prior to 1997 and 1998, Malayan flying foxes were not observed in the orchards that 
surround pig farms by local farmers, after 1998 they were, and fruit partially eaten by bats had been found 
in pigsties—offering a route of exposure of pigs to bats and Nipah virus and ultimately spillover into 
humans (167).  
 
Analysis predicts that 15% to 37% of plant and animal species will be extinct by 2050 due to 
climate change (169).  We are currently in Earth’s sixth mass extinction.  Species are being lost at an 
unprecedented rate.  Over the last century, conservatively, 200 species of vertebrates have gone extinct.  
Measured against the background extinction rate that has occurred over 2 million years, these 200 species 
should have taken 10,00 years to disappear.  The rate of loss of biodiversity is attributed to deforestation, 
consumption of natural resources, toxification, disease, and climate change, but ultimately the product of 
human over-population and over-consumption (170).  While climate change is considered a factor in 
species loss, a trait-based analysis demonstrated that prior mass extinctions had a uniform distribution of 
loss regardless of body size as it pertains to oceanic species.  Larger-bodied species were lost at the same 
rate as small-bodied species.  Losses in the modern oceans have all had large body masses, indicating that 
we have not yet seen loss due to climate change.  Climate change results in the acidification of oceans and 
subsequent loss in benthic marine micro fauna, which leads to nutrient pollution, and a lack of oxygen in 





compare to species decline as a product of human encroachment and over-fishing.  The negative impact 
of climate change has not yet fully started (171). 
 
Illegal wildlife trafficking is ranked among the top ten most profitable black-market trades and is 
estimated to generate between $7 and $10 billion annually.  It is actualized in the form of poaching and 
trapping to sell bush meat, prized wildlife parts, and live animals for the exotic pet trade (172).  It is 
estimated that tropical wildlife species are being hunted for bush meat six times the sustainable rate (173).  
A review of the multiple mortality events (MMEs) in bat that have occurred globally since 1790 
determined that the number one cause of bat losses is anthropogenic in origin, and account for 54% of all 
MMEs, in particular wind turbines.  While wind turbines remain the number one cause of MMEs, 
documented intentional killings of bats by humans account for 205 events out of 1180 (147). 
 
Intentional killing of bats predominates in the Eastern Hemisphere—where all of the non-rabies 
bat-related EIDs originate—compared to the Western Hemisphere.  People kill bats for food in Asia and 
Africa.  In Africa, straw colored fruit bats are the species of choice, the proposed reservoir for Ebola virus 
(147), and encroachment on bats may have instigated the emergence of Ebola and Marburg virus (174).  
In Asia bats are frequently taken to animal markets.  The spillover event of SARS-CoV from the 
incidental host, masked palm civets (Paguma larvata) to humans occurred in Xinuan Live Animal Market 
in Guangdong Province, China (175, 176).  In Borneo in 2003, 4500 large flying foxes (P. vampyrus 
natunaei) were killed for food in one day (147).  On Niue Island in the South Pacific, 1555 pteropus bats 
were shot between 1998 and 1999; an estimated 38% to 76% of the population (173).  Anecdotally, in 
North Sulawesi culture in Indonesia, flying foxes have been consumed for decades.  In the 1970s the 
economic benefit of selling bats in markets was appreciated, and instigated an increase in bat hunting.  As 
local bat populations dwindle, the rate of importation of flying foxes from Borneo increased so that locals 
never appreciate a market deficit and bat population decline.  Approximately 45 to 75 flying foxes are 





bats are sold.  The bats that are most frequently eaten in Indonesia are listed as CITES Appendix I or II 
animals, but there is no local enforcement to prevent hunting (177).  Pteropid bat hunting has doubled in 
Malaysia since 1996 (173).  
 
In Australia pteropid bats are shot, trapped, exterminated with explosives, burned, and 
electrocuted with electric grids.  Millions of bats have been killed in the name of crop protection (147).  
In Europe and North America, bats are terminated by similar means as in Australia but also via 
fumigation, although documentation suggests to a lesser extent than in Australia.  In South America, 
where rabies transmission from vampire bats has become a public health threat, bat killing occurs 
indiscriminately of species with fumigation, electrocution, intentional disease introduction, shooting, and 
trapping (147).  Bats are long-lived animals with a low reproductive rate and replacing their losses will 
take a long time (178).  Of the more than 1100 bat species, the International Union for the Conservation 
of Nature (IUCN) lists 18 as Critically Endangered, 40 as Endangered, and 83 as Vulnerable (179-182).   
 
1.5: Conclusion 
 There is no doubt that bats harbor more zoonotic pathogens than any other species.  Elucidating 
the mechanism by which this occurs may reveal a means by which intervention can be implemented and 
decrease risk of spillover.  The principle ecological trait that has been revealed to correlate to the ability 
to harbor zoonotic pathogens is sympatry—inter-mingling of species, yet a real-world demonstration of 
how this has impacted disease emergence has yet to be seen.  The immunological profile of bats suggests 
they constitutively express type I IFN.  This imparts that a major immune defense that is typically 
activated in the face of infection is already “on” in bats and may mitigate viral infection and propagation.  
Furthermore, bats may not undergo somatic hypermutation, which would be a weakness in their learned 
immunity and decrease affinity maturation.  This may be a mechanism by which bats can circulate and re-





another bat species.  More research needs to be conducted to determine how evolutionarily conserved 
physiology is across bat species. 
 
Ultimately the reasons behind disease emergence are a tangled web of viral ecology, host 
ecology, natural ecology, and human encroachment where one size may not fit all.  Delineating a clear 
explanation will take much concerted effort.  By exploring novel viruses in Jamaican fruit bats and 
studying the resultant pathology we hope to add to the repertoire of data to understand the role bats play 
in disease emergence.  
 
1.6:  Rationale for the Current Study 
 The overall aim of the study described in the next four chapters was to better understand disease 
processes of novel viruses in bats.  A captive Jamaican fruit bat colony (Artibeus jamaicensis) is 
maintained at Colorado State University, and the following two chapters used these bats to conduct 
experimental inoculations of bat influenza virus and Zika virus to elucidate pathophysiology. Expanding 
upon experimental inoculations, we also conducted field research and serological investigations for 
evidence of Tacaribe virus in Trinidadian fruit bats.  The final chapter of this work details de novo 
sequencing of the Jamaican fruit bat genome to lay the groundwork for future projects that require bat 
specific reagents. 
 
H17N10 and H18N11 influenza A viruses were discovered in New World bats in 2010 and 2011 
(181, 182).  These viruses are highly divergent from other influenza A viruses and incite intrigue as to the 
role bats play in influenza virus ecology (179-182).  This chapter describes the use of rescued bat 
influenza viruses to conduct the first in vivo bat investigations since discovery of the viruses.  Route of 
transmission and susceptibility of naïve bats were included in overall study design.  This work is 






 Zika virus (ZIKV) was first introduced into the New World in 2014 and quickly spread 
throughout South America, Central America and the Caribbean (183, 184).  Limited research was 
conducted in the 1950s and 1960s that explored susceptibility of bats to Zika virus, and found bats could 
be infected (179-182).  Given that Jamaican fruit bats are endemic to a spatial geography that overlaps 
with current presence of Zika virus in the Western Hemisphere, and that both wild New World bats and 
Old World bats have been found with evidence for dengue virus and chikungunya virus infection (viruses 
related to ZIKV) (13, 185), we sought to investigate the susceptibility of Jamaican fruit bat to ZIKV to 
ascertain if they might be a reservoir host.  Dengue virus, chikungunya virus and ZIKV are all vectored 
by Aedes mosquitos, and evidence of dengue and chikungunya virus infection in bats implies that the 
vector for ZIKV will feed on bat species (179-182, 186).  Additionally, experiments were conducted with 
postulation that these bats may serve as a unique animal-model for ZIKV infection.  This work is 
described in chapter three. 
 
 The experiments described in chapter two and chapter three both investigate the adaptive immune 
response, potential morbidity, gross pathology and histopathology, viral tropism, and time course of 
disease to their perspective viruses.  Taken together these experiments further the understanding of 
pathophysiology in bats and expand knowledge on virus-host ecology.  These two virus types in bats may 
be usable as models to better understand the role of bats as reservoirs, given the viruses cause minimal 
pathology.   
 
Chapter four details the serological investigation of Tacaribe virus (TCRV) exposure in wild-
caught fruit bats.  TCRV is a New World mammarenavirus that was first isolated from moribund bats and 
a single mosquito pool in the 1950s (154).  Serological studies in the 1960s surveyed more than 2,000 
animal species and found bats to be the only animals with antibody titers to TCRV (187).  TCRV was not 
isolated again until just recently where it was discovered in questing amblyomma ticks in Florida (188).  





that rodents are the reservoir for multiple arenaviruses, not bats.  The research described in this chapter 




























CHAPTER 2: INFECTION AND PATHOLOGY OF BAT INFLUENZA VIRUSES IN 
JAMAICAN FRUIT BATS (ARTIBEUS JAMAICENSIS) 
 
2.1: Introduction 
In 2009 and 2010 two novel influenza viruses were discovered in two different bat species in 
South America.  Later classified H17N10 and H18N11 for the newly discovered hemagglutinin and 
neuraminidase glycoproteins, these viruses align most closely with group one influenza A viruses (IAV), 
yet are highly divergent (181, 182).  Because these viruses were detected in animals that garner much 
scientific attention, and because the viruses deviate from canonical understanding of influenza viruses, 
many questions are raised; are bats a natural reservoir of influenza viruses, is zoonosis a risk, what 
information can be gleamed in regards to influenza virus evolution (179, 180)?  
 
The H17N10 IAV was discovered in rectal swabs collected from three little yellow-shouldered 
bats (Sturnira lilium) out of 316 rectal swabs collected from 21 different bat species in Guatemala.  
Samples were collected in 2009 and 2010 and positive samples detected by qRT-PCR using pan-influenza 
primers (181).  The H18N11 IAV was discovered in samples collected from a flat-faced fruit bat 
(Artibeus planirostris) in 2010 in Peru.  Of the 110 animals screened from 18 different species, one flat-
faced fruit bat rectal swab, and correlating intestinal tract were positive via qRT-PCR using pan-influenza 
primers.  Fifty-five of the 110 animals tested were seropositive for H18N11 (182).  These are the only 
publications that describe the identification of bat influenza viruses in wild populations of bats.  The 
viruses themselves were not isolated (181, 182).  Next generation sequencing with de novo assembly and 
RT-PCR amplicon-based Sanger sequencing identified the viral genome sequences of both viruses (181, 
182).   
 
The hemagglutinin (HA) glycoprotein of IAV facilitates virus attachment to the sialic acid 





glycoprotein functions in viral release by cleaving sialic acid from viral glycoproteins (103).  Structural 
analysis revealed that H17N10 and H18N11 HA and NA proteins are similar to their related counterparts; 
however, there are critical differences (182, 189-192).  The receptor-binding cavity of H17 and H18 is 
much smaller than other HAs, which may inhibit binding with sialic acid.  Additionally, in other IAVs, 
uncharged residues permit binding to the negatively charged sialic acid, but in bat influenza HAs these 
same residues are negatively charged and may repel sialic acid (182, 190, 192).  If bat influenza HAs do 
not bind sialic acid then bat influenza NAs may not need to function as a neuraminidase (193).  While bat 
influenza NAs share the same homotetrameric structure as the established IAV NA, bat influenza NAs 
have a wider 150-cavity—an additional cavity adjacent to the active site of almost all group one NAs.  
Furthermore, the established conserved active site and framework amino acids vary in bat influenza NAs 
(182, 189, 191, 194). 
 
Structural suppositions were corroborated with experiments that used both pseudotyped and 
rescued bat influenza virus.  Protease-treated rhabdoviruses, with native glycoproteins deleted and 
expressing bat influenza glycoproteins, yield limited cell tropism.  Human, monkey, bat, canine, porcine 
and avian cell lines failed to support viral infection and propagation.  There are a few cell lines that permit 
viral propagation including bat cell lines, MDCK-II, and RIE 1495 cells (195-197).  Pseudotyped virus 
research has allowed for the acquisition of the following information:  HA cleavage is necessary for 
cellular infectivity, HA mediates attachment and entry, a low pH may be required for membrane fusion, 
and bat influenza HAs use a receptor other than sialic acid (195, 196).  Reverse genetics to rescue all 
eight gene segments of influenza viruses was first established in 1999 and has since become an 
established practice in influenza virus research (198-200).  The rescue of H17N10 virions, propagated 
through reverse genetics, supported research using pseudotyped viruses, and indicated an inability to 
infect canine, mink, porcine, primate, human and bat cell lines (201).  Combined with pseudotyped virus 






The majority of the research conducted to date to characterize bat influenza viruses has occurred 
in vitro.  No research has been conducted in vivo in any bat species.  With the successful generation of 
H17N10 and H18N11 viruses through reverse genetics, generously donated by Dr. Wenjun Ma at Kansas 
State University, we were able to investigate susceptibility of Jamaican fruit bats (Artibeus jamaicensis) 
to both rescued H17N10 and H18N11 viruses.  The objective of the studies presented here were to 
determine susceptibility, disease characterization, pathophysiology, organ burden and antibody response 
to the viruses.  Given that bat cell lines from numerous bat families supported pseudotyped viral infection 
(196), we hypothesized that Jamaican fruit bats would be susceptible to infection.  Moreover, we 
hypothesized viral tropism would target tissues of the gastrointestinal tract as bat influenza viruses were 
first identified in rectal swabs of bats (181, 182).    
 
2.2: Methods and Materials 
2.2.1: Bats 
All bat procedures were approved by the Colorado State University (CSU) Institutional Animal 
Care and Use Committees and were in compliance with U.S. Animal Welfare Act.  CSU maintains a 
captive colony of Jamaican fruit bats (Artibeus jamaicensis).  The colony was first established at CSU in 
2016 as a subset of bats from the University of Northern Colorado.  The colony been closed since 2006.  
Bats are kept in a free flight room measuring 1λ’w x 10’l x λ’h.  Roosting baskets are hung from the 
ceiling throughout the room and drapes of different cloth material are positioned for hanging and roosting.  
Ambient temperature is maintained between 20°C and 25°C, with humidity between 50% and 70%, and a 
12 hour light/12 hour dark light cycle via a computer-controlled system.  Bats are fed from multiple 
feeding trays once a day a combination of fruits, Tekald primate diet (Envigo, Huntington, UK), 
molasses, nonfat dry milk and cherry gelatin.  Water is provided in a water tray.  In addition, fruit is hung 






For infection experiments, bats were trapped using a butterfly net and placed in an β0” d x 1β” w 
x 1κ” h cage for 24 hours prior to inoculations to allow for acclimation.  Hanging clothes were provided 
for roosting and coverage.  Food and water were placed in open trays in the bottom of the cage and 
changed daily.  Tray liners were changed every two days, and cages and hanging clothes were changed 
every two weeks.  Due to the social nature of these bats, a minimum of two bats were kept in cages at all 
times to mitigate potential stress. 
 
2.2.2: Virus 
Bat influenza viruses have not been isolated from the wild (181, 182).  Reverse genetics was used 
to rescue both bat influenza viruses (H17N10 and H18N11), and were generously provided by Dr. Wen 
Jun Ma at the Department of Diagnostic Medicine/Pathology, College of Veterinary Medicine, Kansas 
State University (KSU), Manhattan, Kansas, USA (201).  
 
2.2.3: Experimental Infection—H17N10 
A pilot study using male bats was conducted to determine susceptibility of Jamaican fruit bats to 
H17N10 IAV.  Male bats were used in both pilot studies because females are prioritized for breeding and 
colony expansion.  Bats were anesthetized with 1% to 3% isoflurane to effect with an oxygen flow rate of 
1.5 L/min, administered with a gas mask.  Animals were placed on a heating pad to maintain body 
temperature and respirations monitored continuously.  Twenty-five microliters of media containing of 
H17N10 was inoculated intranasally with a micropipette—12.5ul into each nostril.  Due to the limited 
tropism in cell culture, a cell culture system had not yet been optimized to determine virus titers.  Bats 
were held upright for one minute to prevent inoculum from draining out of nostrils.  When procedures 
were finished bats were removed from isoflurane and placed back in the cage in ventral recumbency.  
Respirations were monitored until animal was fully awake and ambulated normally.  Animals were 
euthanized at 28 days post-inoculation (DPI).  All procedures were performed in a biosafety cabinet at 





2.2.4: Experimental Infection—H18N11   
Two sets of experiments were performed; a pilot study and a time course study.  For the pilot 
study, three male bats were anesthetized and procedures carried out with the same methods as for the 
H17N10 pilot experiment. Similar to H17N10, an initial viral titer for H18N11 had not yet been 
established for the pilot study.  One of the bats died during recovery from anesthesia and gross necropsy 
performed.  The cause of death was not determined but likely due to complications from anesthesia.  The 
remaining two animals were euthanized at 28 DPI.  All procedures were performed at a biosafety level 
two.  Bats from this study are identified as AJ-1p and AJ-2p. 
 
 For the time course study 10 bats (5 male and 5 female) were anesthetized under the same 
protocol as the pilot studies.  Animals were then placed in ventral recumbency and the dorsum of each 
animal was sprayed with 70% ethanol.  IPTT300 transponders (BioMedic Data Systems, Inc., Seaford, 
DE) were inserted subcutaneously (sc) at the level of the caudal edge of the scapula following delivery of 
0.15 mls of 1% lidocaine. Animal IDs were as follows:  AJ-h1, AJ-h2, AJ-h3, AJ-h4, AJ-h5, AJ-h6, AJ-
h7, AJ-h8, AJ-h9, and AJ-h10.  Twenty-five microliters of H18N11 containing 7.5x105 50% tissue culture 
infective dose (TCID50) was inoculated intranasally with a micropipette under isoflurane anesthesia as 
described above.  Four bats (2 males, 2 females) were placed in one cage and six bats (3 males, 3 females) 
were placed in a second.   
 
 Two days post inoculation of AJ-h1 thru AJ-h10; two naïve bats (one male, one female) were 
anesthetized under the same protocol and IPTT 300 transponders inserted.  These bats, identified as AJ-
t11 and AJ-t12, were not inoculated with H18N11.  AJ-t11 and AJ-t12 were used to study the natural 
transmission cycle of H18N11, and were placed in the cage of four inoculated bats to be exposed to 
experimentally inoculated animals.  The transmission bats remained in the cage with inoculated bats for 






AJ-h1 (male) and AJ-h2 (female) were euthanized at 3 DPI.  AJ-h3 (female) and AJ-h4 (male) 
were euthanized at 6 DPI.  AJ-h5 (male) and AJ-h6 (female) were euthanized at 10 DPI.  AJ-h7 (male) 
and AJ-h8 (female) were euthanized at 17 DPI.  AJ-h9 (male) and AJ-h10 (female) were euthanized at 28 
DPI along with AJ-t11 (male) and AJ-t12 (female)—the two transmission bats.  The transmission bats 
were exposed for a total of 26 days before euthanasia.  Experimental design, including time points for 
euthanasia, necropsies, and tissue collection, and animal identifications are diagramed in figure 2.1.   
 
 
Figure 2.1: Diagram of experimental design.    AJ-h1 thru AJ-h10 represent bats inoculated with 
H18N11 on day 0.  Green hued bats represent AJ-t11 and AJ-t12, the transmission bats exposed to 
inoculated bats two days after inoculation.  Translucent bats indicate animals that were euthanized with 
euthanasia time points immediately to the right.  Blue arrow indicates time points swabs were collected 
for inoculated bats, green arrow indicates time points swabs were collected for transmission bats.  The 










2.2.5: Monitoring and Swabs  
Bats were monitored twice a day through the duration of the experiment for any deviations from 
normal.  In particular food intake, presence of lethargy, inability to ambulate, respirations, nasal or oral 
discharge, and fecal consistency were assessed.  
 
For both the H17N10 and H18N11 pilot studies oropharyngeal and rectal swabs were collected 2, 
4, 7, 15, 21 and 28 DPI.  For the H18N11 time course study, rectal swabs were collected from all existing 
animals at 2, 3, 6, 10, 17 and 28 DPI for inoculated bats.  Because of the study design—transmission 
animals added two days after inoculation—the transmission bats had rectal swabs collected at 1, 4, 8, 15, 
and 26 days post exposure (DPE).  With euthanizing two inoculated bats at each pre-determined time 
point, inoculated animals had rectal swabs taken as follows:  all 10 bats at 3 DPI, 8 bats at 6 DPI. (AJ-h3, 
AJ-h4, AJ-h5, AJ-h6, AJ-h7, AJ-h8, AJ-h9, AJ-h10), 6 bats at 10 DPI (AJ-h5, AJ-h6, AJ-h7, AJ-h8, AJ-
h9, AJ-h10), 4 bats at 17 DPI (AJ-h7, AJ-h8, AJ-h9, AJ-h10), and 2 bats at 28 DPI (AJ-h9, AJ-h10).  
Time points for swabs are diagramed in figure 2.1.  For rectal swabs, a sterile polyester tipped applicator 
(Puritan, Guilford, ME) was inserted into the rectum and swirled gently.   For oropharyngeal swabs, a 
sterile polyester tipped applicator (Puritan, Guilford, ME) was inserted into the oral cavity and swirled 
gently.  Applicators were placed in 500 ul of sterile brain heart infusion broth (BHI) (Millipore Sigma, St. 
Louis, MO) prepared according to manufacturer’s directions.  Swabs were stored at -80°C until use.   
 
2.2.6: Euthanasia and Necropsy 
Bats were anesthetized and maintained with 3% isoflurane and an oxygen flow rate of 1.5 L/min.  
Depth of anesthesia was assessed by firmly pinching skin and toes to test for response.  When deep 
anesthesia was achieved a thoracotomy was performed by puncturing through the skin, skeletal muscle, 
and diaphragm just caudal to the sternum with sterile standard scissors.  A cut was made through the chest 
cavity to allow the heart to be visualized.  Bats were maintained on isoflurane until breathing ceased for 





Cardiac blood was collected with a 21 gauge sterile hypodermic needle.  A total blood volume of 
between 1 and 1.5 ml was collected in a syringe and transferred to a serum separator tube (SST).  SSTs 
were inverted approximately 10 times, allowed to sit at room temperature for one hour for clot formation 
and centrifuged at 1000 x g for 10 min at room temperature.  Serum was removed from the clot, placed in 
a sterile microcentrifuge tube and stored at -20°C.      
 
Necropsies immediately followed euthanasia.  Sterile instruments were used to collect heart, lung, 
liver, spleen, gastrointestional tract, reproductive organs, kidneys, bladder, mandibular salivary glands, 
nasal turbinates, brain and tonsils from all animals.  A 1:10 w/v portion of the tissue was immersed in 
10% buffered-formalin.  A second portion of tissues were placed in microcentrifuge tubes and stored at -
80C for PCR.       
 
2.2.7: Negative Control Bats 
 One male and one female bat (identified as AJ-NCm and AJ-NCf) were trapped from the colony 
and kept in the same type of cage as used to house bats for experimental infections.  Bats were housed in 
the same conditions as experimental animals and euthanized after six days of being kept in the cage.  
Necropsies were immediately performed and tissues and blood collected.  Euthanasia, necropsy and blood 
collection procedures were the same as for inoculated and transmission animals.   
 
2.2.8: RNA Extraction 
RNA extractions were performed using TRIzol Reagent according to Ambion Life Technologies 
protocol for tissues and swabs.  For swabs, applicators were vortexed in the BHI with which they were 
stored.  Two-hundred microliters of BHI was used per one ml of TRIzol Reagent.  For tissues, one ml of 
TRIzol Reagent was added to approximately 50 mg of tissue and a 5 mm stainless steel bead (Qiagen, 
Valencia, CA).  Tissues were homogenized with a TissueLyser LT (Qiagen, Valencia, CA) at 50 Hz for 5 





chloroform (Thermo Fisher Scientific, Waltham, MA) was added, samples vortexed, incubated for 3 
minutes at room temperature, and centrifuged at 12,000 x g for 15 minutes at 4°C.  The aqueous phase 
was removed, placed in a new microcentrifuge tube, and 4 ug of glycogen (Thermo Fisher Scientific, 
Waltham, MA) with 500 ul 100% molecular grade isopropanol added (Thermo Fisher Scientific, 
Waltham, MA).  Samples were incubated at room temperature for 10 minutes and centrifuged at 12,000 x 
g for 10 minutes at 4°C. Supernatant was discarded and 75% molecular grade ethanol (Thermo Fisher 
Scientific, Waltham, MA) was added to the RNA pellet, samples vortexed briefly and centrifuged at 7500 
x g for 5 minutes at 4°C.  Supernatant was discarded and RNA pellets allowed to air dry for 10 minutes.  
RNA was re-suspended in RNase-free water and stored at -80°C.      
 
2.2.9: qRT-PCR 
 Probe-based quantitative reverse transcription PCR (qRT-PCR) was performed with primers and 
probes that target the nucleocapsid protein (NP) gene for both H17N10 and H18N11.  Primers were 
designed using the published viral sequences (National Center for Biotechnology Information) and Primer 
Express 3.0 (table 2.1).  The probe targeted a sequence that had 100% nucleotide identity between 
H17N10 and H18N11 so that the same probe could be used in either reaction.  Roche Real Time Ready 
RNA Virus Master Kit (Roche, Indianapolis, IN) was used on according to manufacturer’s instructions.  
Two-hundred nanograms of sample RNA was used per reaction and reactions were done in technical 
duplicates.  A light-cycler 96 (Roche Diagnostics Corporation, Indianapolis, IN) was used.  Amplification 
was performed according to manufacturer’s protocol for Roche Real Time Ready RNA Virus Master Kit 
(Roche Diagnostics Corporation, Indianapolis, IN) with PCR conditions as follows:  8 min at 50°C, 30 s 
at 95°C, and 45 cycles of 10 s at 95°C, 20 s at 60°C and 10 s at 72°C.  For the time course H18N11 study, 
log dilution series was made of the stock virus, which had a known TCID50, and linear regression applied 







Table 2.1: Primer-probe sequences for H17N10 and H18N11.   
Primer Name Sequence 
H17N10 forward primer 5’-GAGAATCACAGACATGAGGACTG-γ’ 
H17N10 reverse primer 5’-CCCTCGTCATTCCCATCTAGTGGA-γ’ 
H18N11 forward primer 5’ -AAGAATCACTGACATGAGAACTG-γ’ 
H18N11 reverse primer 5’-CCCTCGTCATTCCCATCCAAAGAA-γ’ 
Shared probe sequence 5’-FAM/CAACTAACC/ZEN/CGATAGTGCCT/3IABkFQ-γ’ 
 
 
2.2.10: Histology—Hematoxylin and Eosin Stain (H&E)   
Tissues were fixed in 10%-buffered formalin, cut in, and submitted to Colorado State University 
Veterinary Diagnostic Laboratory (CSU VDL, Fort Collins, CO) for paraffin embedding, sectioning and 
staining with hematoxylin and eosin.  
 
2.2.11: Serology—ELISA  
ELISAs were performed on serum collected from the H18N11 time course bats to assess for 
antibody against H18N11 nucleoprotein (NP).  H18N11 NP antigen was generously provided by Martin 
Schwemmle from the Institute of Virology, University Medical Center Freiburg, Germany.  Ninety-six-
well tissue culture plates were coated with NP antigen at a concentration of 0.5 ug/ml antigen diluted in 
PBS.  Plates were kept at 4C for 12 hours and then washed twice with PBS, and blocked with 0.5% 
bovine serum albumin (BSA) for 30 minutes at room temperature.  Plates were then washed twice with 
PBS.  Bat serum samples were diluted 1:100 in PBS and then two-fold serial dilution series was 
performed with the highest dilution 1:3200.    Fifty microliters of each dilution of serum was added in 
duplicates to wells.  Plates were incubated for one hour at room temperature and washed three times with 
0.5% Tween 20-PBS.  HRP-conjugated protein A/G (Thermo Fisher Scientific, Waltham, MA) was added 
at a concentration of 2 ug/ml and incubated for 30 min at room temperature.  Plates were washed four 
times with 0.5% Tween 20-PBS and 150 ul of ABTS Peroxidase Substrate (2 component) (KPL, 





room temperature.  One-hundred and fifty microliters of ABTS Peroxidase Stop solution (KPL, 
Gaithersburg, MD) was added and plates were read on an EMax Plus Microplate Reader (Cambridge 
Scientific, Watertown, MA) at OD 405.  Limit of detectable response was set at three standard deviation 
values above mean negative control serum.  
 
2.3: Results 
2.3.1: Experimental infections – H17N10 
 A pilot study was conducted for H17N10 to determine if Jamaican fruit bats were susceptible to 
the rescued virus.  Three male bats were experimentally, intranasally inoculated and monitored twice 
daily for 28 days for signs of clinical disease.  No overt clinical signs of disease were observed 
throughout the duration of the study.  
 
2.3.2: Experimental infections – H18N11 
 Two different experiments were conducted for H18N11: a pilot study and a time course study.  
For the pilot study, two male bats (AJ-h1, AJ-h2) were inoculated and monitored twice daily for 28 days 
for clinical disease.  Bats did not exhibit any signs of clinical disease throughout the duration of the study.  
 
 The time course study used 12 bats.  Ten bats, five male and five female (AJ-h1, AJ-h2, AJ-h3, 
AJ-h4, AJ-h5, AJ-h6, AJ-h7, AJ-h8, AJ-h9, AJ-h10) were inoculated with H18N11, 7x105 TCID50.  Two 
additional animals that were not inoculated, one male and one female (AJ-h11t and AJ-h12t) were 
exposed to inoculated bats.  
 
AJ-h12t had mild ocular and nasal discharge, and mild epiphora 6 days post exposure (DPE).  
Both AJ-h12t and AJ-h11t had mild ocular and nasal discharge and mild epiphora 15 DPE.  No 





throughout the duration of the study.  Food consumption were within normal limits.  Production of urine 
and feces were within normal limits. 
 
 One male and one female were used as negative control bats.  Bats were housed in the same size 
cage as infection/transmission bats and received the same husbandry as infected animals.  Bats were 
visually assessed daily for any abnormalities, of which there were none, and were euthanized six days 
after being kept in the cage. 
 
2.3.3: Euthanasia and Necropsy 
 The three bats in the H17N10 study and two bats in the H18N11 pilot studies were euthanized 28 
DPI and necropsies immediately performed.  No gross pathology was observed in any organs.   
 
For the time course study with bats inoculated with H18N11, bats were euthanized and necropsies 
immediately performed.  Gross pathology in the form of congestions was observed in the lungs at time 
points: 3, 6, 10 and 17 DPI.  AJ-h9 had similar lung pathology at 28 DPI while AJ-h10 and the two 
transmission bat lung tissues were within normal limits.  Serosanguinous pleural effusion was present in 
the thorax upon necropsy of AJ-h7 and AJ-h8, 17 DPI.  Negative control animals had mildly congested 


















Table 2.2: Gross lung pathology in time point study Jamaican fruit bats inoculated with H18N11 




























-  indicates no significant gross pathology.  +  indicates mild pathology.  ++ indicates moderate 




2.3.4.1: qRT-PCR H17N10   
Quantitative probe based reverse transcription PCR (qRT-PCR) was performed on rectal and 
oropharyngeal swabs collected at 2, 4, 7, 15, 21 and 28 DPI.  Viral RNA was not detected in any of the 
samples.  Quantitative RT-PCR was performed on RNA extracted from lung, trachea, liver, small 
intestine, large intestine, spleen, and kidney collected 28 DPI.  Viral RNA was not detected in any of the 
samples. 
 
2.3.4.2: qRT-PCR H18N11 
 For AJ-1p and AJ-2p, the pilot study bats, quantitative probe based reverse transcription PCR 
(qRT-PCR) was performed on swabs and tissues.  Viral RNA was detected in rectal swabs on 2 and 4 
DPI.  One bat had viral RNA detected in rectal swab at 7 DPI, while the other was negative, and all 





RT-PCR was performed on lung, trachea, liver, small intestine, large intestine, spleen, and kidney 
collected 28 DPI.  Viral RNA was detected in the lung of AJ-2p with a Ct value of 30.13.  No viral RNA 
was detected in the other tissue samples.  Results are qualitative, and not quantitative, as no tittered virus 
was available to generate a standard curve due to the lack of a cell culture system.   
 
 
Figure 2.2: qRT-PCR Ct values on rectal swabs.  Both bats had viral RNA detected in rectal swabs at 2 
and 4 DPI. AJ-2p had viral RNA detected at 7 DPI, but not AJ-1p.  Remaining time points had no viral 
RNA detected.  Given that a cell culture system was not yet available to determine viral titers this data is 
qualitative and not quantitative.  
 
 For the time point study, probe based qRT-PCR was performed on rectal swabs, large intestines, 
small intestines and lung of both inoculated bats and transmission bats. Both transmission bat (AJ-t11 and 
AJ-t12) rectal swabs had viral RNA detected at 4 and 8 DPE.  The other time points for AJ-t11 and AJ-
t12 were negative (figure 2.3A).  At 3 DPI ten rectal swabs were collected from all ten inoculated bats.  
Eight out of the ten inoculated bats had viral RNA detected at 3 DPI (AJ-h1, AJ-h2, AJ-h3, AJ-h4, AJ-h5, 
AJ-h6, AJ-h8, AJ-h9).  At 6 DPI eight inoculated bats remained and rectal swabs were collected from 
each.  All eight had viral RNA detected.  At 10 DPI six inoculated bats remained and a rectal swab 
collected from each.  Three out of the six remaining inoculated bats had viral RNA detected at 10 DPI 




































Figure 2.3: TCID50 equivalents on rectal swabs from time-point study for transmission and 
inoculated bats.  A) Both transmission bat (AJ-t11 and AJ-t12) rectal swabs were qRT-PCR positive for 
H18N11 at 4 and 8 DPE.  The other time points for AJ-t11 and AJ-t12 were negative.  B) Eight out of the 
ten inoculated bats were positive 3 DPI (AJ-h1, AJ-h2, AJ-h3, AJ-h4, AJ-h5, AJ-h6, AJ-h8, AJ-h9).  
Eight out of the eight inoculated bats were positive 6 DPI (AJ-h3, AJ-h4, AJ-h5, AJ-h6, AJ-h7, AJ-h8, 
AJ-h9, AJ-h10).  Three out of the six inoculated bats were positive at 10 DPI (AJ-h7, AJ-h8, AJ-h9).  All 
subsequent time points were negative.   
 
Viral RNA was detected in large intestine with probe-based qRT-PCR at the following time 
points:  AJ-h1 and AJ-h2 at 3 DPI, and Aj-h3 and AJ-h4 at 6 DPI.  All other time points were negative in 
the large intestine (figure 2.4A).  The small intestine had positive qRT-PCR values as follows:  AJ-h1 at 3 

































































Quantitative RT-PCR on lung tissue yielded one positive at 6 DPI in AJ-h3.  All other bat lung tissues 
were negative (figure 2.4C).           
 
 
Figure 2.4: TCID50 equivalents on large intestine, small intestine and lung from time-point study.  
A)  Large intestine for AJ-h1 and AJ-h2 at 3 DPI, and AJ-h3 and AJh4 at 6 DPI were positive.  B)  Small 
intestine had positive values as follows:  AJ-h1 at 3 DPI, AJ-h3 and AJ-4 at 6 DPI C) Lung tissue yielded 
one positive at 6 DPI in AJ-h3.  All other bat lung tissues were negative.           
 
2.3.5: Histology 
Tissues cut in on bats to evaluate for histology included:  heart, lung, liver, kidney, adrenal gland, 
spleen, intestine, and salivary gland.  AJ-1p kidney had a focal area of mineralized infiltration in the inner 
medulla.  The lungs had mild perivascular and peribronchial infiltrates and iatrogenic atelectasis.  







































































glands showed multifocal sialadenitis.  All other tissues were within normal limits.  AJ-2p lungs had 
multifocal histiocytic, lymphocytic interstitial pneumonia. There were variably dense aggregates of 
macrophages, lymphocytes and plasmacytes intermixed with fewer neutrophils that expand into the 
interstitium, especially around the adventitia with occasional accentuation of peribronchial lymphoid 
tissue. In some areas, on the pleural side, macrophages show increase phagocytic activity.  Small 
intestines showed mild to moderate lymphocytic, plasmacytic and neutrophilic enteritis in which the 
lamina propria was expanded by cellular infiltrates of small to moderate numbers. Villous length was 
normal to mildly shortened.  No lesions were observed in other tissues. 
 
Tissues cut in to evaluate by histology were:  heart, lung, liver, kidney, adrenal gland, spleen, 
intestine, and salivary gland. Tissues were graded based on extensiveness of lesion and annotated as no 
significant histological lesions, mild, moderate or severe.  A grading of the histopathology lesions is listed 
in table 2.3.    
 
Table 2.3: Graded histopathological lesions in time point study bats inoculated with H18N11 and 
transmission bats.  
 
Tissues were graded based on extent of lesion and annotated as (-) for no significant histological lesions, (+) mild, 






 The negative control bats were kept in a cage for six days before being euthanasia.  AJ-NCf had a 
focal area of fibrosis at the apex of the left ventricle of the heart.  There was minimal vacuolation of 
individual cardiomyocytes and focal proliferation of endocardial endothelium with minimal infiltration of 
neutrophils (figure 2.5A).   The outer medulla of the kidney contained multifocal areas of mineralization.  
The lungs showed multifocal alveolar hemorrhages with severe congestion.  Hemorrhages occasionally 
extended to terminal bronchioles with which lumen contained detached epithelial cells (figure 2.5B).  The 
salivary gland had multifocal periductular neutrophilic infiltrates intermixed with lymphocytes and 
macrophages which occasionally spilled into serous tubules and the periglandular adipose tissue (figure 
2.5C).  All other tissues were within normal limits.  AJ-NCm heart had minimal focal segmental necrosis 
of cardiomyocytes with increased satellite cell activity that included a single mitotic figure.  Lungs were 














    
 
Figure 2.5: Histopathology (H&E) in the heart, salivary gland and lungs of negative control AJ-NCf 
A) Heart with fibrosis (F) and focal proliferation of endocardial endothelium with minimal infiltration of 
neutrophils (arrow).  B)  Lung with moderate congestion.  C)  Sialadenitis.   
 
For the time course study AJ-h1 at 3 DPE had lymphocytic interstitial myocarditis with 
multifocal individual cardiomyocyte degeneration.  The kidney had a focal area of lymphocytic and 
plasmacytic infiltration in the renal pelvis.  Lungs had multifocal microscopic alveolar hemorrhage and 
minimal perivascular lymphocytic interstitial pneumonia.  Small intestine showed mild to moderate 
increases in proprial cellularity.  No lesions were observed in other tissues.  AJ-h2 at 3 DPE had 
multifocal interstitial myocardial infiltrates of primarily lymphocytes and fewer macrophages.  The left 
ventricle showed multifocal areas of cardiomyocyte degeneration and necrosis with multifocal 
microscopic hemorrhages.  The lungs had multifocal microscopic alveolar hemorrhage and minimal 





moderate increase in proprial cellularity (figure 2.6A).  The salivary gland had multifocal lymphocytic 
interstitial sialadenitis.  No lesions were observed in other tissues. 
 
   
Figure 2.6: Small intestine of AJ-h2, 3 DPI with H18N11 compared to negative control bat (H&E).  
A)  AJ-h2 small intestine with mild to moderate increase in proprial cellularity populated with 
lymphocytes and neutrophils.  B)  AJ-NCf negative control animal.  
  
At 6 DPI AJ-h3 and AJ-h4 had similar lesions with similar severity in both the lungs and the 
gastrointestinal tract.  In the lungs of both bats there was multifocal areas of alveolar hemorrhage with 
mild suppurative interstitial pneumonia.  The small intestine of both bats showed mildly expanded lamina 
propria due predominately to lymphocytes and neutrophils.  No lesions were observed in other tissues for 
these animals.  
 
 AJ-h5 and AJ-h6 at 10 DPI had blood clots inadvertently cut in as lung tissue for histology.  Due 
to the severity of gross lung pathology it was difficult to distinguish between the two.  As a result, no 
lungs were collected for histology on these two bats.  Ten days post-inoculation time points will be 
repeated in another study.  Histological lesions were seen in the gastrointestinal tract of both bats; 
plasmacytic and lymphocytic, neutrophilic enteritis (figure 2.7).  Lesions in AJ-h6 were more severe than 





   
Figure 2.7: Small intestine of AJ-h5 and AJ-h6 at 10 DPI with H18N11 (H&E).  A)  AJ-h5 small 
intestine with mild to moderate increase in proprial cellularity populated with plasma cells and 
neutrophils.  B)  AJ-h6 shows greater infiltration of neutrophils and plasma cells, expanding both the 
lamina propria and the villi.   
  
At 17 DPI, AJ-h7 heart showed increased satellite activity in the left ventricle.  The liver had 
diffuse vacuolization of hepatocytes throughout the section.  The outer and inner medulla of the kidney 
had moderate multifocal mineralization with no associated inflammation.  AJ-h8 had myocardial 
interstitial infiltrates of lymphocytes and plasma cells.  The liver showed random cellular infiltrates of 
neutrophils and lymphocytes.  The lungs had interstitial septa slightly expanded by increased numbers of 
neutrophils and fewer macrophages and lymphocytes.  No lesions were observed in other tissues. 
 
 At 28 DPI, AJ-h9 had vacuolar hepatopathy of the liver.  Lung pathology was consistent with 
negative control animals.  All other tissues were within normal limits.  AJ-h10 kidney had minimal 
multifocal interstitial infiltrates of lymphocytes and plasmacytes with possible extramedullary 






 The transmission bats, AJ-t11 and AJ-t12 were euthanized 26 days post exposure and had 
minimal histopathology.  AJ-t11 had an inner medullary focus of mineralization of the kidney.  AJ-t12 
tissues had no lesions were observed. 
 
2.3.6: Serology—ELISA  
 ELISAs were performed to assess for antibody against the H18N11 nucleoprotein.  Bats 
euthanized at 3, 6 and 10 DPI did not seroconvert.  Bats at 17 and 28 DPI and both transmission bats 
seroconverted with titers ranging from 200 to 3200 for antibody against nucleoprotein antigen (table 2.4). 
 
Table 2.4: Immunoglobulin titers to H18N11 nucleoprotein antigen determined via ELISA.  
Seroconversion occurred at 17 DPI and 28 DPI as well as in transmission bats (AJ-t11 and AJ-t12). 
Days Post 
Infection/Exposure 
























 This study is the first to describe experimental infections of bats with the novel bat influenza 
viruses H17N10 and H18N11.  This study provides insight into transmission, clinical disease, tissue 






Neither of the bat influenza viruses has been isolated from the wild (181, 182), and so viruses 
were rescued by reverse genetics.  Reverse genetics uses cloned viral cDNA to generate virus.  In 
influenza research, reverse genetics has allowed for genome mutation and recombination to better 
understand viral transmission, replication, virulence, and pathogenesis.  It has application in vaccine 
development and anti-viral therapeutics (202).  In the case of bat influenza viruses it allowed for the 
production of full-length genomes to better understand the viruses and virus-host interactions, given the 
virus has not been isolated from the wild (181, 182, 201).  Because the viral strains used in this study 
were generated through reverse genetics from the published genome sequences, it is difficult to ascertain 
to what extent these viruses recapitulate natural, wild infection.  However, our data is consistent with the 
findings from H18N11 discovery; viral RNA detected in rectal swabs and gastrointestinal tract in an 
Artibeus bat by qRT-PCR (182).  Studies that used reporter expressing rescued influenza A viruses in 
animal models shows that pathophysiology and organ burden are consistent with wild-type viruses (203, 
204). While it is difficult to know if the rescued H18N11 exactly emulates wild-virus infection, there is 
no reason to believe otherwise.   Rescued influenza viruses are generally accepted in the scientific 
community (202, 205).    
 
 Jamaican fruit bats inoculated with H17N10 did not demonstrate apparent clinical disease, and 
virus was not detected in rectal or oropharyngeal swabs.  Thus, Jamaican fruit bats likely do not support 
H17N10 infection.  H17N10 was discovered in little yellow-shouldered bats of the genus Sturnira, family 
Phyllostomidae (181).  Bats from the genus Artibeus also belong to the family Phyllostomidae, but being 
of different genera may make them genetically distinct enough as to not support H17N10 infection. 
 
 The pilot study H18N11 bats had no signs of clinical disease.  In the time course study, mild 
disease was observed in the two transmission bats only in the form of mild ocular and nasal discharge, 
and epiphora in AJ-12t at 6 DPE, and AJ-11t and AJ-12t at 15 DPE.  No signs of clinical disease were 





Lung pathology was seen in bats in the time course study at each time point up until 17 DPI.  Lungs had 
varying degrees of congestion and cellular infiltrates (table 2.3).  Given the severity of lung pathology in 
conjunction with the lack of clinical disease in inoculated bats, it seems as if these bats are very resistant 
to behavioral changes that may impart clinical disease.  This type of stoicism is frequently seen in wildlife 
species, which may in part explain the lack of observable clinical disease. 
 
 Lung congestion was also observed in the negative control bats, which were housed for six days 
in the same type of cage as the inoculated and exposed bats (table 2.2).  This would suggest that lung 
pathology is not solely the product of viral infection but there are other components altering normal 
physiology.  These components may have influenced clinical disease presentation in the transmission 
bats.  Stress, and prevention of flight and normal behaviors due to cage size may contribute to lung 
pathology.  Additionally, study bats were kept in a separate room than colony bats.  The room that housed 
study bats tended to have a decreased ambient temperature and less humidity.  Taken with the qRT-PCR 
lung data, where only one bat, AJ-h3 at 6 DPI, was positive, lung pathology was most likely the product 
of environment and stress (figure 2.4C).  Future studies will include altering bat housing to allow for free 
flight, increasing ambient temperature, and to minimize stress.    
 
 Pilot study H18N11 bats had positive rectal swabs between 2 and 7 DPI detected by probe-based 
qRT-PCR (figure 2.2).  This was substantiated with the time course study where 8/10 bats at 3 DPI, 8/8 
bats 6 DPI, and 3/6 bats at 10 DPI had viral RNA detected by qRT-PCR (figure 2.3B).  Both transmission 
bats had viral RNA detected by qRT-PCR at 4 and 8 DPE (figure 2.3A).  No viral RNA was detected by 
qRT-PCR in subsequent time points.  Oral swabs were collected in the pilot study bats and had no viral 
RNA detected at any time point.  This data provides evidence that H18N11 is shed in the feces, but not in 
saliva, and that infection of naïve animals may be through fecal-oral transmission.  This data is also 
consistent with the original identification of the virus in rectal swabs, but not oral swabs of the flat-faced 





 Further validating the H18N11 positive rectal swab results were qRT-PCR results of both large 
and small intestine from the time course study bats (figure 2.4A and B).  Two/two bats had positive large 
intestine at 3 and 6 DPI for inoculated bats.  One/two bats had positive small intestine at 3 DPI, and 2/2 
positive at 6 DPI.  This data indicates that H18N11 has a predilection for the gastrointestinal tract, and the 
entire length of the intestines is susceptible to viral infection.  Furthermore, infection has a finite course, 
as viral RNA is detectable in early time points but not later time points.  Consistent with this data was the 
gastrointestinal histopathology seen in the earlier time points of inoculated animals (3, 6, and 10 DPI).  
Small intestines at these time points showed varying degrees of cellular infiltration of neutrophils, 
lymphocytes or plasmacytes in the propria lamina (table 2.3, figures 2.6, 2.7).  Similar lesions were seen 
in the pilot study H18N11 bats euthanized at 28 DPI.   
 
The presence of viral RNA and histopathology in the gastrointestinal tract as well as PCR data 
that indicates fecal-oral transmission for H18N11 mimic influenza A infection in waterfowl and low 
pathogenic avian influenza (LPAI) in gallinaceous birds.  In waterfowl influenza viruses are transmitted 
fecal-orally, there is a predilection for cells of the intestinal tract and no disease or histopathology 
associated with infection (103, 206, 207).  It is the lack of disease with viral infection that produce the 
hypothesis that the virus and waterfowl have co-evolved over great periods of time, and water fowl serve 
as a reservoir and play a critical role in the natural history of the virus (103).  LPAI have a high morbidity 
and low mortality in gallinaceous birds.  Presentation may be subclinical to severe with chickens less 
vulnerable to disease than turkeys (208).  Pathology may be seen in the upper and lower respiratory tract, 
reproductive tract, gastrointestinal tract, pancreas and kidneys (103, 208).  In birds, IAV viruses can 
replicate in the gastrointestinal tract and cause related pathology.  This is in contrast to influenza infection 
in mammals, which predominately causes a respiratory infection (209).  
 
At and after 17 DPI all time course study bats seroconverted by ELISA, with titers ranging from 





of bats, outlining the course of events of infection.  Bats are most likely exposed fecal-orally to H18N11 
and become infected.  The virus has tropism for tissue of the gastrointestinal tract and is shed in feces.  
Between 10 and 17 days, bats begin to mount an adaptive immune response and clear the virus.  A study 
that used H1N1 nucleoprotein as antigen detected antibody titers via ELISA in various species of animals 
post-vaccination.  Antibody titers in pigs were approximately 1000 at 28 days post vaccinations.  Foals, a 
month after parturition from vaccinated mares, had antibody titers between 100 and 1000 (210).  When 
H18N11 was discovered, wild bat populations were screened for antibody titers using H18N11 HA and 
NA glycoproteins as antigen.  Baseline dilution of serum was 1:1000 and antibody was detected in 55 out 
of 110 bats.  Eleven of the 55 bats had titers ≥16,000 (181).  Given these high titers, it may be warranted 
to extend our dilution series until signal extinction.  There is evidence that bats have limited somatic 
hypermutation and affinity maturation, which generally account for low antibody titers in bats. (128, 211-
217).  Titers of ≥γβ00 in these experimentally infected bats, and ≥16,000 in wild bats are high compared 
to bat titers demonstrated against other viruses, and compared to the titers of pigs and foals; however, our 
investigation did not assess neutralizing antibody titers.  Neutralizing titers are the product of SHM and 
affinity maturation.   
 
Histological lesions were also present in the heart, liver, kidney and salivary gland of different 
animals (table 2.3, figure 2.5).  These lesions were most likely incidental as similar lesions have been 
seen in other experiments that use Jamaican fruit bats (unpublished data) and were in the negative control 
bats.  It is interesting to note that 7/14 bats, including both negative controls, had focal lesions in the heart 
(table 2.3).  This species of bat may be prone to heart disease.  These data are important to present 
because little is known of bat pathophysiology.  As science continues to explore bat species, and we 
continue research in Jamaican fruit bats, background lesions need to be separated from lesions of interest.  
The more histopathology data presented, the more comparisons between species can be made and the 






This study demonstrated that Jamaican fruit bats are susceptible to infection as indicated by viral 
RNA detected in rectal swabs and gastrointestinal tract of both inoculated bats and naïve bats exposed to 
inoculated animals.  While histopathology was minimal, the TCID50  equivalents were greater in tissues 
and rectal swabs compared to the inoculation dose, suggesting virus is propagating in the gastrointestinal 
tract.  Does the pathophysiology of bat influenza viruses implicate bats as another potential reservoir for 
influenza viruses?  True, tissue tropism in bats is unique from other animals and more closely resembles 
avian reservoir species infection.  However, this is not substantial enough evidence to suggest bats are 
reservoirs for IAVs and there are no documented cases of H18N11 infection in people.  Additionally, bat 
influenza viruses are highly divergent from other influenza A viruses—suggestive that bats and their 
influenza viruses have co-evolved for an extended period of time (181, 182).  Given the limited tropism 
of the virus as demonstrated by cell culture experiments, and the failure of rescued H17N10 to be 
recovered from Artibeus bats—possibly due to the genetic diversity between Jamaican fruit bats and little 
yellow-shouldered bats, it is probable that bat influenza viruses are highly species specific and not a 
reservoir species (182, 189, 191, 194).  
 
Studying these viruses could garner much information about the evolution of influenza viruses 













CHAPTER 3: EXPERIMENTAL INFECTION OF JAMAICAN FRUIT BATS (ARTIBEUS 




Zika virus (ZIKV) was first isolated from a sentinel rhesus macaque in Uganda in 1947 and 
subsequently from Aedes africanus mosquitoes in the same location (218).   The first human cases were 
identified in 1954 in Nigeria and serosurveys found evidence of a broad geographic distribution for ZIKV 
throughout Africa and Asia with sporadic cases of human disease (219, 220).  The first recognized ZIKV 
epidemic occurred in Yap State, Federated State of Micronesia.  An estimated 73% of residents were 
infected in 2007 and of those 18% had clinical disease (221).  In 2013 a second epidemic occurred in 
French Polynesia with 28,000 individuals seeking medical care.  During this outbreak, the incidence rate 
of Guillain-Barré syndrome (GBS) increased 20-fold and cases were temporally coupled to the ZIKV 
outbreak, establishing the first connection between GBS and ZIKV (222).  The virus spread to Brazil 
were it was first diagnosed in 2015 (183, 184) and has since disseminated throughout much of South 
America, Central America, Caribbean, and the United States with more than 200,000 confirmed cases 
(223).  ZIKV is a causal agent for Congenital Zika syndrome (CZS) and GBS and is therefore a virus of 
high concern (220). 
 
The morbidity of ZIKV is approximately 20% with symptoms most frequently characterized by 
fever, maculopapular rash, conjunctivitis, arthralgia, malaise and headache (224).  Taking into account the 
low morbidity, mild symptomology, and lack of epidemics, the virus was not considered a great threat 
until a correlation was made between ZIKV and neurological disease (224).  CZS is a risk when a 
pregnant woman is infected and vertical transmission occurs.  The mechanism of pathology is not well-
delineated but infection of the central and peripheral nervous system of a fetus can result in severe 
microcephaly, collapsed skull, thin cerebral cortices with subcortical calcifications, ocular anomalies, and 





by an infectious agent.  GBS manifests as varying degrees of progressive weakness and flaccid paralysis 
(226).    
 
Much has yet to be learned about the pathophysiology of ZIKV infection.  Vectored through 
mosquitoes, predominately those of the Aedes genus, the virus is inoculated into the dermis and epidermis 
where it is capable of replicating in dermal fibroblasts, epidermal keratinocytes, and dendritic cells (227).  
In addition to a mosquito vector, ZIKV can be transmitted sexually, horizontally, and through blood 
transfusions (228, 229).  Like other flaviviruses it seems ZIKV is able to use multiple cellular receptors to 
initiate cell entry including DC-SIGN, AXL, Tyro3, and TIM-1 (227).  After point of entry, the virus may 
disseminate through the body via the blood.  While tissue tropism has yet to be fully elucidated, RNA has 
been identified in urine, semen, blood, saliva, brain, placenta, and fetuses—suggesting broad tissue 
predilection and ubiquitously distributed receptors (230-233).  
 
In the 1950s and 60s the susceptibility of bats to ZIKV was investigated.  Shepherd and Williams, 
1964 (234), screened 172 wild bats from 12 different species in Uganda for antibodies to ZIKV and found 
16/44 Little free-tail bats (Tadarida pumila) and 26/36 Angolan free-tail bats (T. condylura) antibody 
positive to ZIKV by hemagluttination inhibition assay.  Additionally, two Angolan free-tail bats were 
experimentally inoculated with ZIKV and serially bled.  Both animals were viremic on days 2, 4 and 6—
determined by 1:10 dilutions of serum that caused paralysis in mice (234).    Simpson and O’Sullivan, 
1968 (235), experimentally inoculated three straw colored fruit bats (Eidolon helvum), three Egyptian 
fruit bats (Rousettus aegyptiacusi), and five Angolan free-tail bats.  Two of the straw colored fruit bats 
were viremic and seroconverted.  One of the Egyptian fruit bats was viremic and two seroconverted.  The 
Angolan free-tail bats were euthanized on days 1, 3, 5, 7 and 10 days post inoculation.  At one day post 
infection a kidney was trace positive (235).  Finally, Reagan et al (236) inoculated 20 little brown bats 
(Myotis lucifigus) by 5 different routes:  intracranial, intraperitoneal, intradermal, intrarectal and 





days post inoculation.  Brain tissue was positive in all animals with clinical disease, determined by 
inoculation of mice with brain suspension (236).   
 
Considering the evidence that bats are naturally susceptible to ZIKV and that little brown bats 
develop disease, could bats serve as a natural reservoir host for ZIKV in the New World? To test this 
hypothesis, we inoculated Jamaican fruit bats (Artibeus jamaicensis), one of the most common bats in the 
Caribbean, Central America and Mexico, with ZIKV to examine the virology, immunology and pathology 
of infection. Although virus was detected in several organs, including the testes of males and brains, no 
signs of clinical disease were found and little evidence of viremia or viruria. These results suggest that 
Jamaican fruit bats are not likely a reservoir host but that ZIKV infection may constitute a wildlife disease 
threat to bats. 
 
3.2: Methods and Materials 
3.2.1: Bats 
All animal procedures were approved by the Colorado State University (CSU) Institutional 
Animal Care and Use Committees and were in compliance with U.S. Animal Welfare Act.  CSU has a 
captive colony of Jamaican fruit bats (Artibeus jamaicensis), a neotropical fruit bat indigenous to much of 
South America, Central America and the Caribbean (237).  Colony bats are kept as described in chapter 2, 
section 2.2.1. 
 
For infection experiments, bats were trapped using a butterfly net and placed in an β0” d x 1β” w 
x 1κ” h cage for 24 hours prior to inoculations to allow for acclimation.  Hanging clothes were provided 
for roosting and coverage.  Food and water are placed in open trays in the bottom of the cage and changed 
daily.  Tray liners were changed every two days, and cages and hanging clothes are changed every two 
weeks.  Due to the social nature of these bats, minimums of two bats were kept in cages at all times to 





3.2.2: Experimental infection 
Two sets of experiments were performed; a pilot study and a time course study.  Zika virus strain 
PRVABC59 was used for both studies.  PRVABC59 was isolated in 2015 by Centers for Disease Control 
and Prevention (Fort Collins, CO) from an infected individual who traveled to Puerto Rico (GenBank 
accession no. HQ234499).  The virus stock was prepared by inoculating Vero E6 cells and collecting 
supernatant five days later.  The titer is 3x107 plaque forming units (p.f.u.) per ml of media.  
  
 For the pilot study, three male bats were anesthetized with 1% to 3% isoflurane to effect with an 
oxygen flow rate of 1.5 L/min, administered with a gas mask.  Animals were placed on a heating pad to 
maintain body temperature and respirations continuously monitored.  The dorsum of each animal was 
disinfected with 70% ethanol and 25ul containing 7.5x105 p.f.u of virus was administered subcutaneously 
(sc) at the level of the scapula with a sterile hypodermic 25 gauge needle in a biosafety cabinet.  When 
procedures were finished, bats were removed from isoflurane and placed back in the cage in ventral 
recumbency.  Respirations were monitored until animal was fully awake and ambulated normally.  Bats 
were identified as AJ-z7, AJ-z8 and AJ-z9.  Animals were euthanized at 28 days post-inoculation (DPI). 
 
For the time course study, six male bats were anesthetized under the same protocol as the pilot 
study.  Animals were placed in ventral recumbency.  After disinfecting the dorsum of each animal with 
70% ethanol, 0.15mls of 1% lidocaine was administered sc. at the level of the last rib with a 25 gauge 
sterile hypodermic needle as a local anesthetic.  IPTT300 transponders (BioMedic Data Systems, Inc., 
Seaford, DE) were inserted sc. at the level of the caudal edge of the scapula.  Twenty-five microliters 
containing 7.5x105 p.f.u of virus was administered sc at the level of the cranial edge of the scapula.  
Recovery followed the same protocol as for the pilot study bats.  Animals were identified as AJ-z1 
through AJ-z6.  AJ-z1 and AJ-z2 were euthanized at two DPI.  AJ-z3 and AJ-z4 were euthanized at 5 






Female bats were excluded from the study because they are prioritized for breeding to sustain and 
expand upon the colony.   
 
3.2.3: Monitoring  
For the pilot study, bats were visually assessed twice daily for fourteen days, and then assessed 
once a day for an additional fourteen days.  For the time course study, bats were assessed twice a day 
throughout the experiment.  For both studies behavior, ability to ambulate, respirations, presence of oral 
or nasal discharge, and fecal consistency were all assessed.  
 
3.2.4: Urine Collection 
During the time course study urine was collected at 2, 3, 5 and 10 DPI from as many bats as 
possible.  Urine was collected by allowing bats to grasp screen cloth with their feet and then the bat was 
placed in a clear solo cup (Dart Container, Lake Forest, IL) with the screen covering the top of the cup as 
a lid, and kept in place with a rubber band.  This would allow the bats to hang in a clear container.  Bats 
were monitored for 45 minutes.  If they urinated, bats were removed from the collection cups and placed 
back in the cage without disrupting the urine.  Urine collection was attempted on all remaining bats at 
each time point, but not all bats would urinate at each collection attempt.  Urine was successfully 
collected as follows:  two DPI from AJ-z3 and AJ-z4; three DPI from AJ-z3, AJ-z5 and AJ-z6; five DPI 
from AJ-z3, AJ-z4, AJ-z5 and AJ-z6; and ten DPI from AJ-z5 and AJ-z6.  Urine was pipetted off the 
surface of the cup with a sterile pipette tip and put in a 1.5 ml microcentrifuge tube and stored at -80°C 
for future use.  Urine volume ranged between 5 ul and 15 ul.  
 
3.2.5: Euthanasia, Blood Collection and Necropsy 
Bats were deeply anesthetized and maintained with 3% isoflurane and an oxygen flow rate of 1.5 
L/min.  Deep pain was assessed by firmly pinching skin and toes with forceps and assessed for any 





muscle and diaphragm just caudal to the sternum and cut through the wall of the chest cavity caudally to 
cranially.  
 
Cardiac blood was collected with a 21 gauge sterile needle inserted into the apex of the heart.  A 
maximum blood volume of between 1 and 1.5 ml is collected in a syringe and transferred to a red top tube 
(RTT).  RTTs sat at room temperature for one hour to allow a clot to form and then centrifuged at 1000 x 
g for 10 min at room temperature.  Serum was removed from the clot, placed in a new microcentrifuge 
tube and stored at -20°C.     
 
Serum from bats at 2 and 5 DPI were used to assess for viremia.  Serum from 10 DPI and the 28 
DPI pilot study bats were used to determine antibody titers.  Because blood draws yield a small volume of 
blood it was necessary to prioritize samples to optimize data retrieved.  
  
Necropsies were performed immediately after euthanasia.  Bats were assessed for gross 
pathology.  The following tissues were collected for both experiments:  heart, lung, liver, spleen, kidney, 
urinary bladder, prostate, testes, and brain.  A portion of tissues were collected and kept at -80°C for RNA 
extraction, and a portion placed in 10% buffered formalin for histology. 
 
For a negative control animal, a male bat was trapped from the colony and euthanized under the 
same protocol as the experimental infection bats. 
 
3.2.6: Serology—ELISA   
Vero E6 cells were propagated to 60% confluency in a 96-well tissue culture plate and infected 
with ZIKV strain PRVABC at an m.o.i. of 0.1.  After a one hour incubation period, virus was removed 
and replaced with 2% FBS-DMEM and incubated for a maximum of three days.  Media was then replaced 





enzyme-linked-immunosorbent assay (ELISA).  Plates were stored at 4°C until use and used within two 
weeks. Plates were washed five times with PBS containing 0.05% Tween 20 and blocked with 
SuperBlock T20 (TBS) Blocking Buffer (Thermo Fisher Scientific, Waltham, MA) for one hour at room 
temperature.  Serum from an uninfected bat was used for a negative control.  A convalescent human 
serum sample was used as a positive control.  A two-fold serial dilution was used starting at 1:100 to 
1:12800.  Diluted serum was placed in wells and incubated for two hours at room temperature.  Serum 
was removed and plates washed.  HRP-conjugated protein A/G (Thermo Fisher Scientific, Waltham, MA) 
was added at a concentration of 2 ug/ml to each well, and incubated for 30 minutes at room temperature.  
HRP-conjugated protein A/G was used in place of a secondary antibody as it targets the Fc portion of an 
antibody, which is highly conserved and therefore can be used for multiple animal species (238).  Plates 
were washed and 150 ul of ABTS Peroxidase Substrate (2 component) (KPL, Gaithersburg, MD) added 
according to manufacturer’s instructions, incubated at room temperature for 30 minutes, and then 150 ul 
of ABTS Peroxidase Stop solution (KPL, Gaithersburg, MD) added.  Plates were read on a EMax Plus 
Microplate Reader (Cambridge Scientific, Watertown, MA).  Absorbance was measured at 405 nm and 
the limit of detectable response was set at three standard deviation values above mean negative control 
serum. 
 
3.2.7: RNA Extraction 
 TRIzol Reagent was used according to Ambion, Life Technologies protocol for RNA extraction 
from serum-cell supernatants, serum, urine and tissues.  For tissues, approximately 50 mg of tissue was 
homogenized with one mL of TRIzol Reagent.  A 5mm stainless steel bead (Qiagen, Valencia, CA) was 
used with a TissueLyser LT (Qiagen, Valencia, CA) at 50 Hz for 5 minutes.  One ml of TRIzol was added 
to urine to 5 to 15 ul of urine.  One ml of TRIzol was added to 160 ul of serum from AJ-z2, AJ-z3, and 
AJ-z4.  Two-hundred microliters of serum-cell supernatants were added to one ml of TRIzol.  Samples 
were then incubated at room temperature for 5 minutes.  Chloroform (Thermo Fisher Scientific, Waltham, 





12,000 x g for 15 minutes at 4°C.  The aqueous phase was removed, 4 ug of glycogen (Thermo Fisher 
Scientific, Waltham, MA) and 100% molecular grade isopropanol added (Thermo Fisher Scientific, 
Waltham, MA).  Samples were incubated at room temperature for 10 minutes and then centrifuged at 
12,000 x g for 10 minutes at 4°C.  Supernatant was removed and 75% molecular grade ethanol (Thermo 
Fisher Scientific, Waltham, MA) was added to RNA pellet.  Samples were vortexed and centrifuged at 
7500 x g for 5 minutes at 4°C.  Wash was removed and air-dried.  RNA was re-suspended in RNase-free 
water and stored at -80°C for future use.   
 
3.2.8: Viral RNA Detection in Serum Samples 
Vero cells were grown to 70 to 80% confluency in a 48-well tissue culture plate with 10% FBS-
DMEM.  Media was removed and 100 ul of bat serum from 2 DPI bats and 5 DPI bats was inoculated 
onto cells.  Additionally, serum from each bat was diluted 10-fold in 2% FBS-PBS supplemented with 
1% calcium and magnesium, and inoculated onto cells.  Samples were incubated for one hour at 37°C.  
Inoculum was removed and cells washed twice in sterile PBS.  Two-percent FBS-DMEM was added to 
wells and plates were incubated at 37°C, 5% CO2.  Cells were assessed daily for cytopathology (CPE) 
thru day 7.  Two-hundred microliters of the supernatant was removed on day 7 and used for RNA 
extractions.  An additional 100 ul of supernatant was blind passaged onto Vero cells at 70 to 80% 
confluency.  Cells were incubated for one hour at 37°C, washed twice with sterile PBS and 2% FBS-
DMEM added.  Cells were monitored daily for CPE for seven days, of which there was none.  On day 
seven, supernatant was removed and TRIzol extractions performed for RNA recovery.  Serum was treated 
as such in an attempt to amplify viral load and increase assay sensitivity serum may not be the most 
sensitive diagnostic sample (239-242).   
If any serum was remaining it was directly used for TRIzol RNA extractions.  Serum samples 








 Roche Real Time Ready RNA Virus Master Kit (Roche, Indianapolis, IN) was used on RNA 
extracted from serum-cell supernatants, serum, urine and tissue to assay for ZIKV RNA according to 
manufacturer’s instructions.  Primers used were ZIKV 1086 (CCGCTGCCCAACACAAG) and ZIKV 
1162c (CCACTAACGTTCTTTTGCAGACAT).  Probe was ZIKV 1107-FAM 
(AGCCTACCTTGACAAGCAGTCAGACACTCAA) (243).  Two-hundred nanograms of sample RNA 
was added to each reaction.  Reactions were performed in duplicate.  Standards were generously provided 
by Dr. Rushika Perera, Arthropod-Borne Infectious Diseases Laboratory, Department of Microbiology, 
Immunology and Pathology, Colorado State University.  Standards were a non-infectious clone of full 
length ZIKV strain PRVABC59 by which concentration was determined through optical density.  
Molecular weight of the genome sequence was used to calculate copy number (96).  A log10 dilution 
series of the standard was made and linear regression used to determine copy number equivalents of 
positive samples.  A light-cycler 96 (Roche Diagnostics Corporation, Indianapolis, IN) was used.  
Amplification was performed according to manufacturer’s protocol for Roche Real Time Ready RNA 
Virus Master Kit (Roche Diagnostics Corporation, Indianapolis, IN) with PCR conditions as follows:  8 
min at 50°C, 30 s at 95°C, and 45 cycles of 10 s at 95°C, 20 s at 60°C and 10 s at 72°C.  
 
3.2.10: Histology 
 Tissues fixed in 10% buffered formalin were cut in and submitted to Colorado State University 
Veterinary Diagnostic Laboratory (CSU VDL, Fort Collins, CO) for paraffin embedding, sectioning and 
staining with hematoxylin and eosin, as well as immunohistochemistry (IHC).  Tissues cut in on bats to 
assess for histology included:  heart, lung, liver, kidney, testes, prostate, urinary bladder and brain.  
Additionally, for AJ-z3 and AJ-z5 mandibular salivary gland was cut in.  AJ-z4 had esophagus and 
lymphoid tissue that included palatine salivary gland cut in.  Antibody for IHC was a polyclonal rabbit 





department.  The Bond-III automated instrument (Leica Biosystems, Wetzlar, Germany) was used for 
IHC staining.  
 
3.3: Results 
3.3.1: Experimental Infections 
 Bats for this project were taken from the Colorado State University breeding colony. Two animal-
infection experiments were conducted; a pilot study and a time course study.  In the pilot study three male 
bats (AJ-z7, AJ-z8, AJ-z9) were experimentally inoculated with 7.5x105 plaque forming units (p.f.u) 
ZIKV, strain PRVABC59.  Bats were monitored for 28 days for signs of clinical disease, then euthanized 
for necropsy and sample collection.  After demonstration of susceptibility in the pilot study, a time course 
study was conducted.  Six male bats (AJ-z1 through AJ-z6) were identically inoculated and two were 
euthanized at 2, 5 and 10 DPI. 
 
Bats were visually assessed twice a day for signs of disease as we previously found for Tacaribe 
virus infection (215), including lethargy and neurological abnormalities, unresponsiveness to stimuli, 
behavioral abnormalities (i.e. not roosting in a group), tremors, ataxia, and inability to fly; however, no 
conspicuous signs of disease were observed. Necropsies immediately followed euthanasia and no gross 
pathology was observed.  Necropsies immediately followed euthanasia and gross pathology was assessed 
at time of organ collection.  No apparent gross pathology was seen on necropsy in any animal. 
 
3.3.2: Serology—ELISA 
ELISA was performed on two-fold serial dilutions of serum from 1:100 to 1:12800.  Negative 
control serum was from an uninfected colony bat.  Positive control serum was a convalescent human 
sample.  The three pilot experiment bats (AJ-z7, AJ-z8, AJ-z9) euthanized at 28 DPI each had antibody 
titers of 3200.  The positive control titer was 12800 and the negative control was negative (<100) (table 





Table 3.1: Individual antibody titers in 28 DPI bats inoculated with ZIKV by ELISA. 




Pos Control (convalescent human 
sample) 
≥1βκ00 




Quantitative probe based reverse transcription PCR (qRT-PCR) was performed on serum-cell 
supernatants, serum, brain, lung, liver, spleen, kidney, urinary bladder, prostate and testes for bats from 
both studies.  In addition, urine collected during the time course study was assayed. Viral RNA copy 
numbers were estimated using a non-infectious clone of full length ZIKV strain PRVABC59 with 
concentration determined through optical density (96).  Urine from AJ-z6 at 3 DPI had 5.32x102 copy 
number equivalents and AJ-z7 at 5 DPI had 3.52x102 copy number equivalents.  AJ-z1, euthanized at 2 
dpi, had a positive brain by qRT-PCR with 1.08x103 copy number equivalents. All other samples were 
negative.  Serum samples from early infection bats (AJ-z2, AJ-z3 and AJ-z4) were negative.  Sera were 




Tissues cut in on bats to assess for histology included:  heart, lung, liver, kidney, testes, prostate, 
urinary bladder, and brain on all animals, and salivary gland on 3/9 animals.  A summary of the consistent 
histopathology findings is listed in table 3.2 at the end of this section. 
    
For the time course study AJ-z1 at 2 DPI had congested lungs with multifocal areas of interstitial 





amounts of mucous.  Kidneys had multifocal interstitial infiltrates of small numbers of lymphocytes.  All 
other tissues were within normal limits.  AJ-z2 at 2 DPI lungs showed milder pathology than AJ-z1 with 
minimal interstitial to perivascular infiltrates predominately lymphocytes and macrophages with a band of 
collapsed air spaces parallel to the pleural surface.  There were focal lesions in the left ventricle of the 
heart where there was individual cell loss or fragmentation of the sarcoplasm and infiltration of small 
numbers of macrophages, lymphocytes and satellite cells.  No lesions were observed in other tissues. 
 
 AJ-z3 at 5 DPI lungs had minimal focal interstitial hystiocytic pneumonia with atelectasis.  
Kidneys showed multifocal chronic lymphocytic, histiocytic pyelitis of the renal pelvis.  Mandibular 
salivary gland showed focal moderate cellular infiltrates of lymphocytes and macrophages that 
surrounded ducts, and contained detached and degenerate epithelial cells.  Rare apoptosis was evident in 
the lining epithelium of ducts.  No lesions were observed in other tissues.  AJ-z4 at 5 DPI had lungs with 
minimal alveolar septal infiltrates scattered within collapsed lung parenchyma with multifocal 
microscopic hemorrhages.  Kidneys had multifocal areas of mineralization.  In the outer medulla and at 
the corticomedullary junction were rare perivascular infiltrates with lymphocytes and plasmacytes.  
Esophagus and lymphoid tissue was cut in with palatine salivary gland that showed focal lymphocytic and 
plasmacytic inflammation.  Moderate numbers of lymphocytes and plasma cells were arranged in 
columns parallel to the respiratory mucosal epithelium of the nasopharynx.  The lumen contained 
increased amounts of mucous and a few inflammatory cells, mainly neutrophils and lymphocytes.  There 
was focal testicular degeneration manifested by presence of giant spermatids in the lumen of affected 
seminiferous tubules and accumulation of a small numbers of lymphocytes.  No lesions were observed in 
other tissues. 
 
 AJ-z5 at 10 DPI lungs had minimal interstitial to perivascular infiltrates with multifocal 
atelectasis and microscopic hemorrhages.  The left papillary muscle of the heart showed rare areas of 





appeared hypereosinophilic.  There was loss of cross striations, and minimal interstitial hypercellularity 
due to increased activity of satellite cells and infiltration of small numbers of lymphocytes.  Kidneys had 
an area of focal lymphocytic, plasmacytic pyelitis.  Additionally, there was a focal area of mineralization 
and inflammation in the inner medulla.  Mandibular salivary glands were cut in but within normal limits.  
All other tissues were within normal limits.  AJ-z6 at 10 DPI had occasional focal inflammation and 
cardiomyocyte degeneration in the left ventricle and septum of the heart.  Area A3 of the hippocampus in 
the brain showed focal pyramidal neuronal necrosis with a focal area of mineralization around a vessel in 




Figure 3.1: Hippocampus from AJ-z6, 10 DPI compared to negative control bat (H&E).  A)  AJ-z6, 
10 DPI area A3 of the hippocampus with focal pyramidal neuronal necrosis, circled.  B)  AJ-z6, 10 DPI 
400x magnification of lesion from figure A demonstrating angular, pyknotic, hypereosinophilic nuclei of 
necrosed neuronal cell bodies.  C)  Negative control bat hippocampus showing normal focal pyramidal 






In the pilot study bats, AJ-z7 at 28 DPI had more prominent interstitial pneumonia with 
congestion of the lungs compared to earlier time points.  The heart had minimal cardiomyocyte 
degeneration and necrosis with hyper cellular interstitium and increased amounts of mature fibrous 
connective tissue.  The kidney had focal interstitial infiltrates of the renal interstitium.  The brain showed 
degenerate neurons in area A3 of the hippocampus.  All other tissues were within normal limits.  AJ-z8 
had minimal focal testicular degeneration (figure 3.2).  No lesions were observed in other tissues.  AJ-z9 
had perivascular lymphocyte infiltrates and atelectasis.  Heart demonstrated locally extensive lymphocytic 
and histiocytic pericarditis.  Kidney showed multifocal interstitial lymphocytic infiltrates.  Brain had focal 
lymphocytic, perivascular infiltrates of small numbers at the subfornical commissure.  The reticular 
formation showed multifocal neuronal degeneration.     
 
  
Figure 3.2: Testes from AJ-z8, 28 DPI compared to negative control bat (H&E).  A)  Focal testicular 
degeneration.  Seminiferous tubules are disorganized with no mature sperm in lumen and giant 















Table 3.2: Histopathological findings in bats inoculated with ZIKV.   
 
 
Lesions in the lungs, heart, and kidney may be incidental as similar lesions have been seen in other 
experiments with different infectious agents (unpublished data), indicated by “+/-”.  δesions in the testes, 






3.3.4.2: Immunohistochemistry   
Tissues were stained with an antibody for ZIKV by CSU Experimental Pathology Core.  AJz-3 at 
5 DPI had inflammation of the mandibular salivary gland with immunoreactivity (figure 3.3).  AJ-z5 at 10 
DPI had immunoreactive cells in the brain and mononuclear cell immunoreactivity in the testes (figure 
3.4).  Additionally, AJ-z5 demonstrated immunoreactivity in purkinje cells of the cerebellum (figure 
3.5A).  AJ-z8 at 28 DPI had immunoreactive cells around the pulmonary arteries in the lungs (figure 
3.6A).  AJ-z8 also had perivascular immunoreactivity in the tunica albuginea of the testes (figure 3.7A).  
Scrotal skin was also cut in and had focal lymphocytic dermatitis with immunoreactive mononuclear cells 
(figure 3.7D).  Cell morphology consistently identified mononuclear cells, macrophages and fibroblasts as 
the cell types that were immunoreactive with ZIKV antigen.   
 
 
Figure 3.3: Salivary gland from AJ-z3, 5 DPI, IHC staining for ZIKV antigen. Glandular 













Figure 3.5:  Immunoreactivity in AJ-z5, 10 DPI cerebellum, IHC staining for ZIKV antigen 
compared to negative control bat.  A)  Multifocal purkinje cell immunoreactivity in AJ-z5.  B)  








Figure 3.6: Immunoreactivity in AJ-z8, 28 DPI lung, IHC staining for ZIKV antigen compared to 
negative control bat.  A)  Hilum of the lung shows immunoreactivity in mononuclear cells around the 
pulmonary artery.  PA, pulmonary artery.  PV, pulmonary vein.  BW, bronchiolar wall.  B)  Negative 




Figure 3.7: Immunoreactivity in AJ-z8, 28 DPI testes, IHC staining for ZIKV antigen compared to 
negative control bat.  A)  Tunica albugineal perivascular immunoreactivity mostly in macrophages and 
fibroblasts of AJ-z8.  B)  Negative control without immunoreactivity.  C) Interstitial immunoreactive 







 Two animal infection experiments were conducted in this investigation; 1) a pilot study to 
determine susceptibility of Jamaican fruit bats to ZIKV, and 2) a time course study to better understand 
pathophysiology.  The goal was to ascertain whether bats could be used as an animal model for ZIKV 
pathology and assess the possible role bats might play in viral ecology.  
 
 In the pilot experiment, no signs of disease were apparent during the 28 days. Sera collected at 
euthanasia indicated modest antibody titers of 3200 for each bat by ELISA (table 3.1), whereas the human 
convalescent control serum titer was 12,800. Bats typically have low to modest antibody titers and this 
may be because of limited somatic hypermutation and affinity maturation (128, 211-217). 
 
Viruria is commonly detected in ZIKV-infected humans (242) and it may be a more sensitive 
diagnostic indicator, with higher viral load for a longer period of time compared to blood in both humans 
and rhesus macaques (239-242).  Urine collection from the bats was challenging; however, we were able 
to collect urine from some of the bats in the time course study. AJ-z6 exhibited viruria only at 3 DPI, and 
AJ-z7 was equivocal only at 5 DPI, suggesting urine may be a route of viral shedding early in infection. 
 
Blood collection from live bats yields a small volume.  In order to assay the serum for viral RNA 
and perform serology, earlier time points were used to assess for viremia and later time points for 
seroconversion.  Along with sample partitioning for data maximization, the small blood volume generated 
concern that there would be an undetectably small viral load.  To circumvent this issue neat serum and 
1:10 diluted serum were inoculated onto Vero cells to amplify virus that may have been present in low 
numbers.  One blind passage on Vero cells was done and cell supernatants assayed by qRT-PCR.  The 
remaining serum for three of the four bats was assayed directly for ZIKV RNA.   Cell-serum 
supernatants, blind passage supernatants, and neat serum results were all negative.  Although serum is 





In one investigation ZIKV patient had negative serum for the duration of the study, whereas whole blood 
yielded positive qRT-PCR results from day nine to day 101 (230).  Urine from this patient was positive 
from the first time point (6 DPI) through 14 DPI and again on day 56.  Saliva was positive from day nine 
through day 14 and again on day 49 (230).  Another investigation compared diagnostic samples of 80 
positive individuals and showed that urine was positive in 50 of them, whereas serum was positive in only 
19 of them by qRT-PCR.  The paper concluded that viral loads in urine were ten-fold higher compared to 
serum and that uremia lasted longer (241).  These data corroborated the first study that identified ZIKV 
shed in urine in which there was a higher viral load in urine for longer duration compared to serum (242).  
Similar results have been observed in rhesus macaque models.  ZIKV RNA in plasma was assayable by 
qRT-PCR between two and six DPI, but between two to 17 DPI in urine (242).  The lack of detectable 
viremia in the serum of bats may be due to a lack of viremia, diagnostic assays that are not sensitive 
enough, or the finite blood volume collected preventing proper assay optimization.  Additional 
experiments may be warranted to further investigate the lack of viremia.       
 
ZIKV exhibited tropism for the testes and brain of bats.  AJ-z5 at 10 DPI and AJ-z8 at 28 DPI 
had positive immunoreactivity by immunohistochemistry for ZIKV (figure 3.4, 3.5, & 3.7).  
Histologically, AJ-z5 testes were within normal limits and AJ-z8 had focal testicular degeneration (figure 
3.4) suggesting that viral related pathology may be minimal.   AJ-z4 at 5 DPI was negative for ZIKV by 
IHC and qRT-PCR, but did have focal testicular degeneration on histology, and had IHC positive brain.  
AJ-z1 at 2 DPI had positive brain tissue by qRT-PCR.  Additionally, three of the nine bats (AJ-z6, AJ-z7, 
AJ-z9) that were negative for ZIKV by IHC and qRT-PCR had histopathology in the hippocampus at later 
time points (10 and 28 DPI).   
 
While in humans it has yet to be completely elucidated what reproductive organs harbor ZIKV, it 
has been determined that semen contain ZIKV both in vasectomized and unvasectomized men (230, 233).  





ZIKV infection and associated pathology in the testes (244-246).  Limited investigation has been done as 
to infection of accessory sex glands in mouse models, but one study that assessed the prostate found no 
virus, possibly due to differential expression of the receptor candidate in the testes but not in the prostate 
(244).  For this experiment, the finding of viral antigen and viral RNA in the testes but not in the prostate 
is consistent with published animal models.   
 
ZIKV has a predilection for nervous tissue as determined by animal studies and disease 
manifestation in humans.  As a neurological teratogen, ZIKV has been demonstrated in the brain, 
specifically mononuclear cells, as determined by IHC, of newborns with fatal microcephaly and fetal 
miscarriages, but no other tissues.  Histological lesions included parenchymal calcification, microglial 
nodules, gliosis, cell degeneration and necrosis (231).   In rhesus macaque animal models, viral tropism 
has been found in peripheral nervous tissue but not the brain itself (247).  In immunocompromised mouse 
models, the virus does have a predilection for the brain but with the mice engineered for specific immune 
traits it is difficult to know to what extent this emulates natural ZIKV pathophysiology (224).  In the bats 
used in this experiment, evidence of virus and pathology in the brain is consistent with what has been 
seen in human newborns and fetuses. 
 
In addition to brain and testes on IHC, scrotal skin and mandibular salivary gland harbored viral 
antigen, suggest that infection of Jamaican fruit bats may recapitulate human infection, which is thought 
to start with epidermal and dermal cells, and because viral RNA can be detected in human saliva (227, 
232).    The histopathology for AJ-z5, 5 DPI showed sialadenitis and the presence ZIKV antigen by IHC 
(figure 3.3).  This suggests ZIKV may be shed in the saliva, although additional animal experiments 
would need to be performed to confirm. 
 
A goal of this study was to determine if Jamaican fruit bats might be a suitable animal model for 





transmission, in utero transmission, teratogenesis and neurological pathophysiology.  The limitations in 
using Jamaican fruit bats as an animal model for disease are the slow reproductive rate that may limit the 
number bats that can be used in a study, and the specific husbandry requirements bats require, which can 
make them difficult to work with.   Furthermore, the immune system of bats appears to be unique in that 
they constitutively express type I IFNS, and have limited affinity maturation of antibodies, which would 
lead to differences in the viral-host ecology of bats compared to humans (115, 116, 128, 211-217).  Bats 
harbor many zoonotic pathogens with minimal disease that are BSL-3 and BSL-4 level agents (16, 17, 36, 
60, 64, 76).  ZIKV, being BSL-2 level virus, may facilitate investigations with greater ease compared to 
BSL-3 and BSL-4 level viruses of how bats can harbor viruses with minimal disease.      
 
ZIKV is thought to be maintained in two different distinct cycles:  sylvatic—cycling between 
non-human primates (NHP) and mosquito species, and urban—cycling between humans and mosquito 
species (220).  Indeed, it has been demonstrated that numerous NHPs have antibody to ZIKV including 
numerous monkey species wild trapped near Zika Forest (248), and wild and semi-captive orangutans in 
Borneo (249).  Not only have NHP been found to be seropositive, but also many other mammals, 
including rodents, horses, cows, and goats (250, 251).  Furthermore, experimental inoculation of various 
North American species resulted in seroconversion (cottontail rabbits, boar goats, pigs, and leopard frogs) 
and demonstrated viremia (nine-banded armadillo and leopard frogs) (252).  Molecular epidemiology 
suggests animals play an important role in an enzootic cycle (253).  Much about the enzootic cycle of 
ZIKV has yet to be understood but it stands to reason that bats may be capable of maintaining the virus in 
nature.  Jamaican fruit bats are found in northern South America, Central America, and the Caribbean—
areas that now have ZIKV potentially exposing bat populations to the virus (223, 237).  Wild New World 
bats, including Jamaican fruit bats, have been found infected with dengue virus and Old World bats have 
been found with evidence for chikungunya virus infection (185).  These viruses, like ZIKV, are 
predominately vectored by Aedes aegypti and A. albopictus (186), thus this provides evidence that the 





presented here suggest it is unlikely that bats can serve as reservoir hosts of ZIKV, unless virus sequesters 
in some as-yet unidentified way that could lead to periodic shedding of virus, at which point ZIKV in bats 
would be more of a wildlife disease concern with less public health implications.  It may also be that 
some bats become persistently infected and can transmit sexually to maintain virus within populations of 
bats. Further experimental and field studies will be necessary to fully understand the ecological role of 
























CHAPTER 4: SEROLOGICAL EVIDENCE OF ARENAVIRUS CIRCULATION AMONG 
FRUIT BATS IN TRINIDAD  
 
4.1: Introduction 
 Tacaribe virus (TCRV) is a New World mammarenavirus first isolated in 1956 from a moribund 
great fruit-eating bat (Artibeus literatus) in Port-of-Spain, Republic of Trinidad and Tobago during a 
rabies virus surveillance program at the Trinidad Regional Virus Laboratory (TRVL) (154, 254). Eighteen 
isolates were obtained from six great fruit-eating bats, five purported Jamaican fruit bats (A. jamaicensis), 
and a single isolate from a pool of 344 mixed mosquito species.  Of those total nineteen isolates only one 
of those isolates remains; TRVL-11573 isolated from a great fruit-eating bat. Serological investigation of 
more than 2,000 mammals found that only bats of the Artibeus genus had evidence of TCRV infection, 
suggesting that artibeus bats may be reservoir hosts.  Work performed about 15 years later also identified 
seropositive artibeus bats, suggesting TCRV continued to circulate in Trinidad (187). Recent phylogenetic 
studies suggest that A. jamaicensis bats in Trinidad and Tobago are likely a distinct species, the flat-faced 
fruit-eating bat (A. planirostris) (12). TCRV is closely related to Junin and Machupo viruses (255), the 
etiologic agents of Argentine and Bolivian hemorrhagic fevers, respectively, and has caused at least one 
laboratory-acquired human infection (256), raising the possibility that TCRV may have zoonotic 
potential.  
 
 Experimental infections of Jamaican fruit bats resulted in significant neurological disease that 
manifested as head tremors, inability to roost, remain upright, or fly and mortality.  Histopathology 
revealed mild to moderate neutrophilic interstitial pneumonia, involvement of the spleen and brain in 
multiple animals.  Brain lesions included lymphocytic leptominingitis, mild to moderate multifocal 
gliosis, or neutrophilic encephalitis.  Several inoculated bats were asymptomatic, seroconverted with 
modest antibody titers by ELISA and low neutralization titers, and appeared to clear virus. These results 





followed by clearance, neither of which is consistent with a typical arenavirus reservoir host (129).  In 
2014 several new isolates of TCRV were made from lone star ticks (Amblyomma americanum) in central 
Florida (188) where artibeus bats are not found. These isolates were genetically distinct from TRVL-
11573 and include an additional 12 amino acids and several other polymorphisms in the glycoprotein 
(257, 258). However, it is likely that TRVL-11573 accumulated mutations during its 20 passages in 
suckling mice (figure 4.1) and subsequent passage in Vero cells for preparation of viral stocks.  Together, 
these data argue against artibeus bats as reservoirs of TCRV, and suggest the TCRV is likely hosted by 
another species, perhaps multiple species, and that spillover to bats results in disease.  
 
 We were interested in determining if artibeus bats are reservoir hosts of TCRV, to determine if 
the virus continues to circulate among bats in Trinidad and, if so, whether new isolates of the virus could 
be obtained.  We collected blood and tissue samples from bats and performed serology, PCR and 
attempted virus isolation from tissues. Although many bats had antibodies reactive to recombinant TCRV 
nucleocapsid, none of the tested samples had neutralizing antibodies or viral RNA, and no isolates of 
TCRV were obtained. These findings are congruent with experimental infection of Jamaican fruit bats 







Figure 4.1: Passage history of Tacaribe virus isolate TRVL-11573.  Obtained from the library archive 
of the Caribbean Epidemiology Centre (CAREC), Port of Spain, Trinidad and Tobago. TCRV-11573 was 
isolated from bat TRVL #802 (great fruit-eating bat, A. literatus) and intracranially passaged in newborn 





4.2: Methods and Materials: 
4.2.1: Bats 
 Bats were captured with mist nets in February, 2012 for sampling, with approval of the Ethics 
Committee, Faculty of Medical Sciences, University of the West Indies, St. Augustine Campus, and under 
a special game license from the Wildlife Section, Forestry Division, Ministry of Agriculture, Land and 
Fisheries, Republic of Trinidad and Tobago. Trap sites were Mount Hope (N 10.67120, W 061.28677), 
Lopinot (N 10.69792, W 061.32243), Santa Cruz (N 10.69596, W 061.44629), and Maracas Valley 
(N10.70945, W061.40177) (figure 4.2). No threatened or endangered species were captured. Live bats 
were individually placed in cloth bags for transport to laboratory facilities at the University of the West 




Figure 4.2: Locations of bat collections.  Mt. Hope bats were collected during the day from a building 
roost on the campus of The University of West Indies. Collections from the remaining three sites were 






 Bats were humanely euthanized by inhalation of isoflurane and thoracotomy prior to tissue 
harvesting at necropsy.  Cardiac blood was collected when the heart was visualized upon thoracotomy and 
transferred to serum separator tubes (SST).  SSTs were inverted ten times, sat at room temperature for one 
hour and then centrifuged at 1000 x g for 10 minutes at room temperature.  Serum was removed from the 
clot, placed in a sterile microcentrifuge tube and stored at -20°C. All personnel were immunized against 
rabies virus and appropriate PPE was worn during collections, and bat necropsies were performed in a 
class II biosafety cabinet. Samples were immediately frozen and stored at -80°C prior to shipment on dry 
ice to Colorado State University (Fort Collins, CO, USA) and Rocky Mountain Laboratories (Hamilton, 
MT, USA) for further processing. Cytochrome B PCR sequencing was performed on DNA from the 
artibeus bats to identify species. 
 
4.2.2: Virus Isolation  
 Lung tissue was processed for attempted virus isolation of TCRV.  Tissues measuring 
approximately 2 mm3 were individually placed into 1.5-ml screw cap tubes with 500 ul 5%FBS-DMEM 
and a 5 mm stainless steel ball, and homogenized on TissueLyser LT (Qiagen, Valencia, CA) for 5 
minutes at 2 Hz to minimize heat and potential virus inactivation.  Tissues were placed on ice and then 
homogenized again to ensure complete tissue disruption.  Tissues were centrifuged at 3000 rpm for 5 min 
at 4°C.  Four hundred microliters of supernatant was added to 500 ul 5%FBS-DMEM and filtered through 
0.2 um Acrodisc filter.  One hundred microliters of filtrate was inoculated onto confluent Vero E6 cells in 
24 well plates.   Inoculated cells were incubated for one hour at 37°C and then 1 ml of 2% FBS-DMEM 
added to each well.  Cells were maintained in an incubator at 37°C with 5% CO2. Fresh medium was 
added on day six.  After ten days of incubation, RNA was extracted from supernatants with the QIAamp 
Viral RNA εini Kit (Qiagen, Valencia, CA) according to manufacturer’s instructions. The homogenized 
tissue pellets were used for RNA extractions by adding 350 ul RLT with 1% 2ME and homogenized 2 x 5 
min at 50 Hz.  Tissue was centrifuged at 3000 rpm for 5 min at 4°C.  Supernatant was processed for RNA 





manufacturer’s instructions.  Control TCRV (TRVL-11573) RNA was isolated from inoculated Vero E6 
stocks.  RNA samples were kept at -80 °C until further use.   
 
4.2.3: Reverse Transcription and conventional PCR 
 RNA was reverse transcribed with random primers using Quantitect Reverse Transcription kit 
(Qiagen, Valencia, CA) according to manufacturer’s instructions.  PCR was performed using TCRV 
primers (forward, 5’-TGTGGCTTTCTGAAGCAGTG-γ’; reverse, 5’-AGGCTCTCGATCGCAAATTA) 
and PCR Core Kit (Qiagen, Valencia, CA) as previously described (129).  Amplification conditions were 
melting for 3 min at 94°C, 35 cycles at 94°C for 30 s, and annealing at 54 °C for 30 s, and extension at 
72°C for 1 min.  Reactions were held at 72°C for 10 minutes.  Samples were resolved on 1% agarose gels.   
 
4.2.4: ELISA and Western Blot 
 Recombinant His-tagged TCRV nucleocapsid antigen (259) was expressed in E. coli BL21(DE3) 
(260) and used for ELISA and western blot.  ELISA was performed as previously described using a 
protein-A/G-HRP conjugate (260). Sera were diluted 1:100 in PBS for the ELISA. Samples with an 
absorbance of 3 times greater than the background absorbance were considered positive. Endpoint titers 
of positive samples were determined by ELISA, and antibody reactivity validated (1:500) by western blot, 
also detected with protein-A/G-HRP (Thermo Fisher Scientific, Waltham, MA).  Control sera were from 
archived samples collected from a previous experimental infection of Jamaican fruit bats (129). 
 
 For the western blot, 20 ug of TCRV nucleoprotein was combined with 4X NuPAGE LDS 
sample buffer (Thermo Fisher Scientific, Waltham, MA), and deionized sterile water to denature protein 
and reduce protein disulfide bonds.  The mixture was heated at 72C for 10 minutes.  A NuPAGE 4-12% 
BT 1.0 mm (single well) gel (Thermo Fisher Scientific, Waltham, MA) was loaded with TCRV 
nucleoprotein and ran for 60 minutes at 200 volts with 1X SDS running buffer and NuPAGE antioxidant 





dampened in methanol and placed on the gel.  TCRV nucleoprotein was allowed to transfer for five hours 
at 150 volts.  The membrane with the TCRV nucleoprotein was then removed and cut into strips.  A 1:500 
dilution was made for each bat serum sample in 5% BSA-TBS.  Antibody to the His-tag was used as a 
control.  A membrane strip was incubated in individual bat serum samples and one strip in His-tag 
antibody for 24 hours at 4C.  Strips were washed 3x in TBS + Tween buffer.  A 1:5000 dilution of 
protein AG in 5% BSA-TBS was prepared and strips incubated in protein AG dilution for 2 hours.  Strips 
were washed 3x in TBS + Tween buffer.  TMB membrane peroxidase system was prepared and dropped 
onto strips.  Strips were incubated for 15 minutes and then washed 3x with TBS + Tween buffer (KPL, 
Gaithersburg, MD) and bands visualized.  
 
4.2.5: Serum Neutralization  
 TCRV TRVL-11573 was used for serum neutralization testing.  Sera were diluted 1:10 in 2% 
FBS-DMEM in the first well and a log2 dilution series was prepared for each sample. TCRV (102 TCID50) 
was added to each well in 100 ul (1:20 final dilution of serum) for 1 hour at 37°C, then the entire volume 
(200 ul) transferred to 96 well plates containing confluent Vero cells.   Fresh media was added on day 




Cytochrome B sequencing showed that artibeus bats were A. planirostris or A. literatus; no A. 
jamaicensis bats were collected (data not shown). Of the six species captured, four had seropositive 
animals; the flat-faced fruit bat (A. planirostris), great fruit-eating bat (A. literatus), Seba’s fruit bat 









Table 4.1: Distribution and serology of study bats of Trinidad. 
Animal ID Site1 Species Sex (M/F/I) Adult/Juvenil
e 
ELISA TT2 WB3 
1 Mt. Hope A. planirostris trinitatis F A - nd 
2 Mt. Hope A. planirostris trinitatis U J - nd 
3 Mt. Hope A. planirostris trinitatis F A 100 + 
4 Mt. Hope A. planirostris trinitatis U J 100 + 
5 Mt. Hope A. planirostris trinitatis F A - nd 
6 Mt. Hope A. planirostris trinitatis F A - nd 
7 Mt. Hope A. planirostris trinitatis U J 200 + 
8 Mt. Hope A. planirostris trinitatis F A - nd 
9 Mt. Hope A. planirostris trinitatis F A 200 + 
10 Mt. Hope A. planirostris trinitatis F A 100 + 
11 Mt. Hope A. planirostris trinitatis F A - nd 
12 Mt. Hope A. planirostris trinitatis M J - nd 
13 Mt. Hope A. planirostris trinitatis M J - nd 
14 Mt. Hope A. planirostris trinitatis F A - nd 
15 Mt. Hope A. planirostris trinitatis M J - nd 
16 Mt. Hope A. planirostris trinitatis M J - nd 
17 Mt. Hope A. planirostris trinitatis M A 100 + 
18 Mt. Hope A. planirostris trinitatis F A 200 + 
19 Mt. Hope A. planirostris trinitatis M J - nd 
20 Mt. Hope A. planirostris trinitatis F A - nd 
21 Mt. Hope A. planirostris trinitatis M J - nd 
22 Mt. Hope A. planirostris trinitatis M J - nd 
23 Mt. Hope A. planirostris trinitatis F J - nd 
24 Mt. Hope A. planirostris trinitatis F A - nd 
25 Mt. Hope A. planirostris trinitatis F J - nd 
26 Mt. Hope A. planirostris trinitatis M J - nd 
27 Mt. Hope A. planirostris trinitatis M J - nd 
28 Lopinot A. planirostris trinitatis F A - nd 
29 Lopinot A. planirostris trinitatis M J 100 + 
30 Lopinot A. literatus F A 200 + 
31 Lopinot A. literatus M J - nd 
32 Lopinot A. literatus M J - nd 
33 Lopinot A. literatus F J - nd 
34 Lopinot A. literatus F A - nd 
35 Lopinot A. literatus F A - nd 
36 Lopinot A. literatus F J - nd 
37 Lopinot A. literatus F A 400 + 
38 Lopinot A. literatus M J 400 + 
39 Lopinot A. literatus F J - nd 
40 Lopinot A. literatus F A - nd 
41 Lopinot A. literatus M A 800 + 
42 Lopinot Glossophaga soricina F A - nd 
43 Lopinot Glossophaga soricina F A - nd 
44 Lopinot A. planirostris trinitatis M A 200 + 
45 Lopinot A. literatus M A - nd 





47 Lopinot Sarcopteryx bilineata M A - nd 
48 Lopinot Glossophaga soricina F A - nd 
49 Lopinot Sturnira lilium M A 200 + 
50 Lopinot Sturnira lilium F A 100 + 
51 Lopinot Sturnira lilium F A - nd 
52 Lopinot Sarcopteryx bilineata M J - nd 
53 Lopinot A. literatus M A 200 - 
54 Lopinot A. planirostris trinitatis M A - nd 
55 Santa Cruz A. literatus M A - nd 
56 Santa Cruz A. literatus M A 200 - 
57 Santa Cruz Sarcopteryx bilineata M A - - 
58 Santa Cruz Sarcopteryx bilineata F A - - 
59 Santa Cruz A. literatus M A 200 + 
60 Santa Cruz A. literatus M A - - 
61 Santa Cruz A. literatus M A 200  
62 Santa Cruz A. literatus M A - nd 
63 Santa Cruz A. planirostris trinitatis M A 400 + 
64 Santa Cruz A. literatus M A 100 + 
65 Santa Cruz A. literatus M A 100 + 
66 Santa Cruz A. planirostris trinitatis M A - nd 
67 Santa Cruz Sarcopteryx bilineata F A - nd 
68 Santa Cruz Sarcopteryx bilineata F A - nd 
69 Santa Cruz A. literatus M A 200 - 
70 Santa Cruz A. planirostris trinitatis M A - + 
71 Santa Cruz A. literatus M A - + 
72 Santa Cruz A. planirostris trinitatis M A 400 + 
73 Santa Cruz Sarcopteryx bilineata M A 200 - 
74 Santa Cruz A. literatus M A - + 
75 Santa Cruz A. literatus M A 200 + 
76 Santa Cruz A. literatus M A - + 
77 Maracas Valley C. perspicillata M A 100 + 
78 Maracas Valley C. perspicillata F A 200 + 
79 Maracas Valley A. planirostris trinitatis F A 400 nd 
80 Maracas Valley A. literatus M A - nd 
81 Maracas Valley A. literatus M A - nd 
82 Maracas Valley C. perspicillata M A - - 
83 Maracas Valley A. literatus F A 100 - 
84 Maracas Valley C. perspicillata F A 400 - 
Control 673 45 DPI A. jamaicensis pos ctrl  1600 + 
Control 678 45 DPI A. jamaicensis pos ctrl  800 + 
Control 679 45 DPI A. jamaicensis pos ctrl  1600 nd 
Control 680 2 DPI A. jamaicensis neg ctrl  - - 
Control 681 2 DPI A. jamaicensis neg ctrl  - nd 
1Locations of collections are shown on Figure 1. 
2Titer represents the reciprocal of the greatest dilution with signal. 
3+, positive; -, negative; +/-, equivocal; nd, not done. Insufficient sample remained to test bat 61 by 
western blot. 






4.3.2: Virus Isolation and PCR 
 Lung tissue was assayed for TCRV RNA via PCR because results from experimental infections 
of artibeus bats with TCRV demonstrated that, while many organ types yield virus after infection, lung 
tissue was the most consistent location of viral infection.  All PCR results were negative for TCRV.   
  
 The pellets of lung homogenates and supernatants of inoculated Vero cells were also screened for 
TCRV RNA and none of the samples had amplicons (data not shown). 
 
4.3.3: Serology 
 Of the six species captured, four had seropositive animals; the flat-faced fruit bat, great fruit-
eating bat, Seba’s fruit bat, and little yellow-shouldered bat (table 4.2). Although Seba’s fruit bats and 
little yellow-shouldered bats higher seroprevalence rates than either artibeus species, the sample sizes for 
each was low. 
 
Table 4.2: Seroprevalence to TCRV among adult bats of Trinidad. 






Artibeus literatus frugivore 8 25 32 
A. planirostris trinitatis frugivore 8 21 38 
Carollia perspicillata frugivore 2 4 50 
Sarcopteryx bilineata insectivore 0 6 0 
Glossophaga soricina nectarivore 0 3 0 
Sturnira lilium frugivore 2 3 67 
 
 Twenty-seven of the 62 adult bats were seropositive by initial ELISA screening and titers ranged 





specific (figure 4.3) to TCRV nucleocapsid antigen, and two artibeus bats (accession numbers 70 and 74) 
were ELISA-negative but WB-positive. Insufficient serum was available to perform WB analysis on bat 
61 that was ELISA-positive.  Antibodies were detected in some juveniles and may represent maternal 
antibody.  Control sera from bats used in a previous experimental infection (129) had titers between 800 




Figure 4.3: Western blot results on a subset of samples.  Bat identifications are listed on the top of 
each western blot and results on the bottom.  “His” represent controls targeting the his-tag.  PC indicates a 
positive control bat.  NC indicates a negative control bat.  
  
 Serum neutralization was used to assess if these bats had neutralizing antibody to the 
glycoprotein. No bats yielded a neutralizing antibody to TCRV.   
   
 Screening ELISAs were performed on all bat samples.  Thirty three out of the 89 samples had 
ODs greater than the negative cut off of 0.300.  Those that were positive were titered for further 
exploration by ELISA.  Titers on positive animals ranged from 100 to 800.  A subset of samples (bat id: 
680—negative control, 678—positive control, 673—positive control, 57, 58, 59, 60, 63, 64, 65, 70, 71, 
72, 73, 74, 75, 76, 77, 78, 3, 4, 7, 9, 10, 17, 18, 29, 30, 37, 38, 41, 44, 49, 50 53, 56, 69, 82, 83, 84) were 
assayed with a western blot for validation.  Eleven were negative, 27 were positive.  Results were 






 Generally speaking, suitable vertebrate reservoirs of viruses, which have been best studied in 
rodents (261-265), have little to no pathology and remain persistently infected for extended periods of 
time, perhaps for life with some viruses and their hosts. Although few studies of bats as viral reservoirs 
have been performed, those that have typically demonstrate this pattern (37, 266, 267). Perhaps the best 
studied virus/reservoir host systems are the rodent-borne hantaviruses, which are similar to arenaviruses, 
in which the viruses establish apathogenic infections without eliciting aggressive immune responses (261, 
268, 269). In each of these systems, the viruses do not cause meaningful pathology and persist for many 
months or longer, and heterologous hantavirus inoculation of a reservoir host species also result in 
innocuous infections (270, 271). 
 
 Historically, the natural reservoir host(s) of TCRV has been presumed to be artibeus bats (154, 
187). All other mammarenaviruses with known reservoirs are hosted by rodents (272), thus the hypothesis 
that bats may serve as a reservoir of TCRV is unusual. We have obtained serological evidence that TCRV 
or similar arenavirus is circulating in at least two, and possibly four species of fruit bats in Trinidad; flat-
faced fruit bats, great fruit-eating bats, Seba’s fruit bats and yellow-shouldered fruit bats. Flat-faced fruit 
bats, great fruit-eating bats and yellow shouldered fruit bats have previously been identified as having 
antibodies to TCRV (154, 187) but identification of antibodies in Seba’s fruit bat has not been reported 
until now. We did not capture any Jamaican fruit bats (A. jamaicensis), which is one of the two species 
originally identified as a host when TCRV isolates were first made in the 1950s (154). Considering other 
evidence that Jamaican fruit bats are not found in Trinidad (12), it is likely that flat-faced fruit bats were 
misidentified as Jamaican fruit bats in the original paper. 
 
 Viral RNA was not detected in the lung tissues of bats or in Vero cells inoculated with clarified 
lung homogenates, nor was virus isolated from blind passage on Vero cells, suggesting that bats do not 





bats with TCRV TRVL-11573 and determined that high doses of virus caused disease with high fatality 
rates but that low dose virus resulted in clearance without conspicuous disease (129). Interestingly, 
surviving bats in this study had only modest antibody titers by ELISA (table 4.1) and very low 
neutralizing titers (129). Little brown bats (Myotis lucifigus) do not appear to substantially use somatic 
hypermutation (SHM), suggesting that affinity maturation (which accounts for high antibody titers) may 
be limited (123). If SHM is limited in other bat species, it could account for the low titers we observed in 
this study. 
 
 Considering the serological evidence presented here that at least four species of fruit bats and a 
previous study showing other bat species (187) are susceptible to arenaviruses, it may be that bats are 
spillover hosts from rodent reservoirs. The high seroprevalence suggests that after spillover the virus may 
be transmitted among bats and considering the high densities and direct contact among individuals within 
a colony, transmission could occur. However, experimental infections showed that despite detectable viral 
RNA in oral and rectal swabs for several weeks, transmission to sentinel bats did not occur (129). It may 
be that the artificial housing in our experimental model disrupted the natural biology of the bats (e.g., 
confined to cages, behavioral changes, dietary differences, etc.) that may have prevented transmission.  
 
 More than 60 species of bats are found in Trinidad; thus, we cannot exclude the possibility that 
another bat species in Trinidad may be a reservoir host of TCRV. Trinidad is 12 km from Venezuela and 
it is possible that TCRV may move between Trinidad and Venezuela (273). The next closest nation to 
Trinidad and Tobago is Grenada, where artibeus bats are also found. However, the flight distance between 
the islands is about 160 km, making it difficult for artibeus bats to routinely migrate between the islands 
because their range is about 15 km (273).  
 
 The recent isolation of TCRV from lone star ticks in central Florida also suggests that artibeus 





rodents and other terrestrial mammals (274).  Trinidad and Florida do not share common species of 
rodents or bats, other than introduced house mouse (Mus musculus) and Norway rats (Rattus norvegicus), 
neither of which have been shown to host TCRV. Several Cricetidae rodent species are found in Trinidad 
and Florida, and many arenaviruses are hosted by members of this family. Insectivorous velvety free-
tailed bats (Molossus molossus) are common in Trinidad but found only in the Florida Keys, suggesting it 
is not the source of TCRV isolated from central Florida. TCRV may have multiple natural reservoir host 
species, which is unusual but not unprecedented among the mammarenaviruses (272). The original paper 
describing TCRV’s isolation did not identify rodents as potential reservoirs; however, it is unclear as to 
how many species and individuals were sampled (154). Thus, the accumulated evidence suggests that 
























 Several bat genomes are currently available but fail to include Jamaican fruit bats (Artibeus 
jamaicensis) (275).  The transcriptome for Jamaican fruit bats has been sequenced and annotated (276).  
In order to progress the laboratory tools available to research Jamaican fruit bats and compliment the 
transcriptome de novo assembly was conducted.  An Illumina platform was used to draft the genome 
sequence with short read sequences.  De novo assembly was performed using Soapdenovo2.    
 
5.2: Methods and Materials 
5.2.1: Genomic DNA Extraction 
Genomic DNA was extracted from 8th passage Jamaican fruit bat primary kidney epithelial cells.  
The cell line was developed from a mature, male Jamaican fruit bat.  The Quick-DNA™ Miniprep Plus 
Kit (Zymo Research, Irvine, CA) was used according to manufacturer’s protocol to extract genomic 
DNA.   
 
5.2.2: Genomic DNA Library Preparation and Sequencing 
Genomic DNA was sheared through sonification using a Covaris instrument (Covaris, Inc., 
Woburn, MA) with settings appropriate for target fragments of 500 bp. KAPA Hyper Prep Kit (Kapa 
Biosystems, Inc., Wilmington, MA) was used to prepare the library according to protocol instructions.  
Product was amplified using two cycles of PCR.  Product was resolved on a 1% gel and excising product 
between 300 and 600 bp.  DNA was recovered with Zymoclean Gel DNA Recovery Kit (Zymo Research, 
Irvine, CA).  Fragment size and gDNA quality was confirmed with Agilent 4200 TapeStation (Agilent, 
Santa Clara, CA).  Illumina NextSeq 500 (Illumina, Inc., San Diego, CA) sequencing platform was used 





5.2.3: De Novo Assembly 
FastQC Version 0.11.5 was used to assess quality of the sequences both before and after 
trimming (277).  Files were trimmed using Trimmomatic-0.33 with the following settings:  
ILLUMINACLIP: NexteraPE-PE.fa:1:30:10:4:    true    LEADING:20    TRAILING:20 
SLIDINGWINDOW:4:25 MINLEN:60 (278).  Soapdenovo2 was then used to perform assembly with the 
following parameters:  max_rd_len=150,[LIB], avg_ins=580, reverse_seq=0, asm_flags=1, 
rd_len_cutoff=150, rank=1, pair_num_cutoff=3, map_len=32 (279).  A genome quality report was 
generated with QUAST 4.6.0 (280). 
 
5.3: Results 
5.3.1: Quality Assessment Pre- and Post-Trimming 
 FastQC Version 0.11.5 was used to assess quality of raw sequence data both before and after 
trimming to both target any sequencing errors that may have arisen during library preparation, and 
sequencing, and to determine effectiveness of trimming.  Prior to trimming the data had acceptable scores 











      
 
 
Figure 5.1:  Quality of reads pre- and post-trim.  (A)  Pre-trim run one compared to (B) Post-trim run 
one shows an increase in quality score (y-axis) across all bases (x-axis).  (C)  Pre-trim run one compared 
to (D) Post-trim run one demonstrates the normal GC distribution both before and after trimming 
indicating quality of sequence is high both before and after trimming.     
 
 
5.3.2: De Novo Assembly 
 Soapdenovo2 was used to assemble the genome of the Jamaican fruit bat.  QUAST 4.6.0 was 








Figure 5.2:  Quality report of Jamaican fruit bat genome generated by QUAST 4.6.0. 
 
5.4: Discussion 
 De novo sequencing of the Jamaican fruit bat genome generated a 1.4 gigabase (Gb) genome with 
20x coverage.  Comparatively, published bat genomes of different species are ~2.0 Gb (275).  Bat 
genomes are much smaller than other mammalian genomes, and more similarly sized to bird genomes; 
possibly a prelude to flight (281).  A quick gene analysis indicated that some expected genes were 
missing or incomplete.  Given the coverage and genome size, the genome is incomplete.  In the future, 
long-read sequencing may be performed on a new library, and assembled with this short-read sequence in 
order to improve the over-all quality of this genome.  Given the intention of de novo sequencing of the 
Jamaican fruit bat genome was to identify sequences to advance laboratory capabilities, such as primer 














An overwhelming amount of evidence exists that identify bats as having a unique, commensal 
relationships with numerous viruses, particularly viruses with vast public health implications such as 
Ebola virus, SARS-CoV, and Nipah virus, amongst others.  The principal goal of this dissertation 
research was to better understand New World bats and their relationship with novel viruses to add to the 
repertoire of data that investigates bats as reservoir species.   
 
The present study is the first to conduct in vivo experiments with novel influenza A viruses (IAV) 
H17N10 and H18N11 in bats.  H17N10 was first discovered in little yellow-shouldered bats belonging to 
the genus Sturnira.  Inoculation of Jamaican fruit bats with rescued H17N10 did not result in evidence to 
support the hypothesis that Jamaican fruit bats were susceptible to the virus.  It was postulated that the 
evolutionary divergence between little yellow-shouldered bats was great enough, and the virus specific 
enough, so that Jamaican fruit bats could not be infected.  A time-course study was conducted with 
H18N11 in Jamaican fruit bats.  Jamaican fruit bats inoculated with H18N11 shed virus rectally but not 
orally, viral RNA was detected in the gastrointestinal tract, and histology revealed cellular infiltrates in 
the small intestine of bats during time points prior to 17 DPI.  At and after 17 DPI bats seroconverted, 
detected by ELISA.  Furthermore, two uninoculated bats were exposed to inoculated bats to investigate 
transmission potential.  Rectal swabs collected from these naïve bats also detected viral RNA by qRT-
PCR at similar time points early in course of infection.  Both inoculated bats and uninoculated bats 
seroconverted.  These data delineate pathophysiology that is reminiscent of IAV in their reservoir hosts, 
waterfowl, and low pathogenic avian influenza virus in gallinaceous birds.  Transmission of H18N11 in 
bats most likely occurs fecal-orally, virus has tropism for tissues of the gastrointestinal tract, bats mount 
an adaptive immune response and virus is cleared.  It has been suggested that bats may serve as an 





the high level of bat influenzas from canonical IAVs, this is unlikely.  More aptly H18N11 is an 
endogenous virus to bats and circulates amongst bat populations causing minimal disease. 
 
This study is furthermore the first to explore New World bat as a reservoir for Zika virus (ZIKV).  
Given the temporal overlap of ZIKV emerging endemicity in the Western Hemisphere with the native 
range of Jamaican fruit bats, the fact that bats have evidence for infection with dengue and chikungunya 
virus, the Aedes vector for ZIKV will feed on bats, and that an enzootic wildlife reservoir for ZIKV is 
suspected but not identified, it is plausible that bats may be susceptible to infection and serve as a 
reservoir.  Additionally, the experiment was conducted to investigate the potential of bats to function as 
an animal model.  A time-course study was conducted to observe patterns in pathophysiology.  Bats 
seroconverted, albeit low titers, and viral tropism was demonstrated for testes and brain tissues.  
Furthermore, viral RNA was detected in urine, and a salivary gland was IHC positive, offering two routes 
of shedding in bats.  ZIKV is predominately vectored through mosquitoes but has also been transmitted 
vertically and horizontally in humans.  Bats are gregarious, roost in great numbers on top of each other; 
they are rather untidy animals, that drop partially eaten fruit, and urinate frequently on other bats.  While 
documentation of exposure to virus positive urine and saliva does not exist, due to the natural behavior of 
bats, they would be the ideal species to facilitate such transmission.  Evidence for ZIKV was not detected 
in the serum.  This may be because bats do not become viremic, serum may not be the most sensitive 
diagnostic sample (as demonstrated in some human studies and animal-model studies), and/or the small 
size of bats produced a finite blood volume and there were not enough sera to fully optimize viral 
detection.  The lack of evidence for viremia, if true, would prevent mosquitoes from serving as a vector 
for ZIKV and indicates that bats may not be a viable reservoir for human infection.  ZIKV may still 
circulate amongst bats through non-mosquito-vectored transmission routes, making it a wildlife disease 
problem.  While tissue tropism in bats recapitulates human infection, immunological research 





would make they respond to viral infection different from humans, and infers that bats may not be the 
best animal-model for human disease.        
 
Both models of viral infection, H18N11 and ZIKV in Jamaican fruit bats, may be excellent 
systems to better understand the relationship between bats and their viruses given logistical accessibility 
as BSL2 viruses, and the ability to draw upon one of the few experimental captive bat colonies in the 
world.  Furthermore, both studies detail suspected incidental pathology in Jamaican fruit bats.  As more 
research is conducted in bats it is important to know what pathological abnormalities bats are prone to in 
order to separate out background lesions from lesions of interest, therefore it is necessary to describe all 
pathology.  These studies identified frequent lesions in cardiac muscle and lung congestion.  The high-
energy expenditure of flight, and a cardiovascular system that must function at a level to accommodate 
these energy expenditures, may predispose bats to heart-related issues.  Lung congestion was observed in 
negative control bats that were kept in the same style of cage that inoculated bats were housed in.  Lung 
congestion has not been observed in bats euthanized, necropsied and examined histologically directly 
from the free-flight colony room.  Restricting normal mobility and flight may predispose bats to lung 
disease.  Another difference between free-flight colony bats, and caged inoculated bats were the rooms 
they were kept in.  The colony room is often warmer and more humid than the inoculation room.  Given 
that bats are heterotherms, the difference in ambient temperatures may play a role in lung pathology.  The 
mechanism for this will be important to ascertain for future studies as to prevent pathology that might 
interfere with viral-host ecology.     
 
This study also provides novel evidence that TCRV, or a similar virus, may still be circulating in 
Trinidad.  Furthermore, the research presented here expands the host range of TCRV in bats as previously 
flat-faced fruit bats, great fruit-eating bats, yellow shouldered-fruit bats have been found seropositive for 






These studies explore novel viruses in New World bats and further our understanding of the 
relationship of bats with their viruses.  This is paramount given the capacity of bats to serve as reservoirs 
for emerging infectious diseases and the anthropogenic rate of biodiversity loss and human encroachment 
on wildlife species thereby increasing potential exposure to novel pathogens.  The more scientists 
understand about bats, public health, and disease ecology the more it is possible to intervene to both 






























1. Schulte P, Alegret L, Arenillas I, Arz J, Barton P, Bown P, Bralower T, Christeson G, 
Clayes P, Cockell C, Collins G, Deutsch A, Goldin T, Goto K, Grajales N, J, Grieve R, 
Gulick S, Johnson K, Kiessling W, Koeberl C, Kring D, Macleod K, Matsui T, Melosh J, 
Montanari A, Morgan J, Neal C, Nichols D, Norris R, Pierazzo E, Ravizza G, Rebolledo-
Vieyra M, Reimold W, Robin E, Salge T, Speijer R, Sweet A, Urrutia-Fucugauchi J, Vajda 
V, Whalen M, Willumsen P. 2010. The Chicxulub asteroid impact and mass extinction at the 
Cretaceous-Paleogene boundary. Science 327:1214-1218. 
2. Benton M, Ayala F. 2003. Dating the tree of life. Science 300:1698-1700. 
3. O'Leary M, Bloch J, Flynn J, Gaudin T, Giallombardo A, Giannini N, Goldberg S, Kraatz 
B, Luo Z, Meng J, Ni X, Novacek M, Perini M, Randall Z, Rougier G, Sargis E, Silcox M, 
Simmons N, Spaulding M, Velazco P, Weksler M, Wible J, Cirranello. 2013. The placental 
mammal ancester and the post-K-Pg radiation of placentals. Science 339:662-667. 
4. Teeling E, Springer M, Madsen O, Bates P, O'Brien S, Murphy W. 2005. A molecular 
phylogeny for bats illuminates biogeography and the fossil record. Science 307:580-584. 
5. Agnarsson I, Zambrana-Torrelio C, Flores-Saldana N, May-Collado L. 2011. A time-
calibrated species level phylogeny of bats (Chiroptera, Mammalia). PLoS Curr 3:RRN1212. 
6. Zhang G, Cowled C, Shi Z, Huang Z, Bishop-Lilly K, Fang X, Wynne J, Xiong Z, Baker M, 
Zhao W, Tachedjian M, Zhu Y, Zhou P, Jiang X, Ng J, Yang L, Xiao J, Feng Y, Chen Y, 
Sun X, Zhang Y, Marsh G, Crameri G, Broder C, Frey K, Wang L, Wang J. 2013. 
Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. 
Science 339:456-460. 
7. Simmons N, Seymour K, Habersetzer J, Gunnell G. 2008. Primitive early eocene bat from 
Wyoming and the evolution of flight and echolocation. Nature 451:818-821. 
8. Eiting T, Gunnell G. 2009. Global completeness of the bat fossil record. J Mammal Evol 16. 
9. Simmons N. 2005. Order Chiroptera, p 312-529. In Wilson D, Reeder D (ed), Mammal Species 
of the World: A Taxonomic and Geographic Reference, 3 ed. Smithsonian Institution Press, 
Washington DC. 
10. Tsagkogeorga G, Parker J, Stupka E, Cotton J, Rossiter S. 2013. Phylogenomic analyses 
elucidate the evolutionary relationships of bats. Curr Biol 23:2262-2267. 
11. Simmons N. 2005. An Eocene big bang for bats. Science 307:527-528. 
12. Larsen P, Marchan-Rivadeneira M, Baker R. 2010. Natural hybridization generates 
mammalian lineage with species characteristics. Proc Natl Acad Sci 107:11447-11452. 
13. Ortega J, Castro-Arellano I. 2001. Artibeus jamaicensis. Mammalian Species 662:1-9. 
14. Delmas O, Holmes E, Talbi C, Larrous F, Dacheux L, Bouchier C, Bourhy H. 2008. 
Genomic diversity and evolution of the lyssaviruses. PLoS One 3:e2057. 
15. Velasco-Villa A, Mauldin M, Shi M, Escobar L, Gallardo-Romero N, Damon I, Olson V, 
Streicker D, Emerson G. 2017. The history of rabies in the Western Hemisphere. Antiviral Res 
146:221-232. 
16. Amman B, Carroll S, Reed Z, Sealy T, Balinandi S, Swanepoel R, Kemp A, Erickson B, 
Comer J, Campbell S, Cannon D, Khristova M, Atimnedi P, Paddock C, Crockett R, 
Flietstra T, Warfield K, Unfer R, Katongole-Mbidde E, Downing R, Tappero J, Zaki S, 
Rollin P, Ksiazek T, Nichol S, Towner J. 2012. Seasonal pulses of Marburg virus circulation in 
juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. 
PLoS Pathog 8:e1002877. 
17. Swanepoel R, Smit S, Rollin P, Formenty P, Leman P, Kemp A, Burt F, Grobbelaar A, 





Paweska J. 2007. Studies of reservoir hosts for Marburg virus. Emerg Infect Diseases 13:1847-
1851. 
18. Towner J, Amman B, Sealy T, Carroll S, Comer J, Kemp A, Swanepoel R, Paddock C, 
Balinandi S, Khristova M, Formenty P, Albarino C, Miller D, Reed Z, Kayiwa J, Mills J, 
Cannon D, Greer P, Byaruhanga E, Farnon E, Atimnedi P, Okware S, Katongole-Mbidde 
E, Downing R, Tappero J, Zaki S, Ksiazek T, Nichol S, Rollin P. 2009. Isolation of 
genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5:e1000536. 
19. Towner J, Pourrut X, Albarino C, Nkogue C, Bird B, Grard G, Ksiazek T, Gonzalez J, 
Nichol S, Leroy E. 2007. Marburg virus infection detected in a common African bat. PLoS One 
2:e764. 
20. Drexler J, Corman M, Muller M, Maganga G, Vallo P, Binger T, Gloza-Rausch F, Rasche 
A, Yordanov S, Seebens A, Oppong S, Adu Sarkodie Y, Pongombo C, Lukashev A, 
Schmidt-Chanasit J, Stocker A, Borges Carneiro A, Erbar S, Maisner A, Fronhoffs F, 
Buettner R, Kalko E, Kruppa T, Roberto Franke C, Kallies R, Yandoko E, Herrler G, 
Reusken C, Hassanin A, Kruger D, Matthee S, Ulrich R, Leroy E, Drosten C. 2012. Bats 
host major mammalian paramyxoviruses. Nat Commun 3. 
21. Hu B, Ge X, Wang L, Shi Z. 2015. Bat origin of human coronaviruses. Virol J 12. 
22. McCarthy A, Goodman S. 2010. Reassessing conflicting evolutionary histories of the 
Paramyxoviridae and the origins of respiroviruses with Bayesian multigene phylogenies. Infect 
Genet Evol 10:97-107. 
23. Quan P, Firth C, Conte J, Williams S, Zambrana-Torrelio C, Anthony S, Ellison J, Gilbert 
A, Kuzmin I, Niezgoda M, Osinubi M, Recuenco S, Markotter W, Breiman R, Kalemba L, 
Malekani J, Lindblade K, Rostal M, Ojeda-Flores R, Suzan G, Davis L, Blau D, Ogunkoya 
A, Alvarez Castillo D, Moran D, Ngam S, Akaibe D, Agwanda B, Briese T, Epstein J, 
Daszak P, Rupprecht C, Holmes E, Lipkin I. 2013. Bats are a major natural reservoir for 
hepaciviruses and pegiviruses. Proc Natl Acad Sci 110:8194-8199. 
24. Drexler J, Geipel A, Konig A, Corman V, van Riel D, Leijten L, Bremer C, Rasche A, 
Cottontail V, Maganga G, Schlegel M, Muller M, Adam A, Klose S, Borges Carneiro A, 
Stocker A, Roberto Franke C, Gloza-Rausch F, Geyer J, Annan A, Adu Sarkodie Y, 
Oppong S, Binger T, Vallo P, Tschapka M, Ulrich R, Gerlich W, Leroy E, Kuiken T, Glebe 
D, Drosten C. 2013. Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B 
virus and capable of infecting human hepatocytes. Proc Natl Acad Sci 110:16151-16156. 
25. Littlejohn M, Locarnini S, Yuen L. 2016. Origins and evolution of hepatitis B virus and 
hepatitis D virus. Cold Spring Harb Perspect Med 6:a021360. 
26. Anonymous. 2017. Changes to taxonomy and the international code of virus classification and 
nomenclature ratified by the International Committee of Taxonomy of Viruses. Arch Virol 
doi:doi: 10.1007/s00705-017-3358-5. 
27. Lyles D, Kuzmin I, Rupprecht C. 2013. Rhabdoviridae, p 885-922. In Knipe D, Howley P, 
Cohen J, Griffin D, Lamb R, Martin M, Racaniello V, Roizman B (ed), Fields Virology, 6 ed, vol 
1. Lippincott Williams & Wilkins, Philadelphia, PA. 
28. WHO. 2017. Rabies:  epidemiology and burden of disease. Organization WH, 
http://www.who.int/rabies/epidemiology/en/. 
29. Barthold S, Bowen R, Hedrick R, Knowles D, Lairmore M, Parrish C, Saif L, Swayne D. 
2011. Rhabdoviridae, p 327-348. In Maclachlan N, Dubovi E (ed), Fenner's Veterinary Virology, 
4 ed. Elsevier Inc, Oxford. 
30. Turmelle A, Jackson F, Green D, McCracken G, Rupprecht C. 2010. Host immunity to 
repeated rabies virus infecton in big brown bats. J Gen Virol 91:2360-2366. 
31. McColl K, Chamberlain T, Lunt R, Newberry K, Middleton D, Westbury H. 2002. 






32. Haydon D. 2002. Identifying reservoirs of infection:  a conceptual and practical challenge. 
Emerg Infect Diseases 8:1468-1473. 
33. Feldmann H, Sanchez A, Geisbert T. 2013. Filoviridae: Marburg and Ebola virus, p 923-956. 
In Knipe D, Howley P, Cohen J, Griffin D, Lamb R, Martin M, Racaniello V, Roizman B (ed), 
Fields Virology, 6 ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA. 
34. Negredo A, Palacios G, Vazquez-Moron S, Gonzalez F, Dopazo H, Molero F, Juste J, 
Quetglas J, Savji N, de la Cruz Martinez M, Herrera J, Pizarro M, Hutchison S, Echevarria 
J, Lipkin I, Tenorio A. 2011. Discovery of an Ebolavirus-like filovirus in Europe. PLoS Pathog 
7:e1002304. 
35. Bausch D, Schwarz L. 2014. Outbreak of Ebola virus disease in Guinea:  Where ecology meets 
economy. PLoS Negl Trop Dis 8:e3056. 
36. Leroy E, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska J, 
Gonzalez J, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575-576. 
37. Amman B, Jones M, Sealy T, Uebelhoer L, Schuh A, Bird B, Coleman-McCray J, Martin B, 
Nichol S, Towner J. 2015. Oral shedding of Marburg virus in experimentally infected Egyptian 
fruit bats (Rousettus aegyptiacus). J Wildl Dis 51:113-124. 
38. Luis A, Hayman D, O'Shea T, Cryan P, Gilbert A, Pulliam J, Mills J, Timonin M, Willis C, 
Cunningham A, Fooks A, Rupprecht C, Wood J, Webb C. 2013. A comparison of bats and 
rodents as reservoirs of zoonotic viruses: are bats special? Proc R Soc B 280:20122753. 
39. Olival K, Hosseini P, Zambrana-Torrelio C, Ross N, Bogich T, Daszak P. 2017. Host and 
viral traits predict zoonotic spillover from mammals. Nature 546:646-650. 
40. Breman J, Johnson K, van der Groen G, Robbins C, Szczeniowski M, Ruti K, Webb P, 
Meier F, Heymann D, Teams EVS. 1999. A search for Ebola virus in animals in the Democratic 
Republic of the Congo and Cameroon:  Ecologic, virologic, and serologic surveys, 1979-1980. J 
Infect Dis 179:S139-S147. 
41. Germain M. 1978. Collection of mammals and arthropods during the epidemic of haemorrhagic 
fever in Zaire, p 131-133. In Pattyn S (ed), Ebola virus haemorrhagic fever. Elsevier, Amsterdam, 
The Netherlands. 
42. Arata A, Johnson B. 1978. Approaches towards studies on potential reservoirs of viral 
haemorrhagic fever in southern Sudan (1977), p 191-202. In Pattyn S (ed), Ebola virus 
haemorrhagic fever. Elsevier/Netherland Biomedical, Amsterdam. 
43. Swanepoel R, Leman P, Burt F, Zachariades N, Braack L, Ksiazek T, Rollin P, Zaki S, 
Peters C. 1996. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect 
Diseases 2:321-325. 
44. Leendertz S, Gogarten J, Dux A, Calvignac-Spencer S, Leendertz F. 2016. Assessing the 
evidence supporting fruit bats as the primary reservoirs for Ebola virus. Ecohealth 13:18-25. 
45. Pourrut X, Delicat A, Rollin P, Ksiazek T, Gonzalez J, Leroy E. 2007. Spatial and temporal 
patterns of Zaire Ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis 
196:S176-S183. 
46. Ogawa H, Miyamoto H, Nakayama E, Yoshida R, Nakamura I, Sawa H, Ishii A, Thomas Y, 
Nakagawa E, Matsuno K, Kajihara M, Maruyama J, Nao N, Muramatsu M, Kuroda M, 
Simulundu E, Changula K, Hang'ombe B, Namangala B, Nambota A, Katampi J, Igarashi 
M, Ito K, Feldmann H, Sugimoto C, Moonga L, Mweene A, Takada A. 2015. 
Seroepiemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) 
migrating in Africa. J Infect Dis 212:S101-S107. 
47. Ossa G, Kramer-Schadt S, Peel A, Scharf A, Voigt C. 2012. The movement ecology of the 
straw-colored fruit bat, Eidolon helvum, in Sub-Saharan Africa assessed by stable isotope ratios. 
PLoS One 7:e45729. 
48. Hayman D, Yu M, Crameri G, Wang L, Suu-Ire R, Wood J, Cunningham A. 2012. Ebola 





49. Hayman D, Emmerich P, Yu M, Wang L, Suu-Ire R, Fooks A, Cunningham A, Wood J. 
2010. Long-term survival of urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS 
One 5:e11978. 
50. Jones M, Schuh A, Amman B, Sealy T, Zaki S, Nichol S, Towner J. 2015. Experimental 
inoculation of Egyptian rousette bats (Rousettus aegyptiacus) with viruses of the Ebolavirus and 
Marburgvirus genera. Viruses 7. 
51. Paweska J, Storm N, Grobbelaar A, Markotter W, Kemp A, van Vuren P. 2016. 
Experimental inoculation of Egyptian fruit bats (Rousettus aegyptiacus) with Ebola virus. Viruses 
8:E29. 
52. Lamb R, Parks G. 2013. Paramyxoviridae, p 957-994. In Knipe D, Howley P, Cohen J, Griffin 
D, Lamb R, Martin M, Racaniello V, Roizman B (ed), Fields Virology, 6 ed, vol 1. Lippincott 
Williams & Wilkins, Philadelphia, PA. 
53. Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, 
Rodwell B, Ketterer P. 1995. A morbillivirus that caused fatal disease in horses and humans. 
Science 268:94-97. 
54. Selvey L, Wells R, McCormack J, Ansford A, Murray P, Rogers R. 1995. Outbreak of severe 
respiratory disease in humans and horses due to a previously unrecognized paramyxovirus. Med J 
162:642-645. 
55. Sulkin S, Allen R. 1974. Virus infections in bats. In Melnick J (ed), Monographs in Virology, 1 
ed. S Karger, New York. 
56. Pavri K, Singh K, Hollinger F. 1971. Isolation of a new parainfluenza virus from a frugivorous 
bat, Rousettus leschenaultia, collected at Poona, India. Am J Trop Med Hyg 20:125-130. 
57. Henderson G, Laird C, Dermott E, Rima B. 1995. Characterization Mapuera virus: structure, 
proteins and nucleotide sequence of the gene encoding the nucleocapsid protein. J Gen Virol 
76:2509-2518. 
58. Young P, Halpin K, Selleck P, Field H, Gravel J, Kelly M, Mackenzie J. 1996. Serologic 
evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. 
Emerg Infect Diseases 2:239-240. 
59. Selvey L, Taylor R, Arklay A, Gerrard J. 1996. Screening of bat carers for antibodies to equine 
morbillivirus. Commun Dis Intell 20:477-478. 
60. Halpin K, Young P, Field H, Mackenzie J. 2000. Isolation of Hendra virus from pteropid bats: 
a natural reservoir of Hendra virus. J Gen Virol 81:1927-1932. 
61. Williamson M, Hooper P, Selleck P, Daniels P, Westbury H, Murray P. 1998. Transmission 
studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J 12:813-
818. 
62. Williamson M, Hooper P, Selleck P, Westbury H, Slocombe R. 1999. Experimental Hendra 
virus infection in pregnant guinea-pigs and fruit bats (Pteropus poliocephalus). J Comp Path 122. 
63. Chua K, Bellini W, Rota P, Harcourt B, Tamin A, Lam S, Ksiazek T, Rollin P, Zaki S, 
Shieh W, Goldsmith C, Gubler D, Roehrig J, Eaton B, Gould A, Olson J, Field H, Daniels P, 
Ling A, Peters C, Anderson L, Mahy B. 2000. Nipah virus: A recently emergent deadly 
paramyxovirus. Science 288:1432-1435. 
64. Chua K, Koh C, Hooi P, Wee K, Khong J, Chua B, Chan Y, Lim M, Lam S. 2002. Isolation 
of Nipah virus from Malaysian island flying-foxes. Microb Infect 4:145-151. 
65. Luby S, Hossain M, Gurley E, Ahmed B, Banu S, Khan S, Hamaira N, Rota P, Rollin P, 
Comer J, Kenah E, Ksiazek T, Rahman M. 2009. Recurrent zoonotic transmission of Nipah 
virus into humans, Bangladesh, 2001-2007. Emerg Infect Diseases 15:1229-1234. 
66. Luby S, Rahman M, Hossain M, Blum L, Husain M, Gurley E, Khan R, Ahmed B, Rahman 
S, Nahar N, Kenah E, Comer J, Ksiazek T. 2006. Foodborne transmission of Nipah virus, 





67. Middleton D, Morrissy C, van der Heide P, Russell G, Braun M, Westbury H, Halpin K, 
Daniels P. 2007. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J 
Comp Path 136:266-272. 
68. Masters P, Perlman S. 2013. Coronaviridae, p 825-858. In Knipe D, Howley P, Cohen J, Griffin 
D, Lamb R, Martin M, Racaniello V, Roizman B (ed), Fields Virology, 6 ed, vol 1. Lippincott 
Williams & Wilkins, Philadelphia, PA. 
69. Anonymous. 2003. Consensus document on the epidemiology of severe acute respiratory 
syndrome (SARS). response Docdsa, World Health Organization, Geneva, Switzerland.  
70. Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S, Tong S, Urbani C, Comer J, 
Lim W, Rollin P, Dowell S, Ling A, Humphrey C, Shieh W, Guarner J, Paddock C, Rota P, 
Fields B, DeRisi J, Yang J, Cox N, Hughes J, LeDuc J, Bellini W, Anderson L, Group SW. 
2003. A novel coronavirus associated with severe acute respiratory syndrome. New Engl J Med 
348:1953-1966. 
71. Peiris J, Lai S, Poon L, Guan Y, Yam L, Lim W, Nicholls J, Yee W, Yan W, Cheung M, 
Cheng V, Chan K, Tsang D, Yung R, Ng T, Yuen K, Group SS. 2003. Coronavirus as a 
possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. 
72. Prevention CfDCa. 2003. Prevalence of IgG antibody to SARS-associated coronavirus in animal 
traders--Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep 52:986-987. 
73. Guan Y, Zheng B, He Y, Liu X, Zhuang Z, Cheung C, Luo S, Li P, Zhang L, Guan Y, Butt 
K, Wong K, Chan K, Lim W, Shortridge K, Yuen K, Peiris J, Poon L. 2003. Isolation and 
characterization of viruses related to the SARS coronavirus from animals in southern China. 
Science 302:276-278. 
74. Tu C, Crameri G, Kong X, Chen J, Sun Y, Yu M, Xiang H, Xia X, Liu S, Ren T, Yu Y, 
Eaton B, Xuan H, Wang L. 2004. Antibodies to SARS coronavirus in civets. Emerg Infect 
Diseases 10:2244-2248. 
75. Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, Yu Y, Guan Y, Jiang Y, Yin X, Crameri G, 
Wang M, Li C, Liu S, Liao M, Feng L, Xiang H, Sun J, Chen J, Sun Y, Gu S, Liu N, Fu D, 
Eaton B, Wang L, Kong X. 2005. Civets are equally susceptibly to experimental infection by 
two different severe acute respiratory syndrome coronavirus isolates. J Virol 79:2620-2625. 
76. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein J, Wang H, Crameri G, Hu Z, Zhang H, 
Zhang J, McEarchern J, Field H, Daszak P, Eaton B, Zhang S, Wang L. 2005. Bats are 
natural reservoirs of SARS-like coronaviruses. Science 310:676-678. 
77. Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R. 2012. Isolation of a novel 
coronavirus from a man with pneumonia in Saudi Arabia. New Engl J Med 367:1814-1820. 
78. Anonymous. 2017. Middle East respiratory syndrome coronavirus (MERS-CoV). Organization 
WH, http://www.who.int/emergencies/mers-cov/en/. 
79. Reusken C, Haagmans B, Muller M, Gutierrez C, Godeke J, Meyer B, Muth D, Raj S, 
Smits-De Vries L, Corman V, Drexler J, Smits S, El Tahir Y, Sousa R, van Beek J, Nowotny 
N, van Maanen K, Hidalgo-Hermoso E, Bosch B, Rottier P, Osterhaus A, Gortazar-Schmidt 
C, Drosten C, Koopmans M. 2013. Middle East respiratory syndrome coronavirus neutralising 
serum antibodies in dromedary camels: a comparative serological study. Lancet 13:859-866. 
80. Chu D, Poon L, Gomaa M, Shehata M, Perera R, Zeid D, El Rifay A, Siu L, Guan Y, 
Webby R, Ali M, Peiris M, Kayali G. 2014. MERS coronavirus in dromedary camels, Egypt. 
Emerg Infect Diseases 20:1049-1053. 
81. Adney D, van Doremalen N, Brown V, Bushmaker T, Scott D, de Wit E, Bowen R, Munster 
V. 2014. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated 
dromedary camels. Emerg Infect Diseases 20:1999-2005. 
82. Haagmans B, Dhahiry S, Reusken C, Raj S, Galiano M, Myers R, Godeke J, Jonges M, 
Farag E, Diab A, Ghobashy H, Alhajri F, Al-Thani M, Al-Marri S, Romaihi H, Khal A, 
Bermingham A, Osterhaus A, Alhajri M, Koopmans M. 2014. Middle East respiratory 





83. Meyer B, Muller M, Corman V, Reusken C, Ritz D, Godeke J, Lattwein E, Kallies S, 
Siemens A, van Beek J, Drexler J, Muth D, Bosch B, Wernery U, Koopmans M, Wernery R, 
Drosten C. 2014. Antibodies against MERS-coronavirus in dromedaries, United Arab Emirates, 
2003 and 2013. Emerg Infect Diseases 20:552-559. 
84. Lau S, Li K, Tsang A, Lam C, Ahmed S, Chen H, Chan K, Woo P, Yuen K. 2013. Genetic 
characterization of Betacoronavirus lineage C viruses reveals marked sequence divergence in the 
spike protein of Pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the 
origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87:8638-8650. 
85. Memish Z, Mishra N, Olival K, Fagbo S, Kapoor V, Epstein J, AlHakeem R, Asmari M, 
Islam A, Kapoor A, Briese T, Daszak P, Rabeeah A, Lipkin I. 2013. Middle East respiratory 
syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Diseases 19:1819-1823. 
86. Annan A, Baldwin H, Corman M, Klose S, Owusu M, Nkrumah E, Badu E, Anti P, 
Agbenyega O, Meyer B, Oppong S, Sarkodie Y, Kalko E, Lina P, Godlevska E, Reusken C, 
Seebens A, Gloza-Rausch F, Vallo P, Tschapka M, Drosten C, Drexler J. 2013. Human 
betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Diseases 
19:456-459. 
87. Ithete N, Stoffberg S, Corman V, Cottontail V, Richards L, Schoeman M. 2013. Close 
relative of human middle East respiratory syndrome coronavirus in bat, South Africa. Emerg 
Infect Diseases 19:1697-1699. 
88. Falcon A, Vazquez-Moron S, Casas I, Aznar C, Ruiz G, Pozo F. 2022. Detection of alpha and 
betacoronaviruses in multiple Iberian bat species. Arch Virol 156:1883-1890. 
89. Wacharapluesadee S, Sintunawa C, Kaewpom T, Khongnomnan K, Olival K, Epstein J, 
Rodpan A, Sangsri P, Intarut N, Chindamporn A, Suksawa K, Hemachudha T. 2013. Group 
C betacoronaviruses in bat guano fertilizer, Thailand. Emerg Infect Diseases 19:1349-1352. 
90. Anthony S, Ojeda-Flores R, Rico-Chavez O, Navarrete-Macias I, Zambrana-Torrelio C, 
Rostal M, Epstein J, Tipps T, Liang E, Sanchez-Leon M, Sotomayor-Bonilla J, Aguirre A, 
Avila-Flores R, Medellin R, Goldstein T, Suzan G, Daszak P, Lipkin I. 2013. Coronaviruses 
in bats from Mexico. J Gen Virol 94:1028-1038. 
91. Munster V, Adney D, van Doremalen N, Brown V, Miazgowicz K, Milne-Price S, 
Bushmaker T, Rosenke R, Scott D, Hawkinson A, de Wit E, Schountz T, Bowen R. 2016. 
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep 6. 
92. Pfefferle S, Oppong S, Drexler J, Gloza-Rausch F, Ipsen A, Seebens A, Muller M, Annan A, 
Vallo P, Adu Sarkodie Y, Kruppa T, Drosten C. 2009. Distant relatives of severe acute 
respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. 
Emerg Infect Diseases 15:1377-1384. 
93. Corman V, Baldwin H, Tateno A, Zerbinati R, Annan A, Owusu M, Nkrumah E, Maganga 
G, Oppong S, Adu Sarkodie Y, Vallo P, Ferreira da Silva Filho L, Leroy E, Thiel V, van der 
Hoek L, Poon L, Tschapka M, Drosten C, Drexler J. 2015. Evidence for an ancestral 
association of human coronavirus 229E with bats. J Virol 89:11858-11870. 
94. Lindenbach B, Murray C, Thiel H, Rice C. 2013. Flaviviridae, p 712-746. In Knipe D, Howley 
P, Cohen J, Griffin D, Lamb R, Martin M, Racaniello V, Roizman B (ed), Fields Virology, 6 ed, 
vol 1. Lippincott Williams & Wilkins, Philadelphia, PA. 
95. WHO. 2017. Global hepatitis report, 2017. World Health Organization, Geneva, Switzerland. 
http://apps.who.int/iris/bitstream/10665/255017/1/WHO-HIV-2017.06-eng.pdf?ua=1. 
96. Chotiwan N, Brewster C, Magalhaes T, Weger-Lucarelli J, Duggal N, Ruckert C, Nguyen 
C, Garcia Luna S, Fauver J, Andre B, Gray M, Black IV W, Kading R, Ebel G, Kuan G, 
Balmaseda A, Jaenisch T, Marques E, Brault A, Harris E, Foy B, Quackenbush S, Perera 
R, Rovnak J. 2017. Rapid and specific detection of Asian- and African-lineage Zika viruses. Sci 
Transl Med 9:1-13. 
97. Calisher C, Childs J, Field H, Holmes K, Schountz T. 2006. Bats: Important reservoir hosts of 





98. Wang L, Walker P, Poon L. 2011. Mass extinctions, biodiversity and mitochondrial function:  
are bats 'special' as reservoirs for emerging viruses? Curr Opin Virol 1:649-657. 
99. Han H, Wen H, Zhou C, Chen F, Luo L, Liu J, Yu X. 2015. Bats as reservoirs of severe 
emerging infectious diseases. Virus Res 205:1-6. 
100. Plyusnin A, Sironen A. 2014. Evolution of hantaviruses:  co-speciation with reservoir hosts for 
more than 100 MYR. Virus Res 187:22-26. 
101. Fabre P, Hautier L, Dimitrov D, Douzery E. 2012. A glimpse on the pattern of rodent 
diversification: a phylogenetic approach. BMC Evol Biol 12:1471-2148. 
102. Pacheco M, Battistuzzi F, Lentino M, Aguilar R, Kumar S, Escalante A. 2011. Evolution of 
modern birds revealed by mitogenomics: timing the radiation and origin and major orders. Mol 
Biol Evol 28:1927-1942. 
103. Webster R, Bean W, Gorman O, Chambers T, Kawaoka Y. 1992. Evolution and ecology of 
influenza A viruses. Microbiol Rev 56:152-179. 
104. Eizirik E, Murphy W, Koepfli K, Johnson W, Dragoo J, Wayne R, O'Brien S. 2010. Pattern 
and timing of diversification of the mammalian order Carnivora inferred from multiple nuclear 
gene sequences. Mol Phylogenet Evol 56:49-63. 
105. Pozzi L, Hodgson J, Burrell A, Sterner K, Raaum R, Disotell T. 2014. Primate phylogenetic 
relationships and divergence dates inferred from complete mitochondrial genomes. Mol 
Phylogenet Evol 75:165-183. 
106. Tavare S, Marshall C, Will O, Soligo C, Martin R. 2002. Using the fossil record to estimate 
the age of the last common ancestor of extant primates. Nature 416:726-729. 
107. Archibald J, Deutschman D. 2001. Quantitative analysis of the timing of the origin and 
diversification of extant placental orders. J Mammal Evol 8:107-124. 
108. Geoghegan J, Holmes E. 2017. Predicting virus emergence amid evolutionary noice. Open Biol 
7:170189. 
109. Papenfuss A, Baker M, Feng Z, Tachedjian M, Crameri G, Cowled C, Ng J, Janardhana V, 
Field H, Wang L. 2012. The immune gene repertoire of an important viral reservoir, the 
Australian black flying fox. BMC Genomics 13:261. 
110. Secombes C, Zou J. 2017. Evolution of interferons and interferon receptors. Front Immunol 
8:209. 
111. Roberts R, Liu L, Gui Q, Leaman D, Bixby J. 1998. The evolution of the type I interferons. J 
Interferon Cytokine Res 18:805-816. 
112. Tizard I. 2013. Immunity to viruses, p 296-310, Veterinary Immunology, 9 ed. Elsevier Inc, St. 
Louis, MO. 
113. Hughes A, Hughes M. 1999. Small genomes for better flyers. Nature 377:391. 
114. Smith J, Gregory T. 2009. The genome sizes of megabats (Chiroptera:  Pteropodidae). Biol Lett 
5:347-351. 
115. Zhou P, Tachedjian M, Wynne J, Boyd V, Cui J, Smith I, Cowled C, Ng J, Mok L, 
Michalski W, Mendenhall I, Tachedjian G, Wang L, Baker M. 2016. Contraction of the type I 
IFN locus and unusual constiutive expression of IFN-alpha in bats. Proc Natl Acad Sci 113:2696-
2701. 
116. Schountz T, Baker M, Butler J, Munster V. 2017. Immunological control of viral infections in 
bats and the emergence of viruses highly pathogenic to humans. Front Immunol 8:1098. 
117. Fujii H, Watanabe S, Yamane D, Ueda N, Iha K, Taniguchi S, Kato K, Tohya Y, Kyuwa S, 
Yoshikawa Y, Akashi H. 2010. Functional analysis of Rousettus aegyptiacus "signal transducer 
and activator of transcription 1" (STAT1). Dev Comp Immunol 34:598-602. 
118. Zhou P, Cowled C, Marsh G, Shi Z, Wang L, Baker M. 2011. Type III IFN receptor 






119. Zhou P, Cowled C, Todd S, Crameri G, Virtue E, Marsh G, Klein R, Shi Z, Wang L, Baker 
M. 2011. Type III IFNs in pteropid bats:  Differential expression patterns provide evidence for 
distinct roles in antiviral immunity. J Immunol 186:3138-3147. 
120. Wack A, Terczynska-Dyla E, Hartmann R. 2015. Guarding the frontiers: the biology of type 
III interferons. Nat Immunol 16:802-809. 
121. Ng J, Tachedjian M, Deakin J, Wynne J, Cui J, Haring V, Broz I, Chen H, Belov K, Wang 
L, Baker M. 2016. Evolution and comparative analysis of the bat MHC-I region. Sci Rep 
6:21256. 
122. Schroeder H, Cavacini L. 2010. Structure and function of immunoglobulins. J Allergy Clin 
Immunol 125:S41-S52. 
123. Butler J, Wertz N, Zhao Y, Zhang S, Bao Y, Bratsch S, Kunz T, Whitaker Jr. J, Schountz 
T. 2011. The two suborders of chiropterans have the canonical heavy-chain immunoglobulin 
(IgG) gene repertoire of eutherian mammals. Dev Comp Immunol 35:273-284. 
124. Wynne J, Di Rubbo A, Shiell B, Beddome G, Cowled C, Peck G, Huang J, Grimley S, Baker 
M, Michalski W. 2013. Purification and characterisation of immunoglobulins from the 
Australian black flying fox (Pteropus alecto) using anti-Fab-affinity chromatography reveals a 
low abundance IgA. PLoS One 8:e52930. 
125. Baker M, Tachedjian M, Wang L. 2010. Immunoglobulin heavy chain diversity of Pteropid 
bats: evidene for a diverse and highly specific antigen binding repertoire. Immunogenetics 
62:173-184. 
126. Jung D, Giallourakis C, Mostoslavsky R, Alt F. 2006. Mechanism and control of V(D)J 
recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 24:541-570. 
127. Tizard I. 2013. Systemic responses to inflammation, p 53-60, Veterinary Immunology, 9 ed. 
Elsevier Inc, St. Louis, MO. 
128. Bratsch S, Wertz N, Chaloner K, Kunz T, Butler J. 2011. The little brown bat, M. lucifugus, 
displays a highly diverse VH, DH, JH repertoire but little evidence of somatic hypermutation. 
Dev Comp Immunol 35:421-430. 
129. Cogswell-Hawkinson A, Bowen R, James S, Gardiner D, Calisher C, Adams R, Schountz T. 
2012. Tacaribe virus causes fatal infection in an ostensible reservoir host, Jamaican fruit bats. J 
Virol 86:5791-5799. 
130. Ahn M, Cui J, Irving A, Wang L. 2016. Unique loss of the PYHIN gene family in bats amongst 
mammals:  Implications for inflammasome sensing. Sci Rep 6:21722. 
131. O'Shea T, Cryan P, Cunningham A, Fooks A, Hayman D, Luis A, Peel A, Plowright R, 
Wood J. 2014. Bat flight and zoonotic viruses. Emerg Infect Diseases 20:741-745. 
132. Downs C, Zungu M, Brown M. 2012. Seasonal effects on thermoregulatory abilities of the 
Wahlberg's epauletted fruit bat (Epomophorus wahlbergi) in KwaZulu-Natal, South Africa. J 
Therm Biol 37:144-150. 
133. Geiser F. 2004. Metabolic rate and body temperature reduction during hiberation and daily 
torpor. Annu Rev Physiol 66:239-274. 
134. Carpenter R. 1986. Flight physiology of intermediate-sized fruit bats (Pteropodidae). J Exp Biol 
120:79-103. 
135. Voigt C, Lewanzik D. 2010. Trapped in the darkness of the night: thermal and energetic 
constraints of daylight flight in bats. Proc R Soc B 278:2311-2317. 
136. Subudhi S, Rapin N, Bollinger T, Hill J, Donaldson M, Davy C, Warnecke L, Turner J, 
Kyle C, Willis C, Misra V. 2017. A persistently infecting coronavirus in hibernating Myotis 
lucifufugs, the North American little brown bat. J Gen Virol 98:2297-2309. 
137. Osborne C, Cryan P, O'Shea T, Oko L, Ndaluka C, Calisher C, Berglund A, Klavetter M, 
Bowen R, Holmes K, Dominguez S. 2011. Alphacoronaviruses in New World bats: prevalence, 





138. Davis A, Morgan S, Dupuis M, Poulliott, Jarvis J, Franchini R, Clobridge A, Rudd R. 2016. 
Overwintering of rabies virus in silver haired bats (Lasionycteris noctivagans). PLoS One 
11:e0155542. 
139. Jonasson K, Willis C. 2012. Hibernation energetics of free-ranging little brown bats. J Exp Biol 
215:2141-2149. 
140. Shaw M, Garcia-Sastre A, Palese P, Basler C. 2004. Nipah virus V and W proteins have a 
common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear 
compartments, respectively. J Virol 78:5633-5641. 
141. Kopecky-Bromberg S, Martinez-Sobrido L, Frieman M, Baric R, Palese P. 2007. Severe 
acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid 
proteins function as interferon antagonists. J Virol 81:548-557. 
142. Valmas C, Grosch M, Schumann M, Olejnik J, Osvaldo M, Best S, Krahling V, Basler C, 
Muhlberger E. 2010. Marburg virus evades interferon responses by a mechanism different from 
Ebola virus. PLoS Pathog 6:e1000721. 
143. Virtue E, Marsh G, Baker M, Wang L. 2011. Interferon production and signaling pathways are 
antagonized during henipavirus infection of fruit bat cell lines. PLoS One 6:e22488. 
144. Fuchs J, Holzer M, Schilling M, Patzina C, Schoen A, Hoenen T, Zimmer G, Marz M, 
Weber F, Muller M, Kochs G. Evolution and antiviral specificity of interferon-induced Mx 
proteins of bats against Ebola-, Influenza-, and other RNA viruses. J Virol 91:e00361-00317. 
145. Kuzmin I, Schwarz T, Llinykh P, Jordan I, Ksiazek T, Sachidanandam R, Basler C, 
Bukreyev A. 2017. Innate immune responses of bat and human cells to filoviruses:  
commonalities and distinctions. J Virol 91:e02471-02416. 
146. Warnecke L, Turner J, Bollinger T, Misra V, Cryan P, Blehert D, Wibbelt G, Willis C. 
2013. Pathophysiology of white-nose syndrome in bats: a mechanistic model linking wing 
damage to mortality. Biol Lett 9:20130177. 
147. O'Shea T, Cryan P, Hayman D, Plowright R, Streicker D. 2016. Multiple mortality events in 
bats: a global review. Mammal Rev 46:175-190. 
148. Frick W, Puechmaille S, Willis C. 2016. White-nose syndrome in bats. In Voigt C, Kingston T 
(ed), Bats in the anthropocene: conservation of bats in changing world. Springer, Cham. 
149. Muhldorfer K. 2013. Bats and bacterial pathogens:  a review. Zoonoses Public Health 60:93-
103. 
150. Sonntag M, Muhldorfer K, Speck S, Wibbelt G, Kurth A. 2009. New adenovirus in bats, 
Germany. Emerg Infect Diseases 15:2052-2055. 
151. Brook C, Dobson A. 2015. Bats as 'special' reservoirs for emerging zoonotic pathogens. Trends 
in Microbiol 23:172-180. 
152. Evans N, Bown K, Timofte D, Simpson V, Birtles R. 2009. Fatal borreliosis in bat caused by 
relapsing fever spirochete, United Kingdom. Emerg Infect Diseases 15:1331-1333. 
153. Blehert D, Maluping R, Green D, Berlowski-Zier B, Ballmann A, Langenberg J. 2014. Acute 
pasteurellosis in wild big brown bats (Eptesicus fuscus). J Wildl Dis 50:136-139. 
154. Downs W, Anderson C, Spence L, Altken T, greenhall A. 1963. Tacaribe virus, a new agent 
isolated from artibeus bats and mosquitos in Trinidad, West Indies. Am J Trop Med Hyg 12:640-
646. 
155. Moreno-Valdez A, Grant W, Honeycutt R. 2000. A simulation model of Mexican long-nosed 
bat (Leptonycteris nivalis) migration. Ecolol Model 134:117-127. 
156. Richter H, Cumming G. 2008. First application of satellite telemetry to track African straw-
coloured fruit bat migration. J Zool 275:172-176. 
157. Patz J, Daszak P, Tabor G, Aguirre AA, Pearl M, Epstein J, Wolfe N, Kilpatrick AM, 
Foufopoulos J, Molyneux D, Bradley D. 2004. Unhealthy landsapes: Policy recommendations 






158. MacDicken K, Jonsson O, Pina L, Marklund L, Maulo S, Contessa V, Adikari Y, Garzuglia 
M, Lindquist E, Reams G, D'Annunzio R. 2016. Global forest resources assessment 2015. 
Nations FaAOotU, Food and Agricultural Organizations of the United Nations, Rome.  
159. Mickleburgh S, Hutson A, Racey P. 2002. A review of the global conservation status of bats. 
Oryx 36:18-34. 
160. Taylor L, Latham S, Woolhouse M. 2001. Risk factors for human disease emergence. 
Philosophical transactions of the Royal Society of London  Series B, Biological sciences 
356:983-939. 
161. Keesing F, Belden L, Daszak P, Dobson A, Harvell C, Holt R, Hudson P, Jolles A, Jones K, 
Mitchell C, Myers S, Bogich T, Ostfeld R. 2010. Impacts of biodiveristy on the emergence and 
transmission of infectious diseases. Nature 468:647-652. 
162. Plowright R, Eby P, Hudson P, Smith I, Westcott D, Bryden W, Middleton D, Reid P, 
McFarlane R, Martin G, Tabor G, Skerratt L, Anderson D, Crameri G, Quammen D, 
Jordan D, Freeman P, Wang L, Epstein J, Marsh G, Kung N, McCallum H. 2015. Ecological 
dynamics of emerging vat virus spillover. Proc R Soc B 282:20142124. 
163. Agency USEP. 2017. Global greenhouse gas emissions data. Agency USEP, 
https://http://www.epa.gov/ghgemissions/global-greenhouse-gas-emissions-data. 
164. Bindoff NL, Stott PA, AchutaRao KM, Allen MR, Gillett N, Gutzler D, Hansingo K, Hegerl 
G, Hu Y, Jain S, Mokhov II, Overland J, Perlwitz J, Sebbari R, Zhang X. 2013. Detection 
and Attribution of Climate Change: from Global to Regional. In Stocker TF, Qin D, Plattner G-K, 
Tignor M, Allen SK, Boschung J, Nauels A, Xia Y, Bex V, Midgley PM (ed), Climate Change 
2013: The Physical Science Basis. Cambridge University, Cambridge, United Kingdom and New 
York, NY, USA. 
165. Diffenbaugh N, Field C. 2013. Changes in ecologically critical terrestrial climate conditions. 
Science 342:486-492. 
166. Potter S, Cabbage M, McCarthy L. 2017. NASA, NOAA data show 2016 warmest year on 
record globally. NASA, NASA, https://http://www.nasa.gov/press-release/nasa-noaa-data-show-
2016-warmest-year-on-record-globally. 
167. Chua K, Chua B, Wang C. 2002. Anthropogenic deforestation, El Nino and the emergence of 
Nipah virus in Malaysia. Malays J Pathol 24:15-21. 
168. McPhaden M. 1999. Genesis and evolution fo the 1997-1998 El Nino. Science 283:950-954. 
169. Thomas C, Cameron A, Green R, Bakkenes M, Beaumont L, Collingham Y, Erasmus B, 
Ferreira de Siqueira M, Grainger A, Hannah L, Hughes L, Huntley B, van Jaarsveld A, 
Midgley G, Miles L, Ortega-Huerta M, Peterson A, Phillips O, Williams S. 2004. Extinction 
risk from climate change. Nature 427:145-148. 
170. Ceballos G, Ehrlich P, Dirzo R. 2017. Biological annihation via the ongoing sixth mass 
extinction signaled by vertebrate population losses and declines. Proc Natl Acad Sci 114:E6089-
E6096. 
171. Payne J, Bush A, Heim N, Knope M, McCauley D. 2016. Ecological selectivity of the 
emerging mass extinction in the oceans. Science 353:1284-1286. 
172. Wyler L, Sheikh P. 2013. International Illegal Trade in Wildlife: Threats and U.S. Policy. 
Service CR,  
173. Harrison M, Cheyne S, Darma F, Ribowo D, Limin S, Struebig. 2011. Hunting of flying foxes 
and perception of disease risk in Indonesia Borneo. Biol Cons 144:2441-2449. 
174. Daszak P, Cunningham A, Hyatt A. 2000. Emergine infectious diseases of wildlife--threats to 
biodiversity and human health. Science 287:443-449. 
175. Shi Z, Hu Z. 2007. A review of studies on animal reservoirs of the SARS coronavirus. Virus 
Research doi:10.1016/j.virusres.2007.03.012. 
176. Calisher C, Childs J, Field H, Holmes K, Schountz T. 2006. Bats:  Important reservoir hosts of 





177. Sheherazade, Tsang S. 2015. Quantifying the bat bushmeat trade in North Sulawesi, Indonesia, 
with suggestions for conservation action. Glob Ecol Conserv 3:324-330. 
178. Wilkinson G, South J. 2002. Life history, ecology and longevity of bats. Aging Cell 1:124-131. 
179. Brunotte L, Beer M, Horie M, Schwemmle M. 2016. Chiropteran influenza viruses: flu from 
bats or a relic from the past? Curr Opin Virol 16:114-119. 
180. Ma W, Garcia-Sastre A, Schwemmle M. 2015. Expected and unexpected features of the newly 
discovered bat influenza A-like viruses. PLoS Pathog 11:e1004819. 
181. Tong S, Li Y, Rivailler P, Conrardy C, Alvarez Castillo D, Chen L, Recuenco S, Ellison J, 
Davis C, York I, Turmelle A, Moran D, Rogers S, Shi M, Tao Y, Weil M, Tang K, Rowe L, 
Sammons S, Xu X, Frace M, Lindblade K, Cox N, Anderson L, Rupprecht C, Donis R. 
2012. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci 11:4269-4274. 
182. Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, 
Chen L, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney P, Gilbert A, Chang J, 
Guo Z, Davis C, Paulson J, Stevens J, Rupprecht C, Holmes E, Wilson I, Donis R. 2013. 
New world bats harbor diverse influenza A viruses. PLoS Pathog 9:e1003657. 
183. Campos G, Bandeira A, Sardi S. 2015. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 
21:1885-1886. 
184. Zanluca C, Campos Andrade de Melo V, Pamplona Mosimann A, Igor Viana dos Santos G, 
Nunes Duarte dos Santos C, Luz K. 2015. First report of autochonous transmission of Zika 
virus in Brazil. Mem Inst Oswaldo Cruz 110:569-572. 
185. Gonzalez-Salazar C, Stephens C, Sanchez-Cordero. 2017. Predicting the potential role of non-
human hosts in Zika virus mainenance. Ecohealth 14:171-177. 
186. Patterson J, Sammon M, Garg M. 2016. Dengue, Zika and Chikungunya: emerging arboviruses 
in the New World. West J Emerg Med 17:671-679. 
187. Price J. 1987. Serological evidence of infection of Tacaribe virus and arboviruses in Trinidadian 
bats. Am J Trop Med Hyg 27:162-167. 
188. Sayler K, Barbet A, Chamberlain C, Clapp W, Alleman R, Loeb J, Lednicky J. 2014. 
Isolation of Tacaribe virus, a Carribbean arenavirus, from host-seeking Amblyomma americanum 
ticks in Florida. PLoS One 9:e115769. 
189. Li Q, Sun X, Li Z, Liu Y, Vavricka C, Qi J, Gao G. 2012. Structural and functional 
characteristics of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc Natl 
Acad Sci 109:18897-18902. 
190. Sun X, Shi Y, Lu X, He J, Gao F, Yan J, Qi J, Gao G. 2013. Bat-derived influenza 
hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a 
unique entry mechanism. Cell Rep 3:769-778. 
191. Weininger A, Weininger S. 2015. Using common spatial distributions of atoms to relate 
functionally divergent influenza virus N10 and N11 protein structures to functionally 
characterized neuraminidase structures, toxin cell entry domains, and non-influenza virus cell 
entry domains. PLoS One 10:e0117499. 
192. Zhu X, Yu W, McBride R, Li Y, Chen L, Donis R, Tong S, Paulson J, Wilson I. 2013. 
Hemagglutinin homologue from H17N10 bat infuenza virus exhibits divergent receptor-binding 
and pH-dependent fusion activities. Proc Natl Acad Sci 110:1458-1463. 
193. Wu Y, Wu Y, Tefsen B, Shi Y, Gao G. 2014. Bat-derived influenza like viruses H17N10 and 
H18N11. Curr Trends Microbiol 22:183-191. 
194. Zhu X, Yang H, Guo Z, Yu W, Carney P, Li Y, Chen L, Paulson J, Donis R, Tong S, 
Stevens J, Wilson I. 2012. Crystal structures of two subtype N10 neuraminidase-like proteins 
from bat influenza A viruses reveal a diverged putative active site. Proc Natl Acad Sci 
109:18903-18909. 
195. Hoffmann M, Kruger N, Zmora P, Wrensch F, Herrler G, Pholmann S. 2016. The 
hemagglutinin of bat-associated influenza viruses is activated by TMPRSS2 for pH-dependent 





196. Maruyama J, Nao N, Miyamoto H, Maeda K, Ogawa H, Yoshida R, Igarashi M, Takada A. 
2016. Characterization of the glycoproteins of bat-derived influenza viruses. Virology 488:43-50. 
197. Moriera E, Locher S, Kolesnikova L, Bolte H, Aydillo T, Garcia-Sastre A, Schwemmle M, 
ZImmer G. 2016. Synthetically derived bat influenza A-like viruses reveal a cell type- but not a 
species-specific tropism. Proc Natl Acad Sci 113:12797-12802. 
198. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster R. 2000. A DNA transfection 
system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci 97:6108-
6113. 
199. Fodor E, Devenish L, Engelhardt O, Palese P, Brownlee G, Garcia-Sastre A. 1999. Rescue of 
influenza A virus from recombinant DNA. J Virol 73:9679-9682. 
200. Neumann G WT, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez D, Donis R, 
Hoffman E, Hobom G, Kawaoka Y 1999. Generation of influenza A viruses entirely from 
cloned cDNAs. Proc Natl Acad Sci 96:9345-9350. 
201. Zhou B, Ma J, Liu Q, Bawa B, Wang W, Shabman R, Duff M, Lee J, Lang Y, Cao N, Nagy 
A, Lin X, Stockwell T, Richt J, Wentworth D, Ma W. 2014. Characterization of uncultivable 
bat influenza virus using a replicative synthetic virus. PLoS Pathog 10:e1004420. 
202. Neumann G, Kawaoka Y. 2001. Reverse genetics of influenza virus. Virology 287:243-250. 
203. Pan W LF, Meng W, Feng L, Niu X, Li C, Luo Q, Li Z, Sun C, Chen L. 2013. Visualizing 
influenza virus infection in living mice. Nat Commun 4:1-8. 
204. Karlsson E MV, Savage C, Livingston B, Mehle A, Schultz-Cherry S. 2014. Visualizing real-
time influenza virus infection, transmission and protection in ferrets. Nat Commun 6:1-10. 
205. Li J AM, Zeng M. 2013. Engineering influenza viral vectors. Bioengineered 4:9-14. 
206. ves Daoust P, Kibenge F, Fouchier R, van de Bildt M, van Riel D, Kuiken T. 2011. 
Replication of low pathogenic avian influenza virus in naturally infected mallard ducks (Anas 
platyrhnchos) causes no morphological lesions. J Wildl Dis 47:401-409. 
207. Hofle U, van de Bildt M, Leijten L, van Amerongen G, Verhagen J, Fouchier R, Osterhaus 
A, Kuiken T. 2012. Tissue tropism and pathology of natural influenza virus infection in black-
headed gulls (Chroicocephalus ridibundus). Avian Pathol 41:547-553. 
208. Franca M BJ. 2014. Influenza pathobiology and pathogenesis in avian species. Curr Top 
Microbiol Immunol 385:221-242. 
209. Short K RM, Verhagen J, van Riel D, Schrauwen E, van den Brand J, Manz B, Bodewes R, 
Herfst S. 2015. One health, multiple challenges: The inter-species transmission of influenza A 
viruses. One Health 1:1-13. 
210. de Boer G, Back W, Osterhaus A. 1990. An ELISA for detection of antibodies against influenza 
A nucleoprotein in humans and various animal species. Arch Virol 115:47-61. 
211. Williams M, Hooper P, Selleck P, Gleeson L, Daniels P, Westbury H, Murray P. 1998. 
Transmission studies of Hendra virus (equine morbillivirus) in the fruit bats, horses and cats. Aust 
Vet J 76:813-818. 
212. Halpin K, Hyatt A, Fogarty R, Middleton D, Bingham J, Epstein J, Rahman S, Hughes T, 
Smith C, Field H, Daszak P, Group HER. 2011. Pteropid bats are confirmed as the reservoir 
hosts of henipaviruses:  A comprehensive experimental study of virus transmission. Am J Trop 
Med Hyg 85:946-951. 
213. Chakraborty A, Chakravarty A. 1984. Antibody-mediated immune response in the bat, 
Pteropus giganteus. Dev Comp Immunol 8:415-423. 
214. Wellehan J, Green L, Duke D, Bootorabi S, Heard D, Klein P, Jacobson E. 2009. Detection 
of specfic antibody responses to vaccinatin in variable flying foxes (Pteropus hypomelanus). 
Comp Immunol Microbiol Infect Dis 32:379-394. 
215. Cogswell-Hawkinson A, Bowen R, James S, Gardiner D, Calisher C, Adams R, Schountz T. 






216. Munster V, Adney D, van Doremalen N, Brown V, Miazgowicz K, Milne-Price S, 
Bushmaker T, Rosenke R, Scott D, Hawkinson A, de Wit E, Schountz T, Bowen R. 2016. 
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep 
6:21878. 
217. Gerrard D, Hawkinson A, Sherman T, Modahl C, Hume G, Campbell C, Schountz T, 
Frietze S. 2017. Transcriptomic signatures of tacaribe virus-infected Jamaican fruit bats. 
mSphere 2:e00245-00217. 
218. Dick G, Kitchen S, Haddow A. 1952. Zika virus. I. Isolations and serological specificity. Trans 
R Soc Trop 46:509-520. 
219. Macnamara F. 1954. Zika virus:  A report on three cases of human infection during an epidemic 
of jaundice in Nigeria. Trans R Soc Trop 48:139-145. 
220. Weaver S, Costa F, Garcia-Blanco M, Ko A, Ribeiro G, Saade G, Shi P, Vasilaksi N. 2016. 
Zika virus: History, emergence, biology, and prospects for control. Antiviral Res 130:69-80. 
221. Duffy M, Chen T, Hancock W, Powers A, Kool J, Lanciotti R, Pretrick M, Marfel M, 
Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert A, Laven J, Kosoy O, 
Panella A, Biggerstaff B, Fischer M, Hayes E. 2009. Zika virus outbreak on Yap Island, 
Federated States of Micronesia. N Engl J Med 360:2536-2543. 
222. Musso D, Nilles E, Cao-Lormeau V. 2014. Rapid spread of emerging Zika virus in the Pacific 
area. Clin Microbiol Infect 20:O595-596. 
223. Anonymous. 2017. Zika cases and congenital syndrome associated with Zika virus reported by 
countries and territories in the Americas, 2015-2017.  Pan American Health Organization, World 
Health Organization,  
224. Pawitwar S, Dhar S, Tiwari S, Ojha C, Lapierre J, Martins K, Rodzinski A, Parira T, 
Paudel I, Li J, Dutta R, Silva M, Kaushik A, El-Hage N. 2017. Overview of the current status 
of Zika virus pathogenesis and animal related research. J Neuroimmune Pharmacol Epub ahead 
of print. 
225. Moore C, Staples E, Dobyns W, Pessoa A, Ventura L, Neto N, Arena J, Rasmussen S. 2017. 
Characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians. 
JAMA Pediatr 171:288-295. 
226. Eelco F, Wijdicks M, Klein C. 2017. Guillain-Barre Syndrome. Mayo Clin Proc 92:467-479. 
227. Hamel R, Dejarnac O, Wichit S, Ekchariyawat, P, Neyret A, Luplertlop N, Perera-Lecoin 
M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau V, Choumet V, Briant L, 
Despres P, Amara A, Yssel H, Misse D. 2015. Biology of Zika virus infection in human skin 
cells. J Virol 89:8880-8896. 
228. Motta I, Spencer B, Cordeiro da Silva S, Arruda M, Dobbin J, Gonzaga Y, Arcuri I, 
Tavares R, Atta E, Fernandes R, Costa D, Ribeiro L, Limonte F, Higa L, Voloch C, 
Brindeiro R, Tanuri A, Ferreira O. 2016. Evidence for transmission of Zika virus by platelet 
transfusion. N Engl J Med 375:1101-1103. 
229. Rasmussen S, Jamieson D, Honein M, Petersen L. 2016. Zika virus and birth defects - 
reviewing the evidence for causality. N Engl J Med 374:1981-1987. 
230. Froeschl G, Huber K, von Sonnenburg F, Nothdurft H, Bretzel G, Hoelscher M, Zoeller L, 
Trottmann M, Pan-Montojo F, Dobler G, Woelfel S. 2017. Long-term kinetics of Zika virus 
RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case 
report. BMC Infect Dis 17:55. 
231. Martines R, Bhatnagar J, Keating K, Silva-Flannery L, Muehlenbachs A, Gary J, 
Goldsmith C, Hale G, Ritter J, Rollin D, Shieh W, Luz K, Ramos A, Davi H, Oliveria W, 
Lanciotti R, Lambert A, Zaki S. 2016. Notes from the field: Evidence of Zika virus infection in 
brain and placental tissues from two congenitally infected newborns and two fetal losses-Brazil, 
2015. MMWR Morb Mortal Wkly Rep 65:159-160. 
232. Musso D, Roche C, Nahn T, Robin E, Teissier A, Cao-Lormeau V. 2015. Detection of Zika 





233. Paz-Bailey G, Rosenberg E, Doyle K, Munoz-Jordan J, Santiago G, Klein L, Perez-Padilla 
J, Medina F, Waterman S, Gubern C, Alvarado L, Sharp T. 2017. Persistence of Zika virus in 
body fluids-Preliminary report. N Engl J Med Epub ahead of print. 
234. Shepherd R, Williams M. 1964. Studies on viruses in East African bats (Chiroptera). 1. 
Haemagglutination inhibition and circulation of arboviruses. Zoonoses Res 3:125-139. 
235. Simpson D, O'Sullivan J. 1968. Studies on arboviruses and bats (Chiroptera) in East Africa.  II.  
Isolation and haemagglutination-inhibition studies on bats collected in Kenya and throughout 
Uganda. Ann Trop Med Parasitol 62:432-440. 
236. Reagan R, Rumbaugh H, Nelson H, Brueckner A. 1955. Effect of Zika virus and Bwamba 
virus in the cave bat (Myotis lucifugus). Trans Amer Micro Soc 74:77-79. 
237. Ortega J, Castro-Arellano I. 2001. Mammalian Species:  Artibeus jamaicensis. J Mammal 
662:1-9. 
238. Eliasson M, Olsson A, Palmcrantz E, Wilberg K, Inganas M, Guss B, Lindberg M, Uhlen 
M. 198. Chimeric IgG-binding receptors engineered from staphylococcal protein A and 
streptococcal protein G. J Biol Chem 263:4323-4327. 
239. Corman V, Rasche A, Baronti C, Aldabbagh S, Cadar D, Reusken C, Pas S, Goorhuis A, 
Schinkel J, Molenkamp R, Kummerer B, Bleicker T, Brunink S, Eschbach-Bludau M, Eis-
Hubinger A, Koopmans M, Schmidt-Chanasit J, de Lamballerie X, Drosten C, Drexler J. 
2016. Assay optimization for molecular detection of Zika virus. Bull World Health Organ 
94:879-892. 
240. Dudley D, Aliota M, Mohr E, Weiler A, Lehrer-Brey G, Weisgrau K, Mohns M, Breitbach 
M, Rasheed M, Newman C, Gellerup D, Moncla L, Post J, Schultz-Darken N, Schotzko M, 
Hayes J, Eudailey J, Moody M, Permar S, O'Connor S, Rakasz E, Simmons H, Capuano S, 
Golos T, Osorio J, Friedrich T, O'Connor D. 2016. A rhesus macaque model of Asian-lineage 
Zika virus infection. Nat Commun 7:12204. 
241. George K, Sohi I, Dufort E, Dean A, White J, Limberger R, Sommer J, Ostrowski S, Wong 
S, Backenson P, Kuhles D, Blog D, Taylor J, Hutton B, Zucker H. 2017. Zika virus testing 
considerations: lessons learned from the first eighty real-time RT-PCR-positive cases diagnosed 
in New York State. J Clin Microbiol 55:535-544. 
242. Gourinat A, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. 2015. Detection of 
Zika virus in urine. Emerg Infect Dis 21:84-86. 
243. Lanciotti R, Kosoy O, Laven J, Velez J, Lambert A, Johnson A, Stanfield S, Duffy M. 2008. 
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, 
Micronesia, 2007. Emerg Infect Dis 14:1232-1239. 
244. Ma W, Li S, Ma S, Jia L, Zhang F, Zhang Y, Zhang J, Wong G, Zhang S, Lu X, Liu M, Yan 
J, Li W, Qin C, Han D, Qin C, Wang N, Li X, Gao G. 2016. Zika virus causes testis damage 
and leads to male infertility in mice. Cell 167:1511-1524. 
245. Govero J, Esakky P, Schaeffer S, Fernandez E, Drury A, Platt D, Gorman M, Richner J, 
Caine E, Salazar V, Moley K, Diamond M. 2016. Zika virus infection damages the testes in 
mice. Nature 540:438-442. 
246. Lazear H, Govero J, Smith A, Platt D, Fernandez E, Miner J, Diamond M. 2016. A mouse 
model of Zika virus pathogenesis. Cell Host Microbe 19:720-270. 
247. Hirsch A, Smith J, Haese N, Broeckel R, Parkins C, Kreklywich C, DeFilippis V, Denton M, 
Smith P, Messer W, Colgin L, Ducore R, Grigsby P, Hennebold J, Swanson T, Legasse A, 
Axthelm M, MacAllister R, Wiley C, Nelson J, Streblow D. 2017. Zika virus infection of 
rhesus macaques leads to viral persistence in multiple tissues. PLoS Pathog 13:e1006219. 
248. McCrae A, Kirya B. 1982. Yellow fever and Zika virus epizootics and enzootics in Uganda. 
Trans R Soc Trop 76:552-562. 
249. Wolfe N, Kilbourn A, Karesh W, Rahman H, Bosi E, Cropp B, Andau M, Spielman A, 
Gubler D. 2001. Sylvatic transmission of arboviruses among bornean orangutans. Am J Trop 





250. Vorou R. 2016. Zika virus, vectors, reservoirs, amplifying hosts, and their potential to spread 
worldwide: what we know and what we should investigate urgently. Int J Infect Dis 48:85-90. 
251. Darwish M, Hoogstraal H, Roberts T, Ahmed I, Omar F. 1983. A sero-epidemiological 
survey for certain arboviruses (Togaviridae) in Pakistan. Trans R Soc Trop 77:442-445. 
252. Ragan I, Blizzard E, Gordy P, Bowen R. 2017. Investigating the potential role of North 
American animals as hosts for Zika virus. Vector Borne Zoonotic Dis 17:161-164. 
253. Faye O, Freire C, Lamarino A, Faye O, de Oliveira J, Diallo M, Zanotto P, Sall A. 2014. 
Molecular evolution of Zika virus during its emergence in the 20th century. PLos Negl Trop Dis 
8:e2636. 
254. Schountz T. 2014. Immunology of bats and their viruses: challenges and opportunities. Viruses 
6:4880-4901. 
255. Bowen M, Peters C, Nichol S. 1996. The phylogeny of New World (Tacaribe complex) 
arenaviruses. Virology 219:285-290. 
256. Gard G. 2009. Personal communication. 
257. Allison L, Salter M, Kiguwa S, Howard C. 1998. Analysis of the glycoprotein gene of Tacaribe 
virus and neutralization-resistant variants. J Gen Virol 72:2025-2029. 
258. Franze-Fernandez M, Zetina C, Lapalucci S, Lucera M, Bouissou C, Lopez R, Rey O, 
Daheli M, Cohen G, Zakin M. 1987. Molecular structure and early events in the replication of 
Tacaribe arenavirus S RNA. Virus Res 7:309-324. 
259. Harmon B, Kozina C, Maar D, Carpenter T, Branda C, Negrete O, Carson B. 2013. 
Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for 
anti-interferon activity. J Biol Chem 288:8702-8711. 
260. Schountz T, Calisher C, Richens T, Rich A, Doty J, Hughes M, Beaty B. 2007. Rapid field 
immunoassay for detecting antibody to Sin Nombre virus in deer mice. Emerg Infect Diseases 
13:1604-1607. 
261. Easterbrook J, Zink M, Klein S. 2007. Regulatory T cells enhance persistence of the zoonotic 
pathogen Seoul virus in its reservoir host. Proc Natl Acad Sci 104:15502-15507. 
262. Fulhorst C, Ksiazek T, Peters C, Tesh R. 1999. Experimental infection of the cane mouse 
Zygodontomys brevicauda (family Muridae) with guanarito virus (Arenaviridae), the etiologic 
agent of Venezuelan hemorrhagic fever. J Infect Dis 180:966-969. 
263. Fulhorst C, Milazzo M, Bradley R, Peppers L. 2001. Experimental infection of Neotoma 
albigula (Muridae) with whitewater arroyo virus (Arenaviridae). Am J Trop Med Hyg 65:147-
151. 
264. Justines G, Johnson K. 1969. Immune tolerance in Calomys callosus infected with Machupo 
virus. Nature 222:1090-1091. 
265. Schountz T, Prescott J, Cogswell A, Oko L, Mirowsky-Garcia K, Galvez A, Hjelle B. 2007. 
Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc 
Natl Acad Sci 104:15496-15501. 
266. Halpin K, Hyatt A, Fogarty R, Middleton D, Bingham J, Epstein J, Rahman S, Hughes T, 
Smith C, Field H, Daszak P, Group HER. 2011. Pteropid bats are confirmed as the reservoir 
hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop 
Med Hyg 85:946-951. 
267. Paweska J, van Vuren J, Masuma J, Leman P, Grobbelaar A, Birkhead M, Clift S, 
Swanepoel R, Kemp A. 2012. Virological and serological findings in Rousettus aegyptiacus 
experimentally inoculated with vero cells-adapted hogan strain of Marburg virus. PLoS One 
7:e45479. 
268. Schountz T, Prescott J. 2014. Hantavirus immunology of rodent reservoirs: current status and 
future directions. Viruses 6:1317-1335. 
269. Easterbrook J, Klein S. 2008. Immunological mechanisms mediating hantavirus persistence in 





270. McGuire A, Miedema K, Fauver J, Rico A, Aboellail T, Quackenbush S, Hawkinson A, 
Schountz T. 2016. Maporal hantavirus causes mild pathology in deer mice (Peromyscus 
maniculatus). Viruses 8:pii: E286. 
271. Spengler J, Haddock E, Gardner D, Hjelle B, Feldmann H, Prescott J. 2013. Experimental 
Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous 
rodent host PLoS One 8:e55310. 
272. Fulhorst C, Bowen M, Salas R, Duno G, Utrera A, Ksiazek T, De Manzione N, De Miller E, 
Vasquez C, Peters C, Tesh R. 1999. Natural rodent host associations of Guanarito and pirital 
viruses (Family Arenaviridae) in central Venezuela. Am J Trop Med Hyg 61:325-330. 
273. Morrison D. 1980. Foraging and day-roosting dynamics of canopy fruit bats in Panama. J 
Mammal 61:20-29. 
274. Kollars T, Oliver J, Durden L, Kollars P. 2000. Host association and seasonal activity of 
Amblyomma americanum (Acari: Ixodidae) in Missouri. J Parasitol 86:1156-1159. 
275. Fang J, Wang X, Mu S, Zhang S, Dong D. 2015. BGD:  A database of bat genomes. PLoS One 
10:e0131296. 
276. Shaw T, Srivastava A, Chou W, Liu L, Hawkinson A, Glenn T, Adams R, Schountz T. 2012. 
Transcriptome sequencing and annotation for the Jamaican fruit bat (Artibeus jamaicensis). PLoS 
One 7:e48472. 
277. Bioinformatics B. 2017. https://http://www.bioinformatics.babraham.ac.uk/projects/fastqc/. 
Accessed  
278. Bolger A, Lohse M, Usadel B. 2014. Trimmomatic:  a flexible trimmer for Illumina sequence 
data. Bioinforma 30:2114-2120. 
279. Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, He G, Chen Y, Pan Q, Liu Y, Tang J, Wu G, 
Zhang H, Shi Y, Liu Y, Yu C, Wang B, Lu Y, Han C, Cheung D, Yiu S, Peng S, Xiaoqian Z, 
Liu G, Liao X, Li Y, Yang H, Wang J, Lam T, Wang J. 2012. SOAPdenovo2: an emperically 
improved memory-efficient short-read de novo assembler. GigaScience 1:18. 
280. Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for 
genome assemblies. Bioinforma 29:1072-1075. 
281. Kapusta A, Suh A, Feschotte C. 2017. Dynamics of genome size evolution in birds and 
mammals. Proc Natl Acad Sci 114:E1460-E1469. 
 
 
 
 
 
